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The Road Not Taken 
 
Two roads diverged in a yellow wood, 
And sorry I could not travel both 
And be one traveler, long I stood 
And looked down one as far as I could 
To where it bent in the undergrowth; 
 
Then took the other, as just as fair, 
And having perhaps the better claim 
Because it was grassy and wanted wear, 
Though as for that the passing there 
Had worn them really about the same, 
 
And both that morning equally lay 
In leaves no step had trodden black. 
Oh, I marked the first for another day! 
Yet knowing how way leads on to way 
I doubted if I should ever come back. 
 
I shall be telling this with a sigh 
Somewhere ages and ages hence: 
Two roads diverged in a wood, and I, 
I took the one less traveled by, 
And that has made all the difference. 
 
 






If you can't fly, then run. 
If you can't run, then walk. 
If you can't walk, then crawl. 
But whatever you do, you have to keep moving forward. 
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The physical and computational modeling of distributed fluid flow to vascular beds 
remains a challenging issue. The computational resources required, and the complexity of 
capillary networks makes modeling infeasible. The resolution limits of manufacturing 
techniques make physical models difficult to fabricate and manipulate under 
experimental conditions. As such, an in vitro polymer construct was developed with 
structural properties of small arteries and the bulk flow characteristics of capillary beds. 
Rapid prototyping and scaffolding techniques were used to fabricate vascular trees 
amendable to scaffold compartments. Several scaffold architectures were evaluated to 
achieve target fluid flow characteristics for implementation in a dynamic contrast-
enhanced computed tomography (DCE-CT) imaging phantom and endothelial cell 
bioreactor, respectively. Experimental flow measurements were compared to 
measurements from computational simulations. In addition, the flow-induced shear stress 
across the construct was modeled to identify the optimal settings within the bioreactor. In 
addition, the cytocompatibility of the polymer construct was optimized. 
Vascular trees were reliably fabricated to achieve arteriole-like flow. Rapid prototyped 
polycaprolactone (PCL) scaffolds produced distinct differential flow ranges, marked by a 
decrease in flow rate across the network. The construct served as a viable dynamic flow 
phantom capable of generating signals typical of organs imaged with DCE-CT. 
Furthermore, simulations of the construct as a bioreactor provided guidance on the 
boundary conditions required for stimulatory shear stress within the scaffolds. Under 
static conditions, endothelial cells were cultured on PCL scaffolds modified with extra-
cellular matrix mimicking biological and chemical agents. All surface modifications 
exhibited similar cell proliferation and function. However, the Arg-Gly-Asp (RGD) 
surface-modified constructs exhibited an optimal spatial distribution for future 
endothelial cell bioreactor investigations.  
xxvii 
 
This work demonstrates a method for modeling and physically simulating a bifurcating 
vascular tree adjoined to scaffold compartments with tunable flow, for application to 
perfusion imaging and in vitro tissue engineering (tissue and tumors).   
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1.1  PROBLEM STATEMENT 
With over 20 invasive sites, including vital organs such at the lungs, brain, and liver, 
cancer causes the greatest mortalities worldwide [1-2]. Over the last three decades, there 
has been increased research focus on prevention, detection, treatment and control of 
cancer [3-6]. The impact of molecular cancer biology discoveries is evident by the 
increase in 5-year patient survival rates, rising from by 51.4 to 68.5 percent [7-8]. The 
greatest increase in survival rates are seen in patients with cancer of the blood (and 
components), bone marrow, tongue, colorectal, kidney and renal system, tonsil and 
oropharynx, and Non-Hodgkin lymphoma [7-8]. However, there has been less of a 
marked increase (in the lungs and brain) and in some cases decreased survival rates (in 
the liver, pancreas, larynx and uterus) and increased incidents (i.e. childhood cancer, 
esophagus, kidney and melanoma of the skin) for some disease sites [7-8]. The impact of 
cancer prevention, detection and treatment can be improved with new and more effective 
approaches. The next stage of treatment therapies is currently evolving through molecular 
targeted therapy and applications of biomarkers, nanomedicine and various forms of 
“personalized” medicine and in vitro three-dimensional models [9-14]. 
Within the perfusion imaging and tissue engineering, the adoption of biomarkers and in 
vitro three-dimensional models incorporating seeded cells and fluid is under 
consideration to maximize the effectiveness of existing therapies and research platforms. 
Despite promising advancements in three-dimensional tissue engineering, the need for in 
vitro culture models remains a prevalent issue limiting the effectiveness of large 
engineered constructs in the promotion of tissue in-growth. Review papers addressing 
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topics such as drug discovery, delivery and drug-induced resistance acknowledge the 
need for culture models more complex than the typical two-dimensional in vitro systems 
[23]. A dynamic endothelial cell bioreactor can provide a platform for studying 
angiogenesis on clinically relevant scaffold dimensions and future co-cultures with 
normal cells or cancer cells for the generation of in vitro solid tissue or tumors, 
respectively. 
Within radiation therapy treatment assessment, there is significant variability in perfusion 
imaging protocols used to acquire, post-process and extract perfusion metrics from image 
datasets [17-19]. The validation of perfusion metrics via a dynamic phantom will allow 
clinicians to make better generalizations of imaging biomarkers and facilitate longitudinal 
multicenter clinical trials [20-22]. Thus, the need for in vitro fluid bioreactors in tissue 
engineering and in vitro dynamic flow phantoms in radiation oncology, converge on the 
need to create three-dimensional branching networks supporting distributed fluid flow. 
The size scale and vast amount of parallel networking of capillary, however, makes the 
creation of exact in vitro anatomic flow networks (i.e. artery, arterioles, capillaries, 
venules and veins), both computationally and physically infeasible, due to the 
computational complexity and extensive multiscale fabrication that is required [15-6]. 
The complexity of modeling microcirculation (defined as venule, arteriole, capillary sized 
vessels, 8-300 μm) has the challenge of appropriately representing anatomical 
architecture and biofluid-mechanical forces (i.e. flow rate and pressure drops). For 
noninvasive imaging procedures, a typical 1-mm voxel resolution is two orders of 
magnitude larger than a capillary. The following thesis addresses the challenges in 
creating computational and physical models of anatomical and hemodynamic 
microcirculatory properties by developing an integrated branching network/modular 




1.1.1    Background 
1.1.1.1   Quality Assurance (QA) of Perfusion Imaging 
Perfusion imaging is currently under investigation as an imaging biomarker indicative of 
tumor aggressiveness, and tissue response to treatments, such as focal irradiation [24-27]. 
Dynamic Contrast Enhanced - Computed Tomography (DCE-CT) imaging is one method 
of perfusion imaging; it involves the acquisition of a time series of single-slice images 
after the injection of a contrast agent into a patient. The presence of agent allows for the 
temporal and spatial localization of blood perfusion in the volume of interest (VOI). The 
acquired images are analyzed to extract perfusion (regional blood supply to tissue) 
metrics such as blood flow and volume (Fig. 1.1). [27-34]. 
 
Figure 1.1 Dynamic Contrast-Enhanced images. Color-coded perfusion maps overlaid on 
corresponding CT images to denote spatial variation in perfusion. The black contour outlines the 
tumor region, while the white contours outline regions of interest to be quantified using post-
processing techniques [35].  
 
There is significant variability in the DCE and other imaging protocols used to acquire 
image datasets and in the post-processing algorithms used to process image data to 
extract perfusion metrics. The quantification of perfusion from image analysis is a subject 
of concern, as there is significant variability in DCE acquisition, processing and 
quantitative metric extraction due to inherent scanner/modality variability, variation in 
acquisition protocols, spatial and temporal resolution, signal-to-noise ratio, acquisition 
delays and post-processing methods. Studies have considered (i) the quantification and 
minimization of measurement variability [29,31], (ii) the discriminatory power of 
extracted values [34], and (iii) the accuracy of measurements in comparison to “gold 
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standard” methods (radio-labeled microspheres, O15-water Positron Emission 
Tomography scans) [27, 32-33], and test-retest and reproducibility cases [32]. 
Unfortunately, these studies evaluated different DCE metrics, in various tissue locations, 
in human and animal experiments. This lack of standardization prevents comparisons 
among studies using the same or different modalities, as the variability in sensitivity of 
metrics such as blood flow volume has not been quantified. These measures of 
comparison and reproducibility are useful, but do not provide a repeatable in vitro 
method that is easy to implement across institutions, such as with physical, imaging 
phantoms. These phantoms provide controllable architectures and fluid environments, 
across which changes in fluid flow can be assessed under typical, clinical imaging 
protocols and systems. 
 
1.1.1.2  Angiogenesis in Engineered Tissue 
Under healthy conditions, angiogenesis is marked by the following stages: endothelial 
cell (EC) migration and differentiation, tubule formation, and vascular network 
maturation, remodeling, and regression.  [36-37]. This physical phenomenon, called 
angiogenesis, is the process by which new capillary blood vessels are grown, either as 
offshoots or as splits from existing vessels [38] (see Fig. 1.2).  Angiogenesis is critical 
step to the sustainment of healthy regenerating tissue and newly implanted tissues, in 
addition to several diseases, such as cancer [37-38]. Tumor angiogenesis is marked by 
initiation and network formation, but lacks the organization and maturation of vessels 
characteristic of normal vascular networks [39]. But, for both those interested in tissue 
regeneration (i.e. bone and cardiovascular) and cancer pathology, re-creating a favorable 
environment for EC proliferation is key to three-dimensional tissue models. However, 
overcoming the mass transfer limitations in three-dimensional engineered tissues, greater 




Figure 1.2 Process of angiogenesis [41]. 
 
Currently, successful tissue replacement therapies are limited to avascular tissues such as 
the epidermis of skin and nasal septae cartilage [42], or thin tissues (less than 2 mm) such 
as adipose tissue [43] and smooth muscle [44]. These autologous grafted tissues are 
supplied oxygen by diffusion. However, oxygen absorption is a limiting factor in cell 
viability [45], with necrosis normally occurring when oxygen must diffuse over a 
distance greater than 40-150 μm [42, 46]. Complete oxygen depletion, and resultantly 
necrosis, occurs within 24 hours of engineered tissue implantation causing donor site 
morbidity, due to inadequate prevascularization and a slow rate of angiogenesis (upwards 
of 6 days) [42]. Larger, more complex, engineered tissue requires adequate 
vascularization to sustain cell viabilityError! Bookmark not defined.. Successful 
ascularization of large tissue involves a distributed flow of blood, via capillary networks, 
to regions of tissue, enabling a high rate of nutrient absorption and waste clearance 
between the cell and capillary [40].  
 
1.2  RESEARCH OBJECTIVES 
This research study investigates the physical and computational modeling of distributed 
flow within an in vitro vascular network system, through the adoption of rapid 
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prototyping (RP) and tissue scaffolding techniques. 
 
1.2.1  Aim One 
Hypothesis: A computer-generated, rapid prototyped bifurcating vascular network can 
model physiologically realistic flow rates. 
Aim 1: To design the architecture and evaluate the flow through vascular trees to achieve 
bulk flow properties (in terms of drop in flow rate and/or velocity) characteristic of an in 
vivo blood supply. To investigate the potential of scaffolds with random and well-
organized pore structures to generate distinct differential flow ranges. 
1.2.1.1  Aim One Rationale 
While not yet translated to complex physical forms, digital models of vascular structures 
have been developed (Fig. 1.3). Karch et al. proposed an optimization algorithm for 
generating 3-D coronary vascular trees based on idealized growth principles [47-48]. 
Similarly, Kretowski et al. presented a more general approach to the modeling of 3-D 
renal and hepatic arterial trees [49-50]. These algorithms are based on the early works of 
Murray and Zamir that explored arterial tree morphometry, bifurcation laws (for radii and 
flow) and work minimization (in terms of blood volume) [51-52]. Computational studies 
on hemodynamic performance and CT dataset comparisons between real and simulated 
networks indicate that even with an intrinsic anatomic variability in computer generated 
trees, these networks behave very similar to in vivo vasculature [53-55].  
 
Figure 1.3 Simulated hepatic vascular network based on optimization algorithm [55]. (Left) Hepatic 




Table  A.1 (see Appendix A) summarizes the potential of rapid prototyping to create 
physical models from digital drawings. Since its advent into the medical arena, in the 
early 1990s, RP technologies utilizing techniques such as SLS have been used to recreate 
human anatomy from image (MRI and CT) data [56-57]. Clinicians then use these 
patient-specific physical models as a visualization tool to more accurately plan treatment, 
practice and teach surgical procedures and formulate diagnoses [58-63]. As well, 
researchers have used RP to fabricate patient-specific models to study disease states, 
anatomical pathologies and the efficacy of medical devices [64-66].  
There have been hemodynamic studies of airway passages modeled as hollowed 
cylindrical tubes; these have been limited to cylindrical tubes with an inner diameter (i.d.) 
of 1-5 cm [67-69]
Error! Bookmark not defined.
. Janssens et al. modeled the nose-throat (i.d. of 
.2-3 cm) passageway in infants to better understand and quantify aerosol deposition in the 
lungs [67]. Clickenbeard et al. used SLS to build tracheobronchial hollow airway models 
for inhaled aerosol drug studies [69]. Within this model, most airways had an i.d. of 1-2 
mm; some airways were slightly smaller than 1 mm. The papers reported clinically 
relevant results based on their models.  
Studies that have attempted to model microcirculation have been unable to fabricate 
designs on the order of 5-100 microns due to RP resolution limits. As a result, dialysis 
cartridges with parallel fibers (i.d. of 200 µm) or polydimethylsiloxane (PDMS) derived 
microchannels (i.d. of 900 µm) have been used to mimic capillary networks [70-72]. 
Some studies have utilized microfabrication techniques. Wang and Hsu used BioMEMS 
technology to fabricate bifurcating vessels with an i.d. of 6 µm, to study velocity profiles 
acting up ECs cultured on the scaffold [73]. Wang et al. studied the use of RP to create 
scaffolds of hepatocytes that could be plated with bioartificial cells [74], to ultimately 
grow an artificial liver. Similarly, Lee et al. modeled an artificial liver sinusoidal for 
hepatocyte culturing using softlithography and replicate molding with PDMS) [75]. 
Yamada et al. recently reported a new technique for microfabricating structures as fine as 




1.2.1.2  Aim One Proposed Solution 
The proposed work uses porous scaffolds with pore sizes less than 1 mm to produce 
variable flow resistances that result in differential flow through the scaffold. Civil 
engineers have taken the approach of modeling the porous media as organized cylindrical 
structures, whereby the porosity and intrinsic permeability can be directly estimated using 
Darcy’s Law [77]. Subsequently, analytical expressions derived from the Navier-Stokes 
law are used to define flow properties [78-79]. In the past few years, tissue engineers 
have adopted this theoretical framework and CFD to evaluate scaffold intrinsic 
permeability and resulting flow characteristics within bioreactor, drug delivery and tissue 
regeneration studies [80-81]. Existing models of fluid flow through scaffolds have been 
limited to stand-alone scaffolds that are not adjoined to feeder networks. 
 
1.2.2  Aim Two 
Hypothesis 2: A physical, dynamic flow phantom with anatomical features and bulk flow 
characteristic of imaged tissue can provide a framework for the quality assurance of 
DCE-CT. 
Aim 2: To prototype a distributed flow phantom that models vessel branching and signals 
visible with DCE-CT.  
1.2.2.1  Aim Two Rationale 
Generally, physicists perform calibration and QA testing on imaging systems using static 
phantoms. Phantoms provide a controlled set-up for delineating deviations from a desired 
output. By simulating an idealized (in terms of branching and symmetry) in vivo vascular 
anatomy, the phantom will model characteristics (vessel bifurcations and diameter size) 
that affect flow rate [82].. The polymer vascular network and scaffold components are 
used to achieve i) a CT-compatible phantom with features less than the resolution 
(approximately less than 1 - 2 mm) of clinical CT, ii) typical contrast-enhancement 
curves and iii) distinct differential flow ranges through the integration of branching 
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networks with porous scaffold compartments. The prototype phantom provides a 
construct for comparing DCE imaging-measured flow rates to experimental and/or 
computational-based measurements. 
Some of the previously implemented flow phantoms have simplified the vascular tree 
geometry by only using single channel, cylindrical tubes [83], or parallel fibers from 
commercial dialysis cartridges [71]. On the opposite end, more complex fresh organ-
based flow phantoms demonstrated a short lifetime [84], while preserved organs were 
sensitive to handling and fixation [85]. Recently, Driscoll et al. developed a re-usable 
dynamic phantom with an internal coiled structure that allowed for variable inputs to 
reproduce imaging data with time-attenuation curves similar to patient-derived data [86]. 
The phantom does not evaluate flow within a piping system that is below the resolution 
of the CT system, as characteristic of in vivo imaging of arterioles, venules and 
capillaries. Instead, the phantom evaluates the bulk flow rates over a VOI encompassing 
large, arterial-sized tubes.. Fig. 1.4 illustrates the most complex dynamic phantoms 
presented in the literature. 
 
Figure 1.4 (a) Porcine ex vivo liver phantom [85]. (b) Phantom fabricated using fused deposition 
model [86]. (c) Single-slice image collected during DCE scan with labeled vasculature [85]. (d) Single 





1.2.2.2  Aim Two Proposed Solution 
The proposed quality assurance phantom seeks to establish a reliable and reproducible 
method to compare flow measurements acquired via DCE-CT imaging.  As well, through 
the adoption of RP and scaffolding techniques, bulk perfusion characteristics of flow 
greater than and below the resolution of the typical CT scanner is evaluated for a given 
input boundary conditions within a physiological flow range.. By altering the porosity 
and tortuosity of scaffolds within a vascular phantom, we can estimate the flow rates 
within a closed-system vascular phantom, and fine tune scaffold characteristics to achieve 
high and low differential flow changes. 
 
1.2.3  Aim Three 
Hypothesis 3:  A biocompatible vascular tree adjoined to large porous scaffolds can be 
optimized to support EC attachment and proliferation. 
Aim 3: To optimize the attachment and proliferation conditions of endothelial cells 
seeded on large scaffolds within an in vitro endothelial cell bioreactor.  
 
1.2.3.1  Aim Three Rationale 
Reconstructive surgeries often require the implantation of new tissue into an avascular 
region, where an adequate nutrient supply cannot be sustained solely by diffusion, but 
instead requires an alternate source of perfusion. There are several techniques actively 
studied that seek to expedite the angiogenesis process [87-89] through (1) the 
implantation of prevascularized engineered or avascular tissue [90-93] that can be pre-
seeded with ECs and controlled-release angiogenic factors [94-97]
 
and (2) in vitro 
endothelialized vessels grown on microdevices [98-103], microfluidic devices [104], 
bioreactors [105-106],
 
or capillary channel fibers or microtubes [1-07-108]. In vitro flow 
perfusion bioreactor studies report that a continuous controlled flow of medium provides 
mechanical stimulation and increased mass transport to support cell proliferation and 
differentiation across porous scaffolds for bone regeneration and angiogenesis [109-112]. 
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These successes have been shown for scaffolds 6-8 mm in diameter and 2-3 mm in 
height. Recently promulgated works by Koch et al. and Arano et al. have demonstrated 
perfusion for larger (6-12 mm diameter and 10-12 mm height) scaffolds [113-114].  
In the area of prevascularized engineered tissue, the arteriovenous loop (AVL) has 
successfully utilized intrinsic vascularization to support new tissue growth within a loop 
construct. Mian et al. and Polykandriotis et al. showed that via angiogenic sprouting, an 
arteriovenous loop (AVL) supported new tissue growth within a loop construct: a femoral 
artery anastomosed to a vein graft and femoral vein [115]. Their AVL studies showed 
that pre-vascularization of scaffolds resulted in increased vessel in-growth towards the 
core of the avascular tissue and subsequently an increased wall shear rate within the loop 
construct. The AVL studies demonstrated that intrinsic prevascularization of scaffolds 
resulted in an increase in perfusion volume, and subsequently an increase in wall shear 
rate and angiogenesis with engineered constructs. However, AVLs did not provide 
distributed flow to a tissue; instead, perfusion is concentrated around the outer boundaries 
of a tissue region. Using an in vivo approach, Laschke et al. implanted a three-
dimensional poly-lactic-glycolic (PLGA) scaffold into a host mouse for 20 days to 
generate microvascular in-growth into the construct [116]. The scaffold was then 
removed and placed into a recipient mouse.  A significant increase in blood perfusion and 
wall shear stress was observed over the 14 day study, with reperfusion of the implant 
occurring within 3-6 days. An AVL study by Hofer et al. reported a 23% increase in 
volume density and the appearance of arterioles within 10 days, along with the 
appearance of venules after 14-21 days [117].  
 
1.2.3.2  Aim Three Proposed Solution 
In the aforementioned studies, it has been shown that 1) thick scaffolds can be adequately 
supplied nutrients/oxygen within a perfusion bioreactor, 2) constructs anastomosed to 
existing vasculature can successfully shunt flow towards a construct, and 3) pre-
vascularized constructs promote angiogenesis faster once implanted into a host. The 
limitations of these existing methods include: the poor nutrient supply to the core of 
implantable constructs or the inability to implant successful in vitro bioreactor setups. 
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These studies support aim three’s approach to a bioreactor design, which seeks to 
promote EC growth into tubules, within an implantable vascular network that offers 
distributed flow across scaffolds, for future in vitro or in vivo applications. A successful 
angiogenesis bioreactor system maintains EC viability and proliferation on scaffolds that 
are embedded within the vascular network construct. As such, the flow conditions, 
cytocompatibility and distribution of ECs cultured in the bioreactor must be optimized, as 
the first step in the development of a viable angiogenesis bioreactor. 
 
1.3  OVERVIEW OF DISSERTATION 
Fig. 1.5 provides a schematic outline of the objectives for Chapters 2 through 6. Chapter 
2 provides a review of the anatomical and bulk flow characteristics of human 
microvascular system that drove the design of the phantom and bioreactor. The 
computer-generated design for the phantom and bioreactor is described, along with the 
scaffolding techniques that allowed for control over flow characteristics within the 
dynamic systems. Chapter 3 reveals the final design of the dynamic imaging phantom 
system. The reliability and spatial resolution of the fabrication method used to generate 
the vascular tree and the investigated scaffold (types: solvent casted/salt leached, inverted 
colloidal crystal and SLS) components are characterized. The intrinsic permeability and 
differential flow ranges achieved by the different scaffold architectures are compared. 
Finally, the utility of the phantom was demonstrated through a DCE-imaging study, 
wherein time-contrast attenuation curves were acquired and examined. Chapter 4 
deconstructs the dynamic imaging system in order to perform computational fluid 
modeling on each component. The mixing of fluids and the uniformity of flow across the 
system was evaluated. Differential flow measurements from a porous jump and porous 
geometry model were compared to experimental differential flow measurements in 
Chapter 3, in order to confirm the flow changes within within the phantom. The scaffolds 
incorporated into the phantom described in Chapter 3 are widely used as bone scaffolds 
for tissue engineering. As such, the phantom design was transformed into an in vitro, 
perfusion bioreactor in Chapters 5 and 6. In Chapter 5, the flow-induced shear stress 
distribution across the scaffold housed within the cell bioreactor design was evaluated for 
13 
 
two scaffold geometries (spherical and orthogonal pores) that have been demonstrated to 
successfully grow bone (chosen to facilitate future work that may co-culture osteoblasts, 
then implant in subcutaneous mouse model). The scaffold geometry and the associated 
inlet velocity that produced the tightest range of shear stress within the physiological 
range required for EC stimulation was used in the in vitro dynamic study. Chapter 6 
explores whether a surface modified-SLS PCL scaffold (addition of vascular endothelial 
growth factor, sodium hydroxide hydrolysis or extracellular matrix adhesion protein) can 
enhance EC attachment, proliferation and function under static conditions. Based on the 
identified optimal surface modification, Chapter 6 then presents a preliminary study on 
the proliferation and cell function of macrovascular ECs under in vitro dynamic 
bioreactor conditions on SLS PCL scaffolds. Based on the limitations of visualizing 
angiogenesis within the designed bioreactor, Chapter 7 reviewed the existing imaging 
techniques available for monitoring angiogenesis, and more specifically tubulation, 
within three-dimensional cell culture constructs (scaffolds, microfluidic devices and 
bioreactors). Finally, Chapter 8 provides the conclusions from this thesis and describes 





Figure 1.5 Flow diagram of dissertation goals. 
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CHAPTER 2  
 
 
Engineering an In Vitro Distributed Flow System  
 
2.1 INTRODUCTION 
This chapter investigates the design and fabrication of a polymer construct that distributes 
fluid flow across a volume via a vascular tree structure. Bifurcation laws and 
optimization rules are adopted in the design of computer generated vascular trees. Rapid 
prototyping techniques available for fabricating small hollow cylinders are assessed. The 
potential of polymer porous constructs (scaffolds) with random and well-organized pore 
structures to model disparate changes in flow rates is discussed.  
 
2.2  BACKGROUND 
2.2.1  Structure and Bio-fluid Mechanics of Blood and Blood Vessels 
The human vascular system circulates blood through the body at an average rate of 5 
L/min [1]. Blood pumped out of the heart through arteries supplies organs with 
oxygenated blood and nutrients in exchange for cellular waste. Arteries branch into 
arterioles, which connect to capillaries, which facilitates active and passive transport of 




Figure 2.1 (a) Schematic illustrates the structural complexity of blood vessel networks from 
artery/vein down to capillaries [2]. (b) Overview of circulatory physiology, in terms of vessel, 
diameter, pressure, cross-sectional area and velocity [3]. (Headings shown in the graph on the top left 
apply to all four plots: elastic arteries, muscular arteries, arterioles, capillaries, venules, veins, vena 
cava.) 
 
The anatomical architecture of the circulatory system shunts fluid from a single source 
through a sequence of serial and parallel vessels whose geometry and composition dictate 
hemodynamic properties. Each vessel type has a diameter size, wall thickness and 
composition that uniquely complement its function in the circulatory system [1]. Based 
on values presented by Boron and Boulpaep [1] and Feher [7], Table 2.1 quantifies a 





wall shear stress (WSS, dyne/cm
2
), pressure drops (∆p, mm Hg) and flow velocity (axial 
and secondary, v, cm/s). Blood flow produces mechanical forces on endothelial cell 
(ECs) lining the surface of blood vessels. WSS (dyne/cm
2
) acts tangentially on the 
surface of ECs. Under physiological conditions, shear stress values within the 1-20 
dyne/cm
2
 range support EC growth and activity [4-6]. 
 
Table 2.1 Summary of average/range in vivo values that define blood vessel structures and 
mechanics, which influence physiological function [1,7]. 
 small 
artery 
arteriole capillary venule small 
vein 
inner diameter [mm] 2-4 0.03 0.006 0.02 5 
wall thickness [mm] 1 - 2 0.02 0.001 0.002 0.5 - 1.5 
cross sectional area [mm2] 0.79 7.1 x 10-5 2.8 x 10-5 7.1 x 10-5 0.79 
aggregate flow [ml/s] 83 
single flow [ml/s] 0.01 4 x 10-6 8 x 10-9 2.1 x 10-6 1 x 10-2 
velocity [m/s] 1.3 x 10-3 6 x 10-3 3 x 10-4 1 x 10-3 2.6 x 10-4 
pressure [mm Hg] 95 60 15 - 35 7-15 15 
shear rate [1/s] > 100 < 100 > 100 
 
The blood that circulates through these vessels is characterized as a heterogeneous 
solution composed of plasma, red blood cells (RBC) and white blood cells. It is 
considered a Newtonian fluid under the following conditions [8-11]: 
 shear rates greater than 100/s;  
 hematocrit levels greater than 20% (adult normal range lies between 37-50%); 
 vessel diameters greater than 800 µm. 
 
Outside of these conditions, blood behaves as a non-Newtonian fluid due to shear-
dependent changes in viscosity that occur as RBCs assemble along the center axes of 
small blood vessels in vessels of decreasing diameter size (known as the Fahraeus-
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Lindqvist effect) (see Fig. 2.2) [12].  This phenomenon is especially evident in 
capillaries, as the inner diameters (i.d.) of these vessels are approximately the same 
diameter as RBCs. The decreasing viscosity associated with decreased hematocrit levels 
in small vessels is characterized as a shear thinning, non-Newtonian fluid. 
 
Figure 2.2 Plot of the dynamic viscosity of blood and plasma across shear rates illustrates the 
assembly of RBCs. Plasma (devoid of RBC) is Newtonian [13]. 
 
2.3 METHODOLOGY 
2.3.1 Computer Generated Vascular Trees 
In vivo observations and formulated principles on vascular branching serve as the basis 
for the implemented three-dimensional vascular network algorithm [14-16]. Two 
investigating groups pioneered the digital modeling of coronary, renal and/or hepatic 
arterial trees (i.d. > 1 mm) [14,16]. Karch et al. and Kretowski et al. presented algorithms 
for generating vascular trees (arterial, renal and hepatic) based on idealized growth 
principles [14-18]. Both algorithms optimized the structural and hemodynamic properties 
of vascular trees based on the following: 
- Each branch is a rigid, hollow, symmetrical cylinder, with some wall thickness; 
- All parent branches give rise to two offspring branches; 
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- Each branch is contained within a pre-defined volume; 
- Branching is randomized, with each coordinate within the given volume equally 
likely to be chosen; 
- The bifurcation rule (Murray’s Law), where r is the radius of the vessel and r > 0 
[19]: 
        
                  
                   
  Equation 2.1 
 
- If a new branch lies within n millimeters of an existing branch, then the new 
branch is destroyed; where the value of n is pre-defined— no branches may 
intersect; 
- Blood is considered an incompressible homogenous Newtonian fluid exhibiting 
laminar flow and governed by Poiseuille’s law [20]:  
           
    
 ,  Equation 2.2 
where ΔP is the pressure drop across the cylinder, Q is the volumetric flow rate , l 
is the  length of cylinder and μ is the fluid’s dynamic viscosity; 
- The law of matter preservation [16]: 
                                          Equation 2.3 
- The pressure drop along a path from root to a terminal branch is the same for all 
terminals. 
 
In this thesis, these conditions are limited to a single-plane with pre-defined architecture 
for initial testing and adaptation to the development of an imaging phantom and cell 
bioreactor. Fig. 2.3 diagrams the implementation of the pre-defined vascular networks in 





Figure 2.3 Flow chart of implementation for pre-defined vascular trees with and without scaffold 
compartments. 
 
The implemented vascular tree algorithm stored the spatial geometry of the generated 
networks in a binary image file. The algorithm imposed the following structural 
conditions: (i) branches were hollow cylinders, with specified wall thickness and i.d., (ii) 
branches were bounded within a pre-defined volume, (iii) branches birfucated and (iv) 
branches did not intersect. The cylindrical geometry of each vessel was outlined about its 
center axis (Fig. 2.4). In Fig. 2.4, the orthonormal vectors, P3 and P4, on the plane 
orthogonal to line segment (P2P1) created by the two known points, the start and end 




Figure 2.4 (a) Illustrates cylinder defined by line segment, P2P1 and radius, r. (b) The cross product 
of two known points P1 and P2 is the normal vector to P3P1. 
 
Assuming X to be a point in the space, not on P2P1, that satisfies (inner radius) < XP1 < 
(outer radius) of the desired vessel, the cylinder was filled based on the following 
properties and using Equations 2.4. Discrete points, XP1, from the inner radius to outer 
radius were stepped through along the distance of the line segment P2P1. 
 
1 2 1 3 2 1
3 1 2 1 4 2 1 3 1
XP P P P P P
P P P P P P P P P
  
   
  
x 1x 3x 4x
y 1y 3y 4y
z 1z 3z 4z
R  = P + rP cos  + rP sin
R  = P + rP cos  + rP sin




    , for  0 2    Equations 2.4 
 
The pre-defined architecture was implemented, whereby vascular networks bifurcated 
symmetrically along a single axis with each vessel having a programmed inner diameter 
and length (with left and right offspring congruent, forming a 90° angle). Based on the 
number of bifurcations desired, the radii size is computed using the bifurcation rule 
(Equation 2.1). 
A three-dimensional binary image represented the geometry of the vascular tree: the 









(IDL, ITT Visual Information Solutions, White Plains, New York, USA), a triangulated 
surface mesh that outlined the geometry of the vascular network was generated from the 
three-dimensional binary image file. A surface mesh rendering of a vascular branching 
element is shown in Fig. 2.5. Fig. 2.6a shows CAD representations of the mirrored 
vascular networks. The initial vessel-generating branching algorithm created surface 
inconsistencies that produced small holes in the bifurcation region during the STL 
generation step. The blue areas in Fig. 2.6a delineate regions where holes occurred. These 
holes were “patched” using rapid prototyping software (Magics, Materialise Belgium) 
Fig. 2.6b.  
 
Figure 2.5 CAD of three-dimensional triangulated surface mesh for a first order bifurcating tree. 
 
  
Figure 2.6 (a) CAD of branching network with holes (blue area; black circles) in the mesh surface at 





2.3.1.1 Rapid Prototyping Implementation and Considerations 
Physical renderings of the designed vascular tree were achieved using rapid prototyping. 
Table 2.2 provides a summary of advantages and disadvantages of available rapid 
prototyping systems. The rapid prototyping techniques involved an automated layer-by-
layer process of fusing raw materials (typically metal or polymer) into a CAD-defined 








In this thesis, FDM and SLS were explored. Both systems used biocompatible polymers 
that offered a direct RP method with a reasonable accuracy (250-500 microns) that did 
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not require internal supporting structures. The SLS system (EOS FORMIGA P100 SLS, 
EOS GmbH, Munich, Germany) deposited polymer particles across a layer on the bed of 
the system, and then selectively fused the particles using a high power laser to produce a 
three-dimensional object. Each layer was outlined by cross-sections of a three-
dimensional image file. Layering was repeated, with each successive layer resting on top 
of the previous layer (see Fig. 2.7) [22]. The system used a 0.08 mm layer thickness 
during the build process. The FDM system created three-dimensional objects in a similar 
layering manner to SLS, however small thermoplastic beads were deposited specifically 
in locations outlined by CAD cross-sections, instead of being etched onto a powdered bed 
(see Fig. 2.8) [23]. The FDM system (Dimension Elite Printer, Stratasys Inc., Eden 
Prairie, Minnesota, USA) used a 0.178 mm layer thickness during the build process. 
FDM used ABSplus
TM
, while SLS used a powdered thermoplastic mixture of 
polycaprolactone (PCL) and hydroxyapatite (HA) (CAPA 6501, Solvay Caprolactones, 
Warrington, Cherise, UK) (HA, Plasma Biotal Ltd., UK). 
The final product of rapid prototyping systems was subject to the variances in a given 
system’s humidity level, beam accuracy, bed temperature, laser age and reliability of its 
mechanical parts [24]. As well, the molecular mass, viscosity and thermal conductivity of 





Figure 2.7 Schematic of SLS system [26]. 
 
 




2.3.2  Controllable Scaffold Architecture 
The literature suggests that in the assessment of bulk properties, such as intrinsic 
permeability and volumetric flow, a simplified porous media model is computationally 
feasible and may be representative of flow resistance at the capillary level [28-29]. This 
thesis proposes the use of porous scaffolds with pore sizes less than 2 mm to produce 
controllable variable flow resistances that result in differential flow through the scaffold. 
In tissue engineering, a scaffold’s pore size, porosity and interconnectivity directly affect 
its ability to maintain an adequate exchange of oxygen to support cells viability and 
proliferation [30-31]. As such, there are a multitude of scaffold fabrication techniques 
offering various methods and materials to control scaffold architecture: electrospinning, 
particle leaching - solvent casting, inverted colloidal crystal (ICC) formation, RP, etc. 
Particle leaching - solvent casting offers a less structured [32], random arrangement of 
pores within a scaffold, while rapid prototyping and ICC provide more structured pore 
lattices [33]. Each method offers a range of pore sizes and scalable dimension (height and 
radius).  
In practice, in vivo capillary networks and/or their pore networks are too complex to 
individually measure or mathematically represent. Consequently, this thesis offers a 
simplified representation of these pore networks. SLS and ICC scaffolding techniques 
consider pores to be equivalent to a collection of vertical and horizontal straight tubes, 
wherein the radii of those tubes are varied to increase and decrease the level of tortuosity. 
The orthogonal intersection of these tubes produces a complex network that creates a 
tortuous flow path for perfusing fluids. The random organization of pores within the 
SL/SC technique offers greater, but unpredictable tortuosity. Each scaffolding technique 
employed in this thesis offers a distinct range of porogen diameter sizes that can be used 
to influence the tortuosity of the final scaffold construct. The increased tortuosity is 
expected to increase the pressure drop, and as a result decrease the volumetric flow rate 
across the scaffold [34-36]. A limitation of this model is that the pore sizes across the 




2.3.2.1  Scaffold Design and Fabrication 
To control the flow characteristics of interest in Aim 2 and 3, several PCL scaffold 
fabrication techniques were explored. Three techniques that produced three distinct 
geometries were identified: inverted colloidal crystal (ICC) (Fig. 2.9), solvent-casted / 
salt-leached (Fig. 2.10) and SLS (Fig. 2.11). The SC/SL technique involved the use of 
salt crystals (less than 1 mm) as porogens to produce sponge-like scaffolds with a random 
distribution of crystals [39]. The ICC technique offered a highly structured scaffold, in 
which microspheres (5 - 300 microns) self-assembled into tightly packed hexagonal 
crystal lattices to form scaffolds [33]. CAD drawings of porous cylindrical scaffolds with 
three-dimensional spherical, orthogonal and hexagonal periodic porous architectures 
were designed. The scaffold geometry consisted of a unit cell (1.5 - 2.22 mm) that 
repeated every 2 mm to fill a desired scaffold height and diameter. The ICC and SLS 
methods facilitated computational modeling of the scaffold.  
 
 
Figure 2.9 ICC fabrication. (a) Unit cell of spherical lattice representative of ICC scaffold geometry, 
where the dark grey spheres are representative of glass microspheres. (b) Schematic of the ICC 






Figure 2.10 SC/SL fabrication. Example of uneven salt crystals (gray) molded within a cylindrical 
mold to produce a porous random structure. 
  
Figure 2.11 SLS fabrication. (a) Top and (b) isometric view of CAD of SLS scaffold. The spherical 
pore size is altered to generated scaffolds of exhibiting variable intrinsic permeability. 
 
2.3.3   Fabrication of a Polymer Construct 
2.3.3.1   Vascular Tree Fabrication 
Fig. 2.12a shows the CAD of a second-order prototype network. Fig. 2.12b and Fig. 
2.12c show pictures of networks that were fabricated by two rapid prototyping methods, 
FDM and SLS, respectively. The networks had a wall thickness of 0.6 mm and inner 
diameters that decreased from 1.4 mm down to 0.9 mm, based on Equation 2.1. Fig. 
2.15d-e shows a more complex fourth-order bifurcation structure manufactured using 
SLS. The network had a wall thickness of 0.6 mm and inner diameter that decreased from 
2.2 mm down to 0.9 mm, based on Equation 2.1. These diameters reported for Fig 2.12 













Figure 2.12 (a) CAD of second-order vascular network. Photograph of second-order vascular 
network fabricated using (b) FDM and (c) SLS. Inner diameters: a = 1.4. mm, b = 1.2 mm, c = 1.0 
mm, d = 0.9 mm (prescribed measurements). Dimensions: 5.5 cm x 2.2 cm x 0.7 cm. The frame seen 
in in b is external to the vessels and is used for resting the network slightly above table surfaces. (d) 
CAD of fourth order vascular. (e) Photograph of fabricated fourth order vascular network shown in 
d. Inner diameters: a = 2.2 mm, b = 2.0 mm, c = 1.58 mm, d = 1.25 mm, e = 1.0 mm, f = 0.79 mm 
(prescribed measurements). Wall thickness = 0.6 mm Dimensions: 8.5 cm x 4.5 cm x 0.7 cm. 
 
2.3.3.2   Scaffold Compartment 
Section 2.3.1 details the design of a vascular tree. FDM and SLS fabrications successfully 
generated vascular trees with inner diameters between 0.9 - 1.4 mm. Since FDM did not 
present any apparent advantages in the development of our vascular network, an in-house 
SLS was used for all future fabrications. The final design was fabricated using SLS to 
generate a fourth-order vascular tree with an inlet inner diameter of 2.2 mm and an outlet 
diameter of 0.90 mm (diameter prescribed to algorithm). As discussed in section 2.3.2, 






flow across the construct. Therefore, the final vascular network design incorporated a 
compartment for scaffolds at the midpoint of the mirrored vascular network design (Fig. 
2.13). The vascular tree discussed in Section 2.2.1 was modified at the outlet of the 
network to connect to a cylindrical opening that led to scaffold compartments (Fig. 2.13a-
b). The construct consisted of an “arterial” branching network adjoined to modular 
scaffolds that collect at a “venous” end. A scaffold compartment was centered between 
the vascular trees. The cylindrical holder shown in Fig. 2.13c was 11 mm in diameter and 
10 mm in length (13.7 mm outer diameter). It was designed to contain porous scaffolds 
and provide a tight, non-leaky fit. Shallow threading and tapering at the ends of the 
holder allowed for a snap fit into the networks. Through the adoption of rapid prototyping 
and scaffolding techniques the final assembled distributed flow system was fabricated 






Figure 2.13 (a) Side view and (b) top view of CAD of vascular network with compartments. (c) 
Isometric view of CAD of scaffold compartment holder, which joined the mirrored ends of vascular 
network. (d) Top view image of a closed vascular network construct enclosing four porous scaffolds: 
feeding vascular network, 16 outlets feed four compartments, four porous scaffolds enclosed in 






2.4  REFERENCES 
[1] Boron, W.F., and Boulpaep, E.L. Medical Physiology: A Cellular and Molecular 
Approach. Philadelphia, PA: Saunders/Elsevier, 2009.  
[2] Purves, W.K., Orians, G.H., and Heller, H.C. Life, the Science of Biology. 
Sunderland, Mass. Salt Lake City, Utah: Sinauer Associates ; W.H. Freeman, 1995. 
[3] Martini, F.H. Fundamentals of Anatomy & Physiology 6th ed. San Francisco: Pearson 
Benjamin Cummings, Chapter 21, 2004. 
[4] Dewey, C.F., Bussolari, S.R., Gimbrone, M.A., and Davies, P.F. The Dynamic-
Response of Vascular Endothelial-Cells to Fluid Shear-Stress. Journal of 
Biomechanical Engineering-Transactions of the Asme 103, 177, 1981.  
[5] Ando, J., and Yamamoto, K. Effects of shear stress and stretch on endothelial 
function. Antioxid Redox Signal 15, 1389, 2011. 
[6] Kadohama, T., Nishimura, K., Hoshino, Y., Sasajima, T., and Sumpio, B.E. Effects of 
different types of fluid shear stress on endothelial cell proliferation and survival. J 
Cell Physiol 212, 244, 2007. 
[7] Feher, J.J. Quantitative Human Physiology: An Introduction. : Academic Press, 2012. 
[8] Rand, P.W., Lacombe, E., Hunt, H.E., Austin, W.H. Viscosity of normal blood under 
normothermic and hypothermic conditions. J. Appl. Physiol. 19, 117-122, 1964. 
[9] Chien, S., Usami, S., Taylor, H.M., Lundberg, J.L., and Gregersen, M.I. Effects of 
hematocrit and plasma proteins on human blood rheology at low shear rates. Journal 
of applied physiology 21, 81, 1966. 
[10] Bugliarello, G., Kapur, C., Hsiao, G. The profile viscosity and other characteristics 
of blood flow in a non-uniform shear field. Proc IVth Int Cong on Rheol 4, Syrup of 
Biorheol (Ed. CopleyAL), pp 351-370, Interscience, New York, 1985. 
[11] Pedley, T.J. The Fluid Mechanics of Large Blood Vessels. : Cambridge University 
Press, 2008. 
[12] Masako Sugihara-Seki and Bingmei, M.F. Blood flow and permeability in 
microvessels. Fluid Dynamics Research 37, 82, 2005. 
46 
 
[13] Rosencranz, R., and Bogen, S.A. Clinical laboratory measurement of serum, plasma, 
and blood viscosity. Am J Clin Pathol 125 Suppl, S78, 2006. 
[14] Karch, R., Neumann, F., Neumann, M., and Schreiner, W. A three-dimensional 
model for arterial tree representation, generated by constrained constructive 
optimization. Comput Biol Med 29, 19, 1999. 
[15] Schreiner, W., and Buxbaum, P.F. Computer-optimization of vascular trees. IEEE 
Trans Biomed Eng 40, 482, 1993. 
[16] Kretowski, M., Rolland, Y., Bezy-Wendling, J., and Coatrieux, J.L. Fast algorithm 
for 3-D vascular tree modeling. Comput Methods Programs Biomed 70, 129, 2003. 
[17] Rolland, Y., Bezy-Wendling, J., Duvauferrier, R., and Bruno, A. Modeling of the 
parenchymous vascularization and perfusion. Invest Radiol 34, 171, 1999. 
[18] Neumann, F., Schreiner, W., and Neumann, M. Computer simulation of coronary 
arterial trees. Advances in Engineering Software; Computer Simulations in 
Biomedicine 28, 353, 1997. 
[19] Sherman, T.F. On connecting large vessels to small. The meaning of Murray's law. J 
Gen Physiol 78, 431, 1981. 
[20] Fung, Y.C. Biomechanics: Circulation. : Springer, 1996. 
[21] Yeong, W.Y., Chua, C.K., Leong, K.F., and Chandrasekaran, M. Rapid prototyping 
in tissue engineering: challenges and potential. Trends Biotechnol 22, 643, 2004.  
[22] Deckard, C.R. Selective Laser Sintering. University of Texas-Austin, Department of 
Mechanical Engineering, 1988. 
[23] Partee, B., Hollister, S.J., and Das, S. Selective Laser Sintering Process Optimization 
for Layered Manufacturing of CAPA 6501 Polycaprolactone Bone Tissue 
Engineering Scaffolds. Journal of Manufacturing Science and Engineering 128, 531, 
2006. 
[24] Boillat, E., Kolossov, S., Glardon, R., Loher, M., Saladin, D., and Levy, G. Finite 
element and neural network models for process optimization in selective laser 
sintering. Proceedings of the Institution of Mechanical Engineers, Part B: Journal of 
Engineering Manufacture 218, 607, 2004. 
47 
 
[25] Choi, S.H., and Samavedam, S. Modelling and optimisation of Rapid Prototyping. 
Computers in Industry 47, 39, 2002. 
[26] CustomPart.Net. CustomPartNet. 2009. August 2012. 
www.custompartnet.com/wu/selective-laser-sintering 
[27] CustomPart.Net. CustomPartNet. 2009. August 2012. 
ww.custompartnet.com/wu/fused-deposition-modeling 
[28] Muskat, M.. The Flow of Fluids Through Porous Media. Journal of Applied Physics. 
8, 4, 274 – 282, 1937. 
[29] Song, F., You-sheng, X.U., and Hua-mei, L.I.. Blood flow in capillaries by using 
porous media model. J. Cent. South. Univ. Technol. s1-0046-04, 2007. 
[30] Kannan, R.Y., Salacinski, H.J., Sales, K., Butler, P., Seifalian, A.M. The roles of 
tissue engineering and vascularization in the development of micro-vascular 
networks: a review. Biomaterials. 26, 14, 1857-1875, 2005. 
[31] Landman, K.A. and Cai, A.Q. Cell proliferation and oxygen diffusion in a 
vascularising scaffold. Bulletin of Mathematical Biology 69, 2405-2428, 2007. 
[32] Murphy, W.L., Dennis, R.G., Kileny, J.L., and Mooney, D.J. Salt fusion: an 
approach to improve pore interconnectivity within tissue engineering scaffolds. 
Tissue Eng 8, 43, 2002. 
[33] Kotov, N.A., Liu, Y., Wang, S., Cumming, C., Eghtedari, M., Vargas, G., 
Motamedi, M., Nichols, J., and Cortiella, J. Inverted colloidal crystals as three-
dimensional cell scaffolds. Langmuir 20, 7887, 2004. 
[34] Hunt, A.G., and SpringerLink (Online service). Percolation Theory for Flow in 
Porous Media. Berlin ; New York: Springer, 2005. 
[35] Chhabra, R.P., Richardson, J.F., Knovel (Firm), and ScienceDirect (Online service). 
Non-Newtonian Flow and Applied Rheology Engineering Applications. 
Amsterdam; Boston: Butterworth-Heinemann/Elsevier, 2008. 
[36] Bear, J. Dynamics of Fluids in Porous Media. New York: American Elsevier, 1972. 
[37] Tofts, P.S., Brix, G., Buckley, D.L., Evelhoch, J.L., Henderson, E., Knopp, M.V., 
Larsson, H.B., Lee, T.Y., Mayr, N.A., Parker, G.J., Port, R.E., Taylor, J., and 
48 
 
Weisskoff, R.M. Estimating kinetic parameters from dynamic contrast-enhanced 
T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J 
Magn Reson Imaging 10, 223, 1999. 
[38] Maes, F., Claessens, T., Moesen, M., Van Oosterwyck, H., Van Ransbeeck, P., and 
Verdonck, P. Computational models for wall shear stress estimation in scaffolds: a 
comparative study of two complete geometries. J Biomech 45, 1586, 2012.  
[39] Kemppainen, J.M. Mechanically stable solid freeform fabricated scaffolds with 
permeability optimized for cartilage tissue engineering. University of Michigan, 




CHAPTER 3  
 
 
Development of a Dynamic Flow Phantom for Quantitative Assessment of Flow with 




Purpose: To use rapid prototyping (RP) and scaffolding techniques to develop a physical, 
dynamic flow phantom with controlled vascular-like structural and flow properties, 
which when imaged by Dynamic Contrast Enhanced-Computed Tomography (DCE-CT) 
generates time-contrast enhancement curves typical of organs imaged by DCE-CT. 
Methods: The dynamic flow phantom consisted of a vascular network adjoined to porous 
scaffold compartments. This work investigated RP as a method to manufacture high-
order computer generate vascular trees that anatomically modeled in vivo arterial and 
venous vasculature. Selective laser sintered (SLS) vascular trees were connected to 
modular scaffold compartments, which were fabricated using solvent-casted/salt-leached 
(SL/SC), Inverted Colloidal Crystal (ICC) and SLS approaches. The different methods 
used variable porous architectures to generate controllable fluid flow characteristics. The 
realizable range of differential flows possible across the porous compartment was 
examined. DCE-CT imaging was performed on the phantom to demonstrate the imaging 
compatibility. From the imaging data, time-contrast enhancement curves were generated 
and velocities of phantom features were measured to demonstrate the application of the 
phantom to detailed DCE post-processing.  
Results:  Computer generated three-dimensional bifurcating cylindrical branches with an 
inner diameter ranging from 2.2 mm down to 770 microns were reproducibly fabricated 
with a polymer material to generate an arterial-like bifurcating vascular tree. Significantly 
different differential flows, from -22% to -90% were achievable using the SLS and 
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SC/SL manufacturing processes. DCE imaging and analysis of a phantom with SLS 
scaffolds embedded generated curves characteristic of in vivo DCE-CT imaging. Further 
post-processing calculated flow rates within the vascular tree and differential flows 
across the scaffold compartment which were similar to the theoretical and experimentally 
measurements, respectively.  
Conclusions: The fabricated vascular trees and porous compartments were patent at sub-
voxel sizes and exhibited various flow rates, showing that RP can successfully generate a 
DCE-compatible phantom with tunable differential flows for DCE imaging and analysis. 
The results of this chapter will provide a method for developing and using a dynamic 
phantom that can be further studied to evaluate the sensitivity of the device and to 
validate DCE-CT measurements in the future. 
 
3.1  INTRODUCTION 
Various estimates of perfusion are currently under investigation as potential biomarkers 
to aid in the prognosis, assessment, and individualization of cancer therapy. Perfusion 
measurements acquired from dynamic contrast-enhanced (DCE) imaging provide a 
quantitative metric for assessing tumor aggressiveness, tumor response to therapy, and 
more recently normal tissue damage following treatment such as focal irradiation [1-3]. 
While quantitative imaging is potentially a very powerful tool to stage and monitor 
treatment, the actual quantification of perfusion from image analysis is a subject of 
concern, as there is significant variability in DCE acquisition, processing and quantitative 
metric extraction [1-2,4-8]. The validation of DCE-derived parameters is limited. 
Existing methods of providing validation for DCE imaging and analyses are limited to 
simulated data, which does not account for variances in image acquisition. Similarly, 
implemented static phantoms neglect the dynamic effects inherent during patient scans 
and dynamic tools incorporate features that are well above the anatomical resolution of 
tissue parenchyma. 
Organ-based perfusion phantoms employing fresh organs have a short lifetime, while 
preserved organs may be sensitive to handling and fixation [15-16]. Several previously 
implemented re-useable three-dimensional flow phantoms have oversimplified the 
vascular tree geometry by using non-leaky cylindrical tubes [17] or parallel fibers from 
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commercial dialysis cartridges [18]. Recently, Chiribiri et al. [19] and Driscoll et al. [20] 
and presented re-usable phantom models that aim to produce a gold standard for 
measuring flow using computed tomography (CT) and magnetic resonance imaging 
(MRI), respectively (see Fig. 3.1-3.2). Driscoll et al. [20] developed a rapid prototyped 
phantom comprised of coiled plastic tubing (6.35 mm diameter) wound about a shell 
(Fig. 3.1) to reproduce target arterial input functions using DCE-CT. The phantom 
produced time-attenuation curves (TACs) with tunable peaks and shapes based on the 
preset arterial input function (AIF), which consisted of blood mimicking fluid (2:3 
glycerol-water, 2.5 - 5 ml/s) and iodinated contrast agent (0.27 - 1.5 ml/s). Their system 
was successful in closely matching the shape (in terms of duration and residual 
enhancement) and peak (in terms of enhancement) of a typical AIF. The phantom and 
system limitations, which may have introduced error in the final TACS included: 
 Heterogeneous mixing of contrast agent and blood mimicking fluid 
 Unrealistic physiologically realistic capillary exchange 
 Enclosing phantom shells that do not represent physiological situations  
 
Figure 3.1 DCE CT flow phantom. qinject, contrast agent input flow; qpump, blood mimicking fluid 
input flow; qin, total input flow ; qtube, output flow ; qcyl , second output flow ; qtotal, total output flow 
[20]. 
 
Chiribiri et al. [19] created a physical four chamber heart phantom composed of two 4-
cm cylinders containing 124 3-mm pipes (Fig. 3.2)  to simulate dynamic first pass 
myocardial perfusion (1-10 ml/ml/min) using MRI. The system was perfused with tap 
water and a gadolinium contrast agent. However, the goal of their reported completed 




creating tunable AIFs and to extract those curves using signal deconvolution. The 
phantom and system limitations, which may have introduced error in the final AIFs 
included: 
 Unrealistic physiologically realistic capillary exchange, unlike animal and human models 
 Poor bolus dispersion 
 Single compartment of distribution 
 Lack of diffusion of contrast agent into interstitial space 
 
Although these two phantoms present more reliable, reusable set-ups for validation 
studies, both designs based estimations on unrealistic representations of physiological 
capillary exchange that were above the resolution of the typical CT scanner. 
 
 
Figure 3.2 Myocardial MR perfusion phantom. RA, right atrium; RV, right ventricle; LA, left 
atrium; LV, left ventricle. Simulated heart rate of 60 beats per minute and cardiac output of 4 L/min. 
[19]. 
 
As such, a flow phantom was designed to increase model complexity over existing flow 
phantoms through the adoption of porous compartments that offered tunable flow 





organs scanned by volumetric imaging systems. The flow phantom consisted of porous 
scaffold compartments centered between an “arterial” and “venous” vascular tree 
network (Fig. 3.3). The selective laser sintering (SLS) RP process was used to determine 
the reliability of manufacturing highly branched vascular trees and porous compartments 
mimicking differential flow ranges was determined. The advantages of the proposed 
design are its anatomical “arterial” vascular tree design and the influence of structure on 
fluid flow across the vascular tree and the porous scaffold compartments. 
The design and assembly of the branching network is described in this study. Two 
scaffold fabrication methods were investigated to produce porous compartments with 
distinct differential flow ranges, for placement within a dynamic DCE vascular phantom 
that covers a range of differential flows. An experimental approach to characterize the 
hydraulic permeability and differential flow across the porous compartments was used. 
Tests of the prototyped phantom included an evaluation of lumenal occlusion to 
determine the feature (cylindrical lumens) resolution limit, an assessment of the accuracy 
of SLS fabrication and precision of inner diameter measurements to evaluate 
reproducibility. 
Experimental analysis of flow through the phantom system, in terms of “arterial” input 
flow and differential flow across the compartments is performed in this chapter. DCE 
imaging is performed to demonstrate the practical application of the phantom system in 
the acquisition of signals, and to confirm compatibility of the phantom to CT. 
Furthermore, a DCE analysis is performed as an example of the level of detailed analysis 
that can be performed on the phantom in order to compare imaging-extracted velocity or 
volumetric flow metrics to experimental and computational (detailed in chapter 4) 
measurements. 
 
3.2  METHODS AND MATERIALS 
3.2.1 Design of vascular phantom 
The phantom (Fig. 3.3) consisted of an “arterial” branching network adjoined to modular 
scaffold compartments that collect at a “venous” branching network. The design was 
fabricated with a Luer-lock fitting (International Standards, ISO 594) at the inlet and 
outlet of the vascular tree. The inlet connected to an inlet inner diameter of 2.2 mm, 
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which bifurcated over four levels to an outlet diameter of 0.79 mm. The design 
incorporates multiple porous scaffolds at the midpoint of the mirrored vascular network 
design (Fig. 3.3a). Each compartment houses an 11 mm x 5.5 mm (height x radius) 
porous cylindrical scaffold.  The compartment encloses 2 mm of space before and after 
the outlets and inlets of the vascular network, respectively. The two mirrored vascular 
trees were adjoined by multiple compartment holders, each of which tightly bounds a 
scaffold, such that fluid passed through the porous scaffolds (Fig. 3.3b). Four scaffolds 
were enclosed within the system, each housed in a different holder. Shallow threading 
and tapering at both ends (0.5 mm length) of the holder allowed for a snap fit into the 
networks. Four outlet vessels from the vascular network serve as fluid entry ports into the 
hollow compartments, which house the scaffolds (Fig. 3.3c).  
 
 
Figure 3.3 (a) Image of top view of (Top) vascular phantom: “arterial” vascular network has 16 
outlets that are connected to four compartments, which are adjoined to a “venous” tree via a 
compartment holder that housed four porous scaffolds; (Bottom) Image of top of opened 
compartments that show the modularity of the phantom design (sectioned at first third bifurcation). 
(b) CAD of fluid domain enclosed within vascular network construct. (c) Front view of the CAD of 







3.2.2  Computerized vascular tree design and manufacturing 
In vivo observations and formulated principles on vascular branching served as the basis 
for the implemented three-dimensional vascular network algorithm [21-23]. The 
algorithm generated three-dimensional binary image files which represented the 
geometry of the vascular networks. Manipulation of these binary files produced 
triangulated surface meshes that were saved to a stereolithography (STL) file format (3D 
Systems, Rock Hill, South Carolina, USA), then imported to the SLS system for 
fabrication. The computer aided design (CAD) of vascular trees scalable to large volumes 
that corresponded to internal organs offered control over geometric properties (i.e. inner 
diameter, length, number of branches, bifurcation order) that dictated regional blood flow 
properties. The implemented vascular tree algorithm generated a binary image file to 
store the spatial geometry of the generated networks. Generated vascular trees enforce 
bifurcations and the following structural conditions: (i) branches were modeled as hollow 
cylinders, with specified wall thickness and inner diameter, (ii) branches were bounded 
within a pre-defined volume and (iii) branches did not intersect. The cylindrical geometry 
of each vessel was outlined about its center axis. The starting point for each offspring’s 
center axis initiated from the last point along the center axis of its parent vessel.  The 
geometry was initially represented as a three-dimensional binary image, whereby ‘1’ 
represents wall and ‘0’ lumenal space. Branches bifurcated at angles between 30-50 
degrees and the prescribed inner radius (r) dimension of each offspring vessel after a 














In the overlapped areas of the saddle region of the bifurcation, where vessel walls of one 
offspring protruded into the lumenal space of the second offspring, the algorithm 
converted the protruded wall into lumenal space (‘1’‘0’) to create a sharp bifurcation 
region (Fig. 3.4a).  
For this preliminary study, a pre-defined architecture was implemented, whereby vascular 
networks bifurcated symmetrically along a single axis with each vessel assigned an inner 





Figure 3.4 (a) Schematic of vessels’ geometry at bifurcation points and (b) coronal view of network 
with smoothed bifurcation regions. The solid wall is shown in yellow and the lumenal space is 
highlighted gray. 
 
The surface renderings of the computer-generated networks served as input to the SLS 
RP method. An STL generator was developed in a data visualization environment (IDL, 
ITT Visual Information Solutions, White Plains, New York, USA) to convert the binary 
image file into a surface mesh (referred to as STL or CAD) that was then manipulated 
with a commercial software tool (Magics X, Materialise, Belgium) to fix inconsistencies 
(i.e. inverted normals, intersecting triangles, bad edges, etc.) in the generated mesh. The 
fixed files were then loaded on to an SLS system (EOS FORMIGA P100, EOS GmbH, 
Munich, Germany). The vascular network and scaffolds were fabricated using a 
powdered thermoplastic mixture of polycaprolactone (PCL) and hydroxyapatite (HA). 
The SLS system deposited plastic particles across a layer on the bed of the system, then 
selectively fused the particles using a high power laser to produce a three-dimensional 
object. The system used a 0.08 mm layer thickness during the build process. The SLS 
fabrication was conducted by preheating the powder to 49.5°C, then scanning the laser 
(450 mm focused beam diameter) at 4.5W power and 1.257 m/s scan speed. Based on 




system, for the given system parameters: the humidity level, beam accuracy, laser age, 
properties of the PCL powder and reliability of the mechanical parts for our system.  
 
3.2.3  Solvent-Casted/Salt-Leached (SC/SL) PCL scaffolds 
Solvent-Casted / Salt-Leached (SC/SL) PCL scaffolds were fabricated based on 
modifications to a protocol developed by Kemppainen et al. [25]. For the SC/SL 
technique, sea salt (sodium chloride, Essentials by Catalina, CA, USA) was used as the 
porogen. Salt crystals were separated by brass sieves (USA standard test sieve: Fisher 
Scientific Inc., CA, USA) with a nominal sieve opening of 106, 180, 300, 600, and 700 
micron. The salt crystals were sieved to six ranges: <106, 106-180, 180-300, 300-600 and 
700-1000 μm, then hydrated with 4% (w/v) deionized water before being casted into 
Teflon (McMaster-Carr, CA, USA) molds. Salt crystals of various diameters were used to 
create spongy scaffolds of different levels of porosity to vary the interconnectivity of 
formed channels, without compromising penetrability caused by ill-formed pore walls. 
The crystals were packed into cylindrical molds with roughly 11 mm diameter and 13 
mm height. 15% (w/v) PCL/chloroform (Polysciences, Inc., PA, USA) (Fisher Scientific 
Inc., CA, USA) was infused into the salt crystal lattice within the mold. The crystal 
lattice were saturated with PCL/chloroform, and then placed under vacuum for 4 hours. 
Thereafter, the scaffolds were dried for 24 hours, for maximum chloroform evaporation. 
The scaffolds underwent repeated saturation within 70% ethanol alcohol and water to 
remove the salt porogens and entrapped air. The top and bottom ends of the scaffold were 
cut to achieve an 11mm scaffold height. Fig 3.5a. illustrates two fabricated SL/SC 
scaffolds. 
 
3.2.4  SLS PCL scaffolds 
To prepare SLS-fabricated PCL scaffolds, porous cylindrical scaffolds with three-
dimensional orthogonal periodic porous architectures were designed using custom written 
programs in a data visualization environment (IDL, ITT Visual Information Solutions, 
White Plains, New York, USA), and then exported as STL files. The scaffold geometry 
consisted of a cubical unit cell enclosed in a sphere with a 2.15 mm or 2.2 mm diameter 
(resolution ± 0.5 mm) (Fig. 3.5b). The unit cell was repeated every 2 mm to fill a 
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cylindrical construct with an 11 mm height and diameter. The generated STL files for the 
respective scaffolds were loaded onto the SLS system for fabrication as detailed in 
section II.A.1. Upon completion of SLS fabrication, the parts were flushed with 
compressed air to remove unsintered PCL powder from the scaffold’s interstices. Fig. 
3.5b illustrates fabricated SLS scaffolds. 
 
 
Figure 3.5 Picture of cylindrical (a) 300-600 and 700-1000 micron SC/SL scaffolds and (b) high (2.2 
mm pore size) and low (2.15 mm pore size) permeability SLS scaffolds. 
 
3.2.5  Inverted Colloidal Crystal (ICC) PCL scaffolds 
The following method to create ICC PCL scaffolds was a modification of a protocol 
developed by the Kotov et al., wherein microspheres are allowed to self-assemble into a 
tightly hexagonally packed crystal lattice (see Fig. 2.11a. Soda lime glass beads 
(Polysciences, Inc., PA, USA) of 30-50 μm and 105-150 μm diameter were used as the 
porogen in the ICC technique[26-27]. Pipettes were secured at the perforated centers of 
the vials’ caps. 9g of microspheres (per scaffold) were added to ethylene glycol (Fischer 
Scientific Inc., CA, USA), then added to a disposable pipette. Each ICC scaffold was cast 
in a borosilicate shell vial (Fisher Scientific Inc., CA, USA) with a 19 mm diameter. The 




ethylene glycol. Every 20 minutes, five drops of microsphere solution was released from 
the pipette into the shell vial. The microspheres settled at the bottom of the vial. Drops 
were continually added until the desired scaffold volume was reached (see Fig. 2.11b). 
Thereafter, the microspheres were left under sonication for an addition hour. The vials 
were removed from the sonicator and the contents dried for 24 hours at 80˚C to evaporate 
the ethylene glycol. The vials were heated to 655˚C to anneal the glass microspheres. The 
solidified ICC was removed from the vial and placed into Teflon mold (19.5 mm 
diameter and 13.2 mm height). 15% (w/v) molten PCL/chloroform was infused into the 
ICC by centrifugation for 60 minutes at 5800 rpm. The PCL saturated scaffolds were then 
placed under vacuum for 24 hours at room temperature. To dissolve the glass porogens, 
the scaffolds were dissolved in a 5% hydrofluoric acid (Fisher Scientific Inc., CA, USA), 
1.0N hydrochloric acid (Fisher Scientific Inc., CA, USA) and then a phosphate buffered 
saline (Fisher Scientific Inc., CA, USA) solution. None of the solvents sued underwent 
further purification.  
 
3.3  CHARACTERIZATION OF PHANTOM COMPONENTS 
3.3.1  Resolution, accuracy and precision of vascular network fabrication 
Fabrication of several test blocks (Fig. 3.6a-3.6b) which contained individual cylindrical 
vessels allowed for the evaluation of the fidelity of inner diameter dimensions and the 
determination of the SLS resolution limit. The CAD of the first test block contained six 
vessels with decreasing inner diameter (4.0 mm, 2.0 mm, 1.5 mm, 1.2 mm, 1.0 mm, 0.9 
mm) repeated over three rows with a constant wall thickness of 0.6 mm. A second block 
contained vessels with a 0.6 mm wall thickness and smaller inner diameters (0.90 mm, 
0.85 mm, 0.80 mm, 0.70 mm, 0.65 mm, 0.60 mm).  To determine the resolution limit of 
the fabricated prototypes, compressed air and water were flushed through the lumens of 
the vessels contained in each test block. For vessels that showed patency, manual caliper 
measurements (accuracy: ± 0.005 mm) were acquired for the inner diameter of fabricated 
vessels and were compared to CAD inner diameter measurements acquired by a diameter 
measurement tool (accuracy: ± 0.0005 mm) in commercial visualization software 
(Solidview, Solid Concepts, Inc., California, USA). Statistical analyses for four 
independent fabrications of the first block are reported as means ± standard deviation 
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(stdev) and percent deviation. A two-tail Student’s t-test assuming unequal variance was 
used to compare the measured dimensions to the inner diameter design specifications 
prescribed in the vascular algorithm, to the CAD and fabricated vessels. Significance was 
set at P -values< 0.05. 
 
 
Figure 3.6 CAD of test block. (a) top-front-right view and (b) side view. The frame holds the vesssels 




Figure 3.7 Photograph of SLS-fabricated mirrored vascular network (two-level bifurcation). Inner 
diameters: inlet  = 1.4. mm, first level birfucation = 1.2 mm, second level bifurcation = 1.0 mm, 
midpoint of vascular network = 0.9 mm (prescribed measurements). Dimensions: 5.5 cm x 2.2 cm x 
0.7 cm. 
 
3.3.2  Scaffold characterization: porosity measurement 
The reproducibility of the scaffolds fabricated using the respective scaffold techniques 
were evaluated in terms of the consistency of properties (integrity and porosity) in 
fabricated architectures. Porosity was defined as the volume of void space over the total 
scaffold volume within a given PCL scaffold. The density-based approach (Archimedes’ 
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whereby m1 = saturated weight of scaffold, m2 = dry weight of scaffold, d1 = density of 
PCL and d2 = density of absolute ethanol. The scaffold was dried for 24 hours then 
measured to determine m2. The dried scaffolds were then submerged in absolute ethanol 
for 24 hours then weighed to determine m1. The salt crystal porogens were assumed to be 
completely dissolved out of the scaffold. For SLS PCL scaffolds, the porosity was 
estimated from volume measurements calculated in commercial visualization software 
(Magics, Materialise, Belgium). The porosity was defined as the volume of scaffold 
divided by the volume of an 11 mm x 11 mm solid cylinder. 
 
3.3.3  Scaffold characterization: experimental measurement of hydraulic 
permeability and differential flow 
For a sample size of six, the height and diameter of each fabricated scaffold was 
recorded. Before testing, the scaffolds were preconditioned to an aqueous environment 
for twelve hours. The volumetric flow rate through each scaffold was measured using an 
in-house flow meter, given a constant hydraulic head [25]. The volumetric input to the 
system was controlled by a pump that dispensed a simulated blood fluid (SBF) at flow 
ranges between 18-25 ml/s. The SBF (65% glycerine, 35% water, 0.0075% Xanthan 
gum) exhibited blood-like shear thinning behavior. The scaffolds were placed inside the 
flow chamber sealed off at the perimeter by a rubber tube to force fluid through scaffold, 
and not around it (Fig. 3.8). The mass of SBF that penetrated the scaffold over a given 
length of time was measured by a scale, which sent the data to a commercial data 
acquisition tool (LabView, National Instruments, TX, USA). The mass flow was 
collected over a time period long enough to acquire stable flow. The hydraulic 
permeability ( ̂, m4/N·s) was calculated for each scaffold using equation 3.3, a derivation 
of the Bernouilli equation and Darcy’s law [28]: 
 
 ̂  
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where   = height of scaffold (m), r = radius of the chamber’s outlet (m), A=cross-
sectional area of medium (m
2
), Ms= mass flow rate through chamber with the scaffold 
(kg/s) and M0 = mass flow rate through chamber without the scaffold (kg/s). Ms and M0 
capture the bulk (mass) flow rate changes across the compartment with and without a 
scaffold present. 
 
Figure 3.8 Schematic of experimental set-up used to estimate hydraulic permeability and differential 
flow. Scaffold was enclosed in a rubber tube fitted to an acrylic chamber. 
 
The differential flow (%) was calculated as the percent change in bulk flow rate across 
the compartment with and without the embedded porous scaffold, using equation 3.4.  
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The statistical significances of differences in hydraulic permeability and differential flow 
were determined by two-tail Student’s t-tests assuming for unequal variance. Significance 
was set at P -values< 0.05. Based on the results of these metrics, the designs with the two 




3.4  DYNAMIC CONTRAST-ENHANCED CT IMAGING 
3.4.1  Vascular flow phantom system and assembly 
Prior to assembly, each scaffold and vascular network was soaked in acetic acid (≥99.7 
w/w %, Certified ACS, Fisher Scientific) to reduce contrast agent uptake (see Appendix 
2.A). The assembled fourth-order PCL constructs was filled with SBF to reduce the 
number of air bubbles present in the system. The constructs were left in SBF for one 
hour. The filled PCL constructs were pulled under a vacuum prior to assembly in the 
system. The prepared PCL vascular construct was placed into the phantom system (Fig. 
3.9). The PCL construct was embedded in a tissue-mimicking equivalent prepared from a 
0.85% iodinated contrast agent (Isovue 300, Iopamidol Injection 61%, Bracco 
Diagnostics, Princeton, NJ, USA) aqueous solution, which was contained in an acrylic 
bounding box. The bounding box (12 in. x 6 in. x 6 in.) consisted of inlets and outlets 
attached to Luer Lock connections of tubing to the vascular network and external tubing. 
The inlet and outlet of the vascular network incorporated Luer Locks for easy connection 
to the dynamic system. Three-sixteenth-inch clear plastic tubing was used for all 
connections, except for the injector, which used One-eighth-inch clear plastic tubing. The 
inlet of the phantom was supplied SBF and contrast agent through a T-shaped stopcock. 
An inline mixer was positioned downstream of the stopcock. The tubing then connected 
to the inlet of the bounding box, which was adjoined to the vascular phantom. Fluid that 
passed through the phantom exited the through the outlet portal of on the bounding box, 
which released fluid in a reservoir (waste). Once set-up on the CT bed, all tubing that 
preceded the inlet of the vascular network was filled with SBF, in order to flush air out of 
the system. SBF from a reservoir circulated through the phantom using a peristaltic pump 
(MasterFlex® L/S® Easy-Load® II, Cole Palmer, Vernon Hills, IL, USA) (a pulse 




Figure 3.9 Schematic representation of the single input single-compartment flow phantom within the 
closed flow system. 
 
3.4.2  DCE-CT image acquisition  
Initial flow phantom experiments were performed for two vascular phantoms with SLS 
scaffolds loaded into their compartments. Fig. 3.10 shows the experimental set up of the 
vascular phantom, pump and reservoirs on the CT bed. Using a radiotherapy CT scanner 
(Brilliance, Philips, Cleveland, Ohio, USA), cine CT data for the phantom were collected 
every second for 50 seconds at a resolution of approximately 1 mm x 1 mm x 1 mm. The 
DCE-CT scans were taken at 120kV and 200 mA with a gantry rotation time of 0.5 s 
using 3 mm slice thickness and a cycle time of 1 per second. Starting at t = 0 s, a bolus of 
iodinated contrast agent (Isovue 300, Iopamidol Injection 61%, Bracco Diagnostics, 
Princeton, NJ, USA) circulated through the fourth-order prototype phantom housing the 
lower (hydraulic) permeability SLS scaffolds. Then, SBF was flushed through the 
system. SBF was allowed to circulate through the system for about one minute before 
DCE-image data collection began. The SBF continuously circulated at a rate of 0.833 
cc/s, while 4 cc of contrast agent entered the system at rate of 2 cc/s for the first bolus. 
The bolus was flushed with 15 cc of SBF at a rate of 1 cc/s. The experiment was repeated 
for with the fourth-order prototype phantom housing the higher permeability SLS 
scaffolds.  
CT axial image slices were generated. The Hounsfield unit of the PCL and contrast 
enhanced-liquid enclosed in the phantom box was evaluated using the CT image data. 
Time-contrast enhancement curves were generated from the experiment (over 20 seconds 





Figure 3.10 (Top) Picture of vascular flow phantom positioned on CT bed connected to a closed 
system, which pumps SBF and contrast agent. (Bottom) View of vascular phantom surrounded by an 
acrylic box filled with an aqueous tissue equivalent solution (in terms of intensity). (Blue arrow 
indicates the direction of fluid flow). 
 
3.4.3  DCE-CT image analysis 
Six tubes filled with iodinated contrast agent (Isovue 300, Iopamidol Injection 61%, 
Bracco Diagnostics, Princeton, NJ, USA) at the concentrations of 0, 5, 10, 30, 50 and 70 
mgI/ml were CT scanned (Brilliance, Philips, Cleveland, Ohio, USA) at 227 mA, 120 
kVp and 3 mm slice thickness. The enhancement was averaged over a uniform three-
dimensional region of interest manually segmented within each tube. A contrast 
calibration curve was generated from the collected static image data. Based on this linear 
relationship, time-contrast enhancement curves extracted from the DCE experiments 
were scaled to generate time-contrast concentration curves. A single channel 
pharmacokinetic model [31] represented in Fig. 3.11a was implemented to extract the 
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velocity from the DCE data. An exponential decay function can be used to describe the 
flow of contrast agent through the lumen (Eq. 3.5-3.6):  
       ( )         
 (   ( )⁄ )   Equation 3.5 
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⁄ )
,  Equation 3.6 
where C(x) = concentration of contrast agent (mgI/ml), x = position of contrast agent in 
vessel relative to the inlet VOI selected in the first level of bifurcation (m); 0 < x < 1 , 
and L = length of tube (m). The volumetric flow rate across each level of bifurcation 
remains constant (Eq. 2.3). The cross-sectional area increases as the diameter decreases, 
across the levels of bifurcation. The in vitro phantom does not capture vascular 
constriction or dilation that inherently incurs in small arteries and arterials, in vivo. The 
constant volumetric flow rate coupled with the increasing cross-sectional area results in 
proportionate changes in velocity, across the levels of bifurcation. The velocity decreases 
along the increasing level of bifurcation: velocity is a function of x, v(x). At each level of 
bifurcation, the offspring vessel was considered to be a single large channel (Fig. 3.11a) 
as shown in Fig. 3.11b. The output concentration, Cvessel of a parent vessel serves as the 









Figure 3.11 (a) A single channel pharmacokinetic model, wherein a differential element of the model 
balances the flow going in and out of the element. Exponential decay occurs across the vessel 
represented by the cylindrical channel. (b) Vascular network modeled by single channel, where the 
cross-section area increases as x increases. Cinput = input contrast agent concentration; Coutput = output 
contrast agent concentration; r = radius of channel; d = diameter of channel; x = fraction of channel 
length; L = length of channel / selected volume of interest; Qin = volumetric flow of fluid into the 
differential element; Qout. = volumetric flow of fluid out of the differential element. 
 
The Peclet number (Pe) indicates whether convection (Pe >>1) or diffusion (Pe << 1) is 
the dominant mode of mass transport within a vessel. The unitless number is calculated 
using Eq. 3.7 
    
  
    
,   Equation 3.7 
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where Q is the volumetric flow rate, l is the length of the vessel and D is the diffusion 
coefficient. A diffusion study is required to determine the diffusion coefficient of the 
iodinated contrast agent within the simulated blood fluid as it travels through the vessel 
lumen. Given the high speed of the fluid within the lumen of the prototyped phantom, 
convective flow is assumed, whereby mixing is caused by variations in the convective 
velocities field. Convection is dominant at the center of the vessel (well mixed), whereas 
at the vessel walls it approaches zero to produce a parabolic velocity profile (largely 
unmixed). Therefore Eq. 3.8 can be used to described the relationship between velocity 
and volumetric flow rate,  
     
       
 
,   Equation 3.8 




Considering Eq. 3.6 and Eq. 3.8,   
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where      = the length of the outlined volume of interest. 
 
For bifurcation level 3 (see Fig. 3.24), 
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For bifurcation level 4 (see Fig. 3.24), 
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The velocities computed in the third and fourth level of bifurcation assume each vessel to 
be a hollow cylindrical channel through which the fluid flows. In the case below, the 
fluid travels a tortuous path through the scaffold. As such, the velocity is superficial. The 
length is the distance of the straight line from the input to output of the compartment. 
This superficial velocity is a function of the true travel time acquired from acquired DCE-
CT image data. 
Before or after the scaffold compartment (see Fig. 3.24), 
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  Equation 3.12 
Q was used to compute the different flow.  
 
Volumes of interest (VOI) were contoured at the inlet of the flow phantom, the outlet of 
the flow phantom, the third level of bifurcation, the fourth level of bifurcation, the entry 
of the scaffold compartment and across the entire compartment, in order to generate time-
contrast enhancement curves. The average intensity of the first four time steps (baseline) 
was subtracted from all phases in the respective time-contrast enhancement curve, as 
described in Eq. 3.13. 
                (           ) Equation 3.13 
                 (           )                          (          ) 
 
Partial volume correction was performed using Eq. 3.14 
                              Equation 3.14 
 (  
                       
             
)                        
                       
             
          , 
where HU = Hounsfield units, and the estimated vessel volume is calculated from the 
caliper-measured diameter and the length of the selected volume of interest. The volume 
of the VOI is computed by the in-house functional image analysis software package [29].  
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The effect of the selected VOI volume on the acquired time-contrast enhancement curve 
was assessed. Four VOI volumes were considered: 25% of full volume, 50%, of full 
volume, 75% of full volume and full volume, for an arbitrarily selected initial VOI 
volume dimension. After baseline removal and partial volume correction, time-contrast 
enhancement curves were generated. The velocities were computed, along with the 
differential flow across the high and low permeability compartment. To assess whether 
there was leakage at the connections that adjoin the compartments to the vascular trees, 
the area under each time-contrast enhancement curve (AUC) was calculated. In MatLab, 
a trapezoidal numerical integration (trapz) was implemented to approximate the integral 
of the scattered data points. The trapz function computed the integral from 0 to 19 
seconds, with unit spacing. In addition, two VOIs were selected at the inlet of the 
vascular tree. Using Eqn. 3.12, where the VOIs represented Cvessel and Cinput, the velocity 
at the inlet of the vascular tree was DCE-measured at the time of peak bolus. The 
measured value was compared to computationally and experimentally measured values. 
The level of analysis achievable using the flow phantom, given the vascular-like 
architecture was demonstrated through analysis of DCE experimental setup enclosing 
high permeability scaffolds. Similar analysis may be performed on a flow phantom 
enclosing lower permeability scaffolds. 
 
A two-tail Student’s t-test assuming unequal variance was used to compare the 
experimentally measured differential flow to that calculated from post-processing DCE 
images. The t-test was also used to compare the computed inlet and outlet AUC for a low 
permeability and high permeability compartment. Significance was set at P-values < 0.05 
or P-values < 0.01.  
 
3.4.4 Measurement of Experimental and Theoretical Boundary Conditions 
The “arterial” input velocity to the flow phantom was measured experimentally, 
independent of the DCE-CT imaging experiment. The contrast agent and SBF were 
loaded into reservoirs which connected two pumps. Each pump was set to the dispense 
fluid at the same rate as in the DCE image acquisition. The experimental flow rate was 
measured using an in-house flow meter system. After an initial 8-9 seconds (delay 
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incorporated to account for travel time of mixed fluid to travel from T-junction to the 
outlet of the system), the mass flow rate was measured over 14 seconds. The 
measurement was repeated three times. The velocity was calculated as the average mass 
flow rate, divided by the density of the mixed fluid and the cross-sectional area of the 
outlet.  
 
The theoretical velocity (Eq. 3.17) at the various levels of bifurcation were calculated 
based on the conservation of mass for identify offspring vessels provided in Eq. 3.16 and 
Eq. 3.8. 
                          Equation 3.16 
                        
           
                    
          
  Equation 3.17 
The experimental inlet velocity was compared to a computational fluid dynamics (CFD)-
based measurement. The details of CFD are described later on in Chapter 4. The 
experimental and CFD measurements were compared to image-extracted velocity 
measurements acquired from the DCE-data. 
 
3.5  RESULTS 
3.5.1 Accuracy and precision of SLS fabrications 
The SLS fabrication process builds vessels with an inner diameter accuracy of 130 - 310 
microns (Table 3.1). For the larger test block (in which all vessels showed patency) t-tests 
were performed on the measurements collected (Table 3.1) to compare inner diameter 
measurements for the CAD and fabricated test blocks against diameters prescribed in the 
vascular algorithm (pre-STL generation). Results indicate that there was no significant 
difference (P-values > 0.05) in the inner diameter measurements between the CAD and 
the fabricated prototypes. However, there was a significant difference (P-values < 0.05) 
between the prescribed inner diameters of vessels and their fabricated (except for 2.0 and 
1.2 mm) and CAD representations. The measured difference between the CAD and 
prescribed inner diameter increased as the prescribed inner diameter size decreased. 
Henceforth, the reported inner diameter measurements are corrected values based on the 
observed diameter-dependent error. 
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Table 3.1 Inner diameter data for test block. Statistical summary and analysis of inner diameter 
measurements collected for vessels with a wall thickness of 0.6 mm. 
Prescribed   
 [mm] 
 CAD (n=12) 
[mm] 
 Fabricated (n=12) 
[mm] 
  mean ± stdev  % deviation*  mean ± stdev  % deviation† 
0.9  0.750 ± 0.013  -16.6  0.77 ± 0.11  -14.4 
1.0  0.862 ± 0.008  -13.8  0.84 ± 0.15   -15.8 
1.2  1.086 ± 0.027  -9.51  1.17 ± 0.06   -2.64 
1.5  1.385 ± 0.041  -7.66  1.44 ± 0.07  -4.33 
2.0  1.930 ± 0.018  -3.48  1.97 ± 0.10  -1.29 
4.0  3.983 ± 0.023  -0.42  3.90 ± 0.12   -2.40 
n = sample size 
* % deviation = (CAD measurement of inner diameter – prescribed inner diameter) / prescribed 
inner diameter x 100 
† % deviation = (physical measurement of inner diameter – prescribed inner diameter) / 
prescribed inner diameter x 100 
 
3.5.2  Limiting resolution for SLS fabrications 
The minimum, reproducible inner diameter dimension was determined through an 
iterative fabrication process that generated straight hollowed cylindrical vessels. Physical 
(digital caliper) measurements demonstrate a reproducible construction of vessels with an 
inner diameter and wall thickness as small as 770 ±110 microns (Table 3.1) and 600 
microns, respectively. For the two test blocks generated, all vessels with prescribed 
diameters greater than or equal to 900 microns (prescribed inner diameter in algorithm) 
showed patency after an air and water flush; vessels smaller than 900 microns diameter 
were occluded by fused PCL powder. All subsequent prototype phantoms built on the 
SLS system consisted of vessels with inner diameters greater than this resolution limit. 
 
3.5.3  SC/SL, SLS and ICC scaffold porosity 
Fig. 3.11 depicts the variability in porosity for the various porogen ranges used to 
fabricate SC/SL scaffolds. Three of the six ranges of examined SC/SL scaffolds produced 
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consistent porosity between 89-93 ± 1-5%. Scaffolds with porogen sizes less than 106 
microns, 106 – 180 microns and 180-300 microns experienced larger standard deviations 
in porosity 79% ± 14%, 84% ± 9%, 81% ± 13% respectively. Since only the 300-600 
micron and 700-1000 micron scaffolds were reliably fabricated with consistent porosity, 
future permeability studies only utilized theses scaffolds. The porosity of the 2.2 mm and 
2.15 mm pore design fabricated on the SLS were 68% and 58%, respectively.  
 
Figure 3.12 A box plot of the porosity for the fabricated SC/SL PCL scaffolds. 
 
Manufactured ICC scaffolds were sponge-like, with the core of the scaffold that still 
enclosed remnant beads, which were not dissolved by the hydrochloric acid. The ICC 
scaffolds were easily malleable and deformed to the touch. In application, the integrity of 
the scaffold was compromised upon placement in the scaffold compartment. As such, the 
architectural and flow characteristics of the scaffold were not evaluated. 
 
3.5.4 Scaffold hydraulic permeability and differential flow 
Hydraulic permeability and differential flow results are reported as mean ± standard 
deviation in Fig. 3.12. The experimentally measured hydraulic permeability values for the 
SLS scaffolds were 7.5 x 10
-6




/N·s and 6.3 x 10
-7





the 2.2 mm and 2.15 mm pore design, respectively. The hydraulic permeability of the 
SC/SL scaffolds were 4.7 x 10
-7




/N·s and 9.1 x 10
-9







the 700 - 1000 micron and 300 - 600 micron porogen fabrications, respectively. Fig 3.12a 
depicts the hydraulic permeability range for both groups. Differences in permeabilities 
were statistically significant (P-values< 0.05) between all groups, except for the low 
permeability SLS scaffold and high permeability SC/SL scaffold. Fig. 3.12b illustrates 
the range of differential flow achievable with the two investigated techniques. SLS 
scaffolds exhibited a -22 ± 3% and -81 ± 6% differential flow, for high and low 
permeability scaffolds, respectively. SC/SL scaffolds showed a differential flow of -82 ± 
4%, and -90 ± 4% for scaffolds with 700 - 1000 micron and 300 - 600 micron particle 
size ranges, respectively. Differences in differential flow were statistically significant (P-
values< 0.05) between all groups, except the low permeability SLS scaffold and high 
permeability SC/SL scaffold. The SC/SL scaffolds and the 2.15 mm SLS performed 
similarly in terms of differential flow, although their estimated hydraulic permeability 





Figure 3.13 (a) Permeability and (b) differential flow for SLS (2.15 mm and 2.2 mm) and SC/SL (300-
600 µm and 700-1000 µm) scaffolds. The differential flow and permeability for all groups was 
statistically significant, except SLS (2.15 mm compared to SC/SL (700-1000 µm). The significance 
bar above the respective bars, along with ‘*’ indicate that the two groups are significantly different 
from one another (p-value < 0.05). 
 
The preliminary DCE-CT experiments discussed in the remainder of this paper were 
conducted using SLS scaffolds, since they were easily reproducible and exhibited low 
variability in their porous architecture. 
 
3.5.5  DCE imaging 
The CT attenuation values of the PCL/HA plastic mixture and phantom background were 





slice of the phantom within the tissue-mimicking bounding box over the time course of a 
DCE experiment. Air pockets were evident within each of the compartments and 
persisted through the duration of the experiments.  
 
 
Figure 3.14 Representative baseline axial image of a single slice of the phantom submerged with 
tissue-mimicking liquid volume. The highlighted regions of interest outline the location of the inlet 
(red) and scaffold compartments (blue). 
 
3.5.5.1  Concentration calibration 
Assuming uniform mixing between SBF and CA, the signal intensity of the SBF over a 
VOI was converted to a CA concentration based on a contrast calibration curve that was 





Figure 3.15 Contrast calibration curve generated from six vessels filled with varied concentrations of 
iodinated contrast agent. Linear fit between enhancement and contrast agent concentration. 
 
3.5.5.2 Volume of Interest Selection 
The mean intensity was measured over the given time course, for a volume of interest at 
the inlet and outlet of the enclosed within the phantom. These time-enhancement curves 
were generated from the acquired DCE-CT data for the high and low permeability 
compartments. The effect of VOI volume on enhancement is shown in Fig. 3.16.  Fig. 
3.16a illustrates four of the six contours examined at the inlet. In Fig 3.16b and Fig 3.16c, 
as the volume increases, the enhancement decreases along both the inlet and outlet. 











Figure 3.16 (a) Single axial image of phantom with four volumes of interest (VOIs) selected. Four 
VOI volumes delineated by the contours over the inlet of the phantom. The 10% and 20% volume 
are not visible in this image. Representative time-contrast enhancement curves generated from the 
VOIs shown in (a) and at the outlet of a high permeability compartment: (b) with VOIS at inlet and 
(b) outlet. Maximum VOI volume = 500 mm3. 
 
3.5.5.3  DCE phantom time-contrast enhancement curve analysis 
Fig. 3.17a and 3.18 outline the contours used to generate time-contrast enhancement 
curves. The three VOI locations selected along the inlet and outlet showed consistent 
enhancement results for all generated curves (A, B, C), except for at the inlet of the low 
permeability compartment. Fig. 3.19a and Fig. 3.19b illustrate input functions for the 
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high and low permeability compartments, respectively. Fig. 3.20a and Fig. 3.20b 
illustrate output functions for the high and low permeability compartments, respectively. 
Fig. 3.21 shows both “arterial” and output time-contrast enhancement curves on a single 
plot. In Fig. 3.21a, the output function is flatter and has a lower enhancement than the 
“arterial” input functions. However, in Fig 3.21b, the “arterial” functions show large 
variability in enhancement that was not alleviated by partial volume corrections or the 
alteration of the VOI volume. Fig 3.17b illustrates the artifact present in the DCE data 
that may have altered the input signals. For both the low and high permeability 
compartments, the input function arrives first at 4-5 seconds, followed by the output 
curve at 6-8 seconds. 
 
Across both phantoms (low and high permeability compartment), at t = 0 seconds, a 
bolus of contrast agent was injected into a plastic tubing connected to the vascular 
network. The curves demonstrate a sharp increase (t = 5 - 7s) in signal intensity across 
the phantom as iodine entered the network and reached the compartments, followed by a 
more gradual decrease as the bolus cleared and SBF entered the network (t = 8 - 19s). 








Figure 3.17 (a) Representative axial slice of DCE-CT scan of low permeability scaffold within 
phantom. Three volumes of interest selected at the input (“arterial”) and output (“venous”) of the 
phantom. t = 8 seconds. (b) Artifact (red arrow) shown in representative axial slice of DCE-CT scan 
of low permeability scaffold within phantom. Three volumes of interest selected at the input 
(“arterial”) and output (“venous”) of the phantom. Blue (A); Red( B); Green (C); from left to right. t 
= 8 seconds. 
 
 
Figure 3.18 Representative axial slice of DCE-CT scan of high permeability scaffold within phantom. 
Three volumes of interest selected at the input (“arterial”) and output (“venous”) of the phantom. 









Figure 3.19 Time contrast attenuation curves. Volumes of interest at inlet of phantom enclosing (a) 
high permeability scaffold and (b) low permeability. Baseline removal and partial volume correction 
performed. Representative axial slice view shown. SBF inlet flow = 1.4 g/s; CA inlet flow = 2.8 g/s. 









Figure 3.20 Time contrast attenuation curves. Volumes of interest at outlet of phantom enclosing (a) 
high permeability scaffold and (b) low permeability. Baseline removal and partial volume correction 
performed. Representative axial slice view shown. SBF inlet flow = 1.4 g/s; CA inlet flow = 2.8 g/s. 










Figure 3.21 Phantom enclosing (a) high permeability scaffold and (b) low permeability shown in 
single-slice view of VOIs used to generate time contrast attenuation curves at the vessel input and 
output. (Combined plots of Figure 3.19 and 3.20.) Baseline removal and partial volume correction 
performed. SBF inlet flow = 1.4 g/s; CA inlet flow = 2.8 g/s. Color coded volumes of interest 
correspond to Figures 1 and 2. Inlet-A (blue); Inlet-B (red); Inlet-C (yellow); Outlet-A (blue); Outlet-
B (red); Outlet-C (yellow). 
 
3.5.5.4  Evaluation of phantom leakage 
Figure 3.22 compares the AUC for the inlet (input function) and outlet (output function) time-contrast 
enhancement curves. For the high permeability scaffold, the input function AUC was 1.3 x 10
3 
± 110 and 
the outlet function AUC was 1.5 x 10
3 
± 79. For the low permeability scaffold, the input function AUC was 
1.6 x 10
3 
± 290 and the outlet function AUC was 2.3 x 10
3 
± 230. Within each compartment, the AUC of 
the output function was slightly higher. There was no statistical difference between the AUC for the input 




Figure 3.22 Area under the curve measurements for time-contrast attenuation curves in Fig. 3.21 
approximated using trapezoidal integration. Calculation performed after baseline subtraction and 
partial volume correction. For the high and low permeability scaffold compartment, there was an 
increase in area of 13% and 39%, respectively. No statistical difference in area under the curve for 
either scaffold type (Two-tailed student’s t-test with significance less than 0.01). 
 
3.5.5.5  Measurement of velocity and differential flow 
Fig. 3.23 outlines the VOIs used to calculate the velocities summarized in Table 3.2 and 
Table 3.3. Table 3.2 summarizes the experimentally, computationally and imaging-
derived velocities at the inlet of the phantom. The experimental and computational 
measurements are similar, while there is a marked decrease in that measured in the 
image. The DCE-measured velocity was computed using Eq. 3.12 at t = 9 seconds where 
Cinput was measured over the blue VOI in Fig 3.17a and Cvessel was measured over the red 
VOI in Fig. 3.17a. Cinput and Cvessel were calculated directly from the contrast calibration 
curve shown in Fig. 3.15. The final DCE-imaging derived velocity estimated distal to the 
T-junction and mixer, prior to the inlet of the vascular tree was 0.61 m/s. In Table 3.3, the 
velocity at the third and fourth level of bifurcation are lower than the theoretical values. 
Table 3.3 summarizes the theoretical (based on Eq. 3.17) “arterial” values and DCE-
imaging extracted measurements for both the “arterial” and “venous” vascular trees. 
Level 3 and 4 were arbitrarily used to demonstrate post-analysis; the same techniques can 
be used to compute the velocity at bifurcation level 1 and 2. The ‘before scaffold’ and 
‘entire scaffold compartment’ values shown in Table 3.2 and Eq. 3.4 (volumetric flow 
used instead of mass flow rate, before the scaffold and across the whole scaffold 
compartment) were used to calculate the differential flow across the low and high 
permeability scaffold. In both cases, compared to the experimental values, the DCE-
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imaging derived measurements underestimated the differential flow, by 12% and 32% for 
the low and high permeability scaffolds, respectively (Fig. 3.24). The high permeability 
compartment DCE-extracted measurement was -29% and for the low permeability 







Figure 3.23 (a) Volumes of interest selected at each level of bifurcation and over the scaffold 
compartment (11 mm). (b) Volume of interest delineates space before scaffold within the 
compartment (2 mm). Axial slice from DCE-CT scan of phantom. t = 8 seconds. Bifurcation level 3 –




Table 3.2. Mass flow measurement acquired distal to T-junction and mixer, prior to the inlet of the 
vascular tree. SBF inlet flow = 1.4 g/s; CA inlet flow = 2.8 g/s. 
 SBF (no bolus) [g/s]  
(Velocity [m/s]) 
SBF with bolus [g/s]  
(Velocity [m/s]) 
Experimental 2.1 ± 0.2 (0.51 ± 0.02) 3.5 ± 0.1 (0.85 ± 0.01) 
Computational 2.4 (0.58) 3.6 (0.88) 
DCE-imaging N/A 0.61 m/s 
Note:  
 Conversion from g/s assumes there is negligible density change to the SBF with the addition of 
contrast agent. 
 Phantom inlet diameter = 2.2 mm. Constant viscosity of fluid assumed to be 1080 kg/m3 
 
Table 3.3 DCE-measured estimated velocities across a high permeability scaffold compartment. 
DCE-extracted measurements were calculated using Eq. 3.10-3.12 and theoretical values were 








"Arterial" Bifurcation Level 3 0.007 0.007
"Arterial" Bifurcation Level 4 0.004 0.001
"Venous" Bifurcation Level 3 0.02
"Venous" Bifurcation Level 4 0.01
Before Scaffold 0.28




3.6  DISCUSSION 
The predictive value of metrics extracted from quantitative DCE imaging is well-
documented in clinical research studies across various organs and modalities. However, 
the lack of a validation phantom and/or standardization across studies limits the practical, 
clinical relevance of protocol/system sensitive results, and comparisons of derived 
metrics such as blood flow rate. Thus, the development of a physical dynamic flow 
phantom that mimics the behavior of time-contrast enhancement curves seen on in vivo 
imaging is multi-center use of DCE-derived metrics. Image-extracted metrics from the 
first-pass bolus kinetic curves provide results dependent on the different biological 
effects in the scanned organ. The hemodynamic changes in blood flow are dependent on 
vessel bifurcations, vessel compliance, vascular network tortuosity and the volume of 
available luminal space [33]. In addition, disease-induced pathologies can alter flow 
and/or the anatomy of vasculature, in cases of occlusion or hyper-vascularization [3]. The 
tunable architecture of the proposed vascular phantom provides the flexibility to model 
both normal and pathological conditions present in variable levels of flow. The change or 
drop in flow rate is measured using the metric, differential flow. A reasonable phantom 
design representative of “arterial” input will house compartments with scaffolds that 
exhibit differential flows that cover disparate ranges of flow resistance. 
While computer generated vascular trees are based on idealized conditions and 
theoretical principles, they have been shown to reasonably reproduce in vivo 
hemodynamic conditions [34-35]. The vascular networks are a key component to the 
flow phantom, as they are representative of the small artery structures that distribute 
blood to smaller microcirculatory-like compartments (Fig. 3.5). The vessels were 
fabricated with an inner diameter precision of 220 microns. The computed dimensional 
accuracy was within reasonable limits since the resolution of clinical CT scanners was 1 
mm, roughly 5 times larger than the calculated error (Table 3.1). Results indicate that 
there was a significant difference (p-values < 0.05) in the prescribed inner diameters of 
vessels and their CAD representations. As the prescribed inner diameter decreased, the 
fabricated inner diameter decreased. Statistical analysis showed a significant mean 
difference between prescribed inner diameters and generated CAD inner diameters, 
indicating a bias between planned and modeled inner diameters using the current 
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algorithms. The shrinkage may be caused by computational rounding and mesh 
smoothing during tree generation. A calibrated correction based on these measurements 
was subsequently applied to correct for this diameter-dependent systematic variation in 
the CAD phase of construction. During the iterative process of building test blocks, it was 
observed that thicker walls caused the lumens of vessels with inner diameters smaller 
than 1mm to completely fuse during the build process. The minimum measured 
(physical) inner diameter size of 620 microns was achievable, however repeated builds 
showed that only a minimum inner diameter of 770 microns was repeatable. The study 
demonstrates that a bifurcating vascular network can be reliably fabricated using SLS, 
but at a minimum resolution greater than that of a capillaries. The apparent limitation of 
the chosen polymer using the SLS fabrication technique is that it produces rigid walls, 
when in fact in vivo vasculature has some elasticity that causes wall motion in response to 
the pulsatile nature of arterial blood flow and compliant nature of the venous system. 
Using SLS or another RP method, an elastomeric material may offer physiological vessel 
wall motion.   
The literature suggests that in the assessment of bulk properties, such as permeability and 
volumetric flow, a simplified porous media may be representative of perfusion at the 
capillary level [36]. A multitude of scaffold fabrication techniques offer control over 
scaffold architecture: pore size, porosity and interconnectivity. SLS and SC/SL scaffolds 
were successfully fabricated with distinct architectural characteristics. SC/SL created a 
less structured, random arrangement of pores within a scaffold, while RP provided a 
more structured pore lattice. The generated SLS scaffolds possess throat sizes that were 
roughly 60% smaller than the pore diameter. SLS scaffolds had 100% interconnectivity 
between pores, and a porosity of 68% for larger pore design and 58% for the smaller pore 
design. SC/SL scaffolds were less interconnected since, during the fabrication process, 
some salt crystals became completely entrapped in molten PCL and did not dissolve out 
of the scaffold structure. SC/SL scaffolds with pore diameters between 300 to 1000 
microns were highly repeatable and achieved a porosity greater than 89% with less than 
5% variability.  
The fluid flow properties, in terms of permeability and differential flow of the porous 
scaffolds were evaluated using a SBF. The permeability of each scaffold described the 
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ease of flow of a fluid through a porous medium under a hydraulic gradient. There was an 
inverse relationship between permeability and differential flow, as lower permeability 
scaffolds exhibited a greater differential flow. The differential flow of the both SC/SL 
scaffolds and the 2.15 mm SLS scaffold exhibited a high differential flow, while the high 
permeability (2.2 mm pore design) SLS scaffold met the low end of the differential flow 
range.  
Based on experimentally measured hydraulic permeability values in the literature, other 
scaffold techniques and design parameters can be selected to achieve a hydraulic 
permeability that can expand the range and/or increase the resolution of the achievable 
differential flow shown in Fig. 3.12. Computational studies using a homogenization 
algorithm [37] estimated that a 100-300 micron porogens could achieve intrinsic 






. The computational estimated hydraulic 
permeability values suggested that a low permeability scaffold could be achieved, under 
more structured, reliable (in terms of porogen size and porosity variability) conditions. 
However, the ICC scaffolds fabricated with porogens between 30 - 150 microns had poor 
integrity and therefore it was tested. The high differential flow achieved by the SLS (2.15 
mm) and SC/SL scaffolds, abrogated the need for a scaffold with lower permeability, at 
the level of ICC scaffolds  
DCE imaging demonstrated that tissue equivalent CT signal values were within a 
reasonable operating range for simulating tissue attenuation effects. For a fourth order 
vascular phantom, the DCE-CT data demonstrated a bolus entrance and clearance form 
with desired behavior (Fig. 3.21). While most DCE analysis will be at a reduced spatial 
resolution, the phantom successfully generated time-contrasts enhancements curves at the 
spatial resolution of the acquired images, as shown in Fig. 3.21. The DCE analysis 
demonstrated the ability of end-users to post-process the phantom data for comparison to 
theoretical, computational and experimental measurements. The difference in AUCs 
between the input and outputs curves for the high and low permeability compartments 
suggest that the phantom was not leaky (Fig. 3.22). DCE-extracted measurements of 
velocity and differential flow (Table 3.2 and 3.3) corresponded closely with experimental 
measurements (Fig. 3.25). It is expected that DCE-measured bifurcation values were less 
than the theoretical measurements, due to frictional forces present. However, within 
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larger channels, such as at the inlet, measurements closer to the experimental and 
computational values were expected. 
Ongoing studies seek to provide a quality assurance tool to assess the reliability and 
reproducibility of regional blood flow estimates extracted during DCE imaging analysis. 
While immediately designed for CT, the phantom may be modified to meet the design 
requirements and output characteristics of MRI, single-photon emission computed 
tomography (SPECT) and/or positron emission tomography (PET) for dynamic imaging 
validation. The sensitivity of image-extracted metrics to parameters such as the volume 
of the selected volume of interest that are susceptible to partial volume averaging and 
noise must be examined in future studies in order to provide a robust validation tool. The 
sensitivity of these metrics may also be examined under a physiological pulsatile fluid 
flow. Along with these future adjustments, the next generation of the phantom would 
minimize the occurrence of air pockets in the compartment, so as to reduce the 
opportunity for signal distortion and the inaccurate calculation of differential flow. The 
phantom system should be tightly sealed at junctions prior to the inlet of the phantom to 
ensure that air is not introduced to the system. After the phantom is pulled under a 
vacuum, it should be transported to the CT scan in a vacuum sealed container, until it is 
ready for connection to the overall flow system. Future studies should consider lower 
SBF rates for which the CA speed can be match so as to generate more accurate estimates 
of velocity. In this study, the velocity was assumed to be the maximum velocity achieved, 
since there was an increase, followed by a decrease in the speed of the injected bolus. In 
addition, during post-processing, the contour of the VOIs on which partial volume 
correction is performed may introduce error into the final calculated velocities. As well, 
the accuracy of VOI volume measurements made by the in-house software analysis tool 
should be determined, as they directly affect the partial volume correction factor. 
To further mimic peak intensity values seen in vivo, the average peak can be adjusted 
through dilutions of the contrast agent. Future studies should also determine the desired 
differential flows and/or velocities that would capture the low and high flow rates seen in 
vivo. Previous studies have been cited as evaluating unrealistic capillaries exchanged 
within their phantoms. Although the developed phantom does not solve this modeling 
challenge, the tortuous nature of scaffolds with their pore diameters which fall below the 
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resolution of typical CT, increases the complexity of exchange within the single channel 
model.  
Overall¸ these vascular networks provide a structure from which a more complex system 
can be design from and coupled with a multitude of scaffold techniques. The stated 
limitations of RP establish the extents to which this technique can be used in the 
development of a vascular phantom. Based on the design, future generations of the device 
can be scaled up to build systems larger volumes (greater than the 4ml shown here) for 
analysis of larger regions of interest. 
 
3.7  CONCLUSION 
The proposed SLS, rapid prototyping technique offers a consistent, reliable method to 
fabricate bifurcating vascular networks to a minimum resolution less than 1 mm. Porous 
compartments that exhibited a distinct range of differential flow were realized. Time-
contrast enhancement curves generated from DCE-CT illustrated the utility of the 
dynamic flow phantom. The DCE-CT signals exhibited desired behavior for an “arterial” 
input function and delayed compartment curve. Further improvements to the dynamic 
flow phantom are necessary for a more comprehensive evaluation of its extractable 
metrics and its sensitivity to post-processing parameters. 
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CHAPTER 4  
 
A Computational Fluid Dynamics (CFD)-Based Approach to Assessing Flow in a 




Purpose:  The complexity of recent dynamic imaging phantoms has increased, such that 
they grossly model anatomical and/or hemodynamic changes representative of in vivo 
perfusion. This study sought to establish the range of differential flow achievable within a 
dynamic imaging phantom, as measured by computational fluid dynamics (CFD).  
Methods: Transient flow of a simulated blood fluid (SBF) was analyzed within a CFD 
representation of a physical flow phantom. The mixing of injected contrast agent with 
SBF was qualitatively and quantitatively evaluated. Using CFD modeling techniques, the 
differential flow across permeable compartments was evaluated using a porous geometry 
and porous jump model. A correlation was generated to create a predictive model, which 
could be used to determine the achievable differential flows across the porous scaffold 
architecture given a known intrinsic permeability. Quantitative comparisons were made 
between the experimentally and computationally measured bulk flow changes within the 
phantom system.  
Results: The performed simulations demonstrated the importance of an inline mixer that 
produced an increase in fluid homogeneity within the phantom system. The CFD 
simulations closely matched experimental differential flow results and provided a 
prediction model to determine the intrinsic permeability of porous media needed to 
increase the resolution of differential flow changes achievable within the system. 
Simulation results were within the error margins of reported experimental results for high 
(-73% to -77%) and low (-21% to -25%) differential flows for the low and high 
permeability scaffold compartment models, respectively.. 
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Conclusions: CFD can be used to assess changes in bulk flow across scaffold 
compartments with controlled architecture that exhibit disparate differential flow changes 
within a physical, dynamic imaging phantom.  
 
4.1  INTRODUCTION  
Dynamic contrast enhanced (DCE) imaging is currently under investigation as an 
imaging biomarker indicative of tumor aggressiveness, and tissue response to treatments, 
such as focal irradiation [1-4]. The imaging technique involves the acquisition of a time 
series of single slice images after the injection of a contrast agent (CA) into a patient. The 
presence of CA allows for the temporal and spatial localization of blood in the volume of 
interest (VOI). Each voxel within the VOI of the acquired image series is analyzed to 
extract bulk properties of tissue perfusion (regional blood supply to tissue). The perfusion 
estimates provide metrics that can be used to directly track and potentially predict disease 
progression [5-7]. Across imaging systems and institutions, the implementation of a 
physical, dynamic phantom capable of validating DCE-extracted measurements can 
support imaging biomarker-based clinical decisions [8-9]. Unfortunately, DCE imaging 
validation studies have evaluated various blood flow metrics, in different tissue types, 
both in human and animal experiments, thus making comparisons difficult [9-16]. 
Using the analysis of time-contrast concentration curves generated from dynamic flow 
phantoms, comparisons can be made on the reliability of various post-processing DCE 
imaging algorithms across systems. Recently, Driscoll et al. [17] presented a re-usable 
phantom to measure flow using DCE- Computed Tomography (CT). The DCE-
Computed Tomography (CT) single compartment phantom developed by Driscoll et al 
[17] generated time-attenuation curves (TACs) with tunable peaks and shapes based on 
arterial input functions (AIF) generated from the flow of blood mimicking fluid (2:3 
glycerol-water, 2.5 - 5 ml/s) and iodinated CA (0.27 - 1.5 ml/s). The system was 
successful in closely matching the shape (in terms of duration and residual enhancement) 
and peak (in terms of enhancement) of a typical AIF. Driscoll et al. cited that the possible 
non-uniform dispersion of CA and heterogeneous mixing of SBF may have caused 
variability in experimental results across the phantom, in terms of the CA retention half-
life and the peak intensity and shape of generated curves over repeated experiments.  
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Thomas et al. developed a phantom with anatomically relevant features that achieved 
bulk flow characteristics below the resolution of a standard clinical CT scanner [18]. The 
vascular phantom consisted of a vascular tree (diameter of small arteries) that perfused 
four porous compartments and then mirrored a vascular tree on the venous (diameter of 
small veins) end of the system. Reported experimental measurements of flow across the 
porous compartments created differential flow (DF) rates that exhibited variable flow 
resistances.  The current study applied CFD to investigate the DF range achievable with 
the branching network phantom we previously developed, as well as to compare these 
CFD models with experimental DCE imaging data. The uniformity of flow across the 
system was qualitatively and quantitatively assessed for system with and without a fluid 
mixer distal to the inlet of the vascular phantom. CFD simulations were performed to 
determine the degree of mixing between the SBF and injected iodinated CA. The results 
provide comparative range of DF values that can be used to evaluate the sensitivity of the 
device to post-processing techniques used in DCE-CT. 
 
4.2  METHODOLOGY 
Each cylindrical compartment houses an 11 mm high x 11 mm diameter porous scaffold 
with 0.5 mm of space before and after the inlets and outlets of the attached vascular tree. 
The two mirrored trees are adjoined by a threaded compartment holder (11 mm inner 
diameter) which tightly bounds the scaffold, such that water only passes through the 
permeable scaffold. The fourth-level of bifurcation in the vascular tree that directly 
perfuse the compartment are 2 mm in length and 0.79 mm in diameter. Four vascular tree 
outlets and inlets are adjoined to the compartment (shown in Fig. 4.1a). The vascular 
phantom incorporates a porous scaffold at the midpoint of the mirrored vascular tree 
design. The vascular phantom is roughly 12.6 cm long and 5.6 cm in width. Fig. 4.1b-c 
illustrates the setup of the modeled dynamic phantom. SBF circulated through the system 
at a pump rate of 50 ml/min. 4cc of CA was injected into the system at rate of 2 cc/s by a 
standard power injector controlled by the CT scanner. The CA inlet tubing was flushed 
with 15 cc of SBF at 1cc/s before and after the injection of the bolus. Imaging 





Figure 4.1 (a) Vascular phantom: “arterial” vascular tree adjoined to four scaffold compartments 
that connect at their outlet to a “venous” vascular tree. (b) Schematic representation of the 
assembled single-input single-compartment flow phantom within the closed flow system. (c) Vascular 
phantom submerged in contrast-enhanced liquid in a bounding acrylic box. Vascular flow phantom 
adjoined to a closed system via luer lock connectors. Setup is positioned on a CT bed. The red box 
delineates the scaffold compartment built into the phantom (‘G’). 
 
4.2.1  Formulation of the CFD Model 
The phantom system was evaluated piecewise: vascular tree, scaffold compartment and 
stopcock (Fig. 4.1).  A CFD model was created for the three components. The generated 
A – SBF reservoir
B – peristaltic pump
C – pulse dampener 
D – contrast injector
E – stopcock
F – mixer
G – phantom (vascular network, scaffold compartment)










CFD model used physiologically relevant boundary conditions to simulate experimental 
and imaging conditions.  
 
4.2.1.1  Fluid Junction Model 
Iodinated CA (iopamidol, Isovue-300, Bristol-Myers Squibb, Princeton, NJ) and 
simulated blood fluid (SBF) combined at the three-way stopcock junction in the phantom 
system. SBF was pumped through three-sixteenth-inch (inner diameter) plastic tubing 
and CA was injected into the system through one-eighth-inch (inner diameter) plastic 
tubing. The respective tubes were fixed to a standard T-shaped medical stopcock via luer 
lock connectors. A 1.45-inch-inline static mixer was positioned downstream (one inch) of 
the stopcock. The inline mixer was designed in a computer-aided design (CAD) software 
program (SolidWorks, Waltham, MA) with five to six helical-like elements that created 
turbulence in order to enhance fluid mixing. Fig 4.2. illustrates the design of the stopcock 





Figure 4.2 CAD of T-junction that funnels CA and SBF into a single entry pathway towards vascular 
phantom. CAD of the inverse of the T-junction with inline fluid mixer positioned downstream of the 
T-junction outlet. (b) Single unit of the helical mixer (complete mixer composed of 6 repeating units). 
 
4.2.1.2  Vascular Tree Model 
The vascular tree component of the phantom was composed of rigid, hollow, symmetrical 
cylinders with a 0.6 mm wall thickness. Each parent branch gave rise to two offspring 
branches. The vascular tree was designed to adhere to the following principles: (1) 
Murray’s law (bifurcation rule) given in Eq. 4.1, where r is the radius of the vessel and r 
> 0 [19]; (2) the conservation of mass provided in Eq. 4.2, where Q is the volumetric flow 
rate; and (3) Poiseuille’s law in Eq. 4.3 [20], which considers blood to be an 















arteries and veins. In Eq. 4.3, ΔP is the pressure drop across the cylinder, l is the length of 
cylinder and μ is the fluid’s dynamic viscosity; 
       
                  
                   
  Equation 4.1 
                                         Equation 4.2 
           
    
 ,  Equation 4.3 
 
Selective laser sintering was used to generate the designed vascular tree. The rapid 
prototyping method accepts stereolithography (STL) files, which store a triangulated 
surface mesh rendering of the designed part. The STL file was reverse engineered using a 
meshing software tool (3-matic™, Materialise, Belgium) to generate Initial Graphics 
Exchange Specification (IGES) files for CFD simulations (Fig. 4.3). The surface mesh of 
the tree was coarsened to balance the geometry accuracy and the amount of 
computational resources needed to reverse engineer the component. The surface mesh 
was modified to rectify bad edges, holes, shells, inverted normal, and intersecting and 
overlapping triangles.  
 
Figure 4.3 Side view of CAD of fluid domain enclosed within vascular tree. Tree decreases in 
diameter over four levels of bifurcation, from one 2.2 mm inlet to sixteen 0.79 mm outlets that 
perfused 4 cylindrical compartments. Vertical black lines indicate cross-sectional planes where the 




4.2.1.3  Modeling of Scaffold Compartment 
A CAD model of a single compartment within the imaging phantom (Fig. 4.4) was 
designed in SolidWorks (Waltham, MA), then meshed and analyzed in a CFD simulation 
platform (ANSYS Workbench and Fluent, Canonsburg, PA). Two compartment models 
were evaluated through CFD simulations. The first model recreated the geometry of a 
single spherical pore scaffold within the compartment space of a vascular tree (Fig. 4.4) 
in order to the fluid behavior of the porous scaffolds. The inlet and outlet geometry of the 
vascular tree, along with that of the scaffold were replicated in Solidworks. Two porous 
compartments were generated to represent two distinct permeability values that were 
previously experimentally evaluated with DCE CT imaging. A 2.15 mm and 2.2 mm 
spherical pore diameter was repeated every 2 mm to fill a cylindrical porous zone within 









intrinsic permeability scaffold, respectively (as discussed in Chapter 2 [18]). The porous 
zone was 11 mm in height and diameter. The four inlets had a diameter of 0.79 mm and 
length of 2 mm. 
 
 
Figure 4.4 Side view of CAD of (a) a scaffold enclosed in a single compartment in bioreactor and (b) 
the inverse geometry of (a) representing the fluid volume in Fluent. Representative volume (11 mm 
height and diameter) shown for spherical pore geometry. (c) Side view of CAD of the porous jump 






In the second model, a porous jump interface provided a two-dimensional simplification 
of the prior model. The porous jump interface was defined as the face at the center of the 
compartment, midway between the inlets and outlets (Fig. 4.4c). The four inlets had a 
diameter of 0.79 mm and length of 2 mm. 
This simplified porous model solved the porous jump Eq. 4.4 (Darcy-Forchheimer 
equation) to determine the resistance to be added to the flow through the volume, based 
on the boundary conditions set for the face (intrinsic) permeability (m
2
) ( ), medium 
thickness (meters) (  ) and pressure jump coefficient (  ).  
 
    (
 
 
    
 
 
   )    , Equation 4.4 
 
where   is the viscosity,   is the velocity normal to the porous face,   is the density and 
   is the pressure drop. The pressure jump coefficient was set to zero (negligible) since 
in the case of laminar flow through a porous media, the pressure drop is proportional to 
velocity. Based on the dimensions of the scaffold, the medium thickness was set to 0.011 
meters. The simplified model evaluated the DF values achievable over a range of intrinsic 
permeability values. The selected intrinsic permeability values represented the range of 
low to high permeability values realizable in physical fabrications of the porous 
compartments. The intrinsic permeability (ki) was calculated as the product of the 
measured hydraulic permeability and the estimated constant viscosity of the fluid.  
 
4.2.1.4  Biofluid Characterization 
 
Simulations were performed using the viscosity of a non-Newtonian mixture of 35% 
water, 65% glycerin and 0.0075% Xanthan gum (by weight) [21]. The dynamic viscosity 
of five SBFs was acquired using a rheometer (AR1000 Rheometer, TA Instruments, New 
Castle, DE) at 25˚C for shear rates ranging between 0.02 to 1500 s
-1
. The viscosity 
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measurements were used to model the non-Newtonian SBF as a Carreau fluid. The shear 
rate dependence of viscosity was described by the Carreau-Yasuda Eq. 4.5 [22], where a 
= dimensionless constant, μ = apparent dynamic viscosity,  μ∞ = infinite shear rate 
viscosity, μ0 = zero shear rate viscosity, λ = time constant,  = shear rate and n = power 
index:  
 Equation 4.5 
 
A non-linear least-squares curve fitting was used to fit the experimental SBF viscosity 
data to the Carreau model, using Microsoft Excel Solver. The solver minimized the sum 
of the squares of the deviations between the actual viscosity data and the predicted values 
of viscosity. The model parameters served as input to the CFD model along with the 
manufacturer reported viscosity and density values for the CA, which were 4.7 cP and 
1.369 g/ml at 37ºC, respectively. 
 
4.2.1.5  Meshing and Boundary Conditions  
Each model was meshed with tetrahedral elements using a patch conforming method. 
Inflation layers were added to the inlet, fluid volume (porous area and static mixer) and 
outlet boundaries. For each inlet, a mass flow rate (kg/s) was set along the primary 
direction of flow, y-direction relative to the orientation of model in the CFD software 
(Fluent, Waltham, MA). An in-house flow meter system was used to measure the flow 
rate of SBF at the outlet of the tubing that connected to the stopcock. The mass flow rate 
at the inlet boundary of the simulation was set to 0.0014 ± 0.0001 kg/s based on the 
acquired flow meter measurement. The mass flow of the CA was set to 0.0028 kg/s. For 
SBF flushes through the CA inlet, the mass flow was set to 0.0014 kg/s. Each outlet was 
set to a pressure outlet (1 atm) boundary condition. The outflow boundary condition 
assumes a zero normal gradient for all flow variables except pressure. Since, each porous 
compartment was close to identical and due to the symmetry of the over vascular 
phantom design, the no pressure variations between outlets was assumed. No-slip on all 




compartments, mesh independence tests were performed to ensure that the number of 
meshing elements reduced the sensitivity to less than 5% (Appendix D.1).   
The fluid entering the network and compartment were modeled as incompressible, 
isothermal and laminar (see Table 4.1). Laminar flow at the inlets was confirmed by 
computation of the Reynolds number, Re, which for values less than 2300 indicate 
laminar flow. The Reynolds number was calculated using the following Eq. 4.6, where   
is the SBF density (kg/m
3
), Q is the volumetric flow rate (m
3
/s),    is the hydraulic 





 Equation 4.6 
 
Table 4.1 Flow conditions required to satisfy laminar flow within the phantom, based on a 50 ml/min 
SBF pump flow rate at the inlet of the system. 
Component Inlet Diameter (mm) Reynolds Number 
Stopcock – SBF inlet 3.2 153 
Stopcock – CA inlet  3.0 55 (126*) 
“Arterial” Vascular Tree 2.20 395 - 576 
Compartment 0.79 102 
* SBF flush precedes and follows CA injection through the CA inlet. 
 
4.2.2  CFD Flow Simulations 
Simulations were carried out with a two-phase mixture model (for stopcock and porous 
compartment) and single-phase model (for vascular tree and porous jump compartment 
model) in commercial CFD packages (version 14.0, ANSYS Fluent). The vascular tree 
and porous compartment were assumed to be rigid solid objects, receiving constant, non-
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  ⃑    ⃑ )              (momentum) Equation 4.7 
   ⃑    (continuity),  Equation 4.8 
 
where   is the fluid density (kg/m3),   is the fluid velocity vector,   is the pressure (Pa), 
  is acceleration due to gravity (m/s2) [24] and   is the rate dependent dynamic viscosity 
defined by the Carreau model (Eq. 4.5). A pressure-based solver, and laminar flow 
model, under the assumption of shear-dependent viscosity and constant density was used. 
In Fluent, the velocity-pressure corrections were calculated using the SIMPLEC (Semi-
Implicit Method for Pressure Linked Equations - Consistent) algorithm [25]. A least 
squares cell based gradient algorithm and standard pressure algorithm were used in for 
spatial discretization. To reduce numerical diffusion, a second order upwind was 
performed. The tolerance of (spatial) convergence for the continuity, x-velocity and y-
velocity were set to 1 x 10
-3 
for the porous jump model and 1 x 10
-6 
for all models. A 
±5% sensitivity level was acceptable for the spatial mesh independence (Appendix D.1). 
In the in commercial CFD code, a two-phase, liquid-liquid, mixture model for miscible 
fluids was implemented under a transient flow field. The transient model was based on an 
Euler-Euler approach (Volume of Fluid model), wherein the model assumes the separated 
heterogeneous flow and solves momentum equations for the mixture. The segregated 
solver was used to solve the governing equations. The second-order upwind scheme was 
used as the discretization scheme in the governing equations. The SIMPLE (Semi-
Implicit Method for Pressure Linked Equations) algorithm [26] was used to resolve the 
velocity-pressure coupling used for the transient calculations for the under-relaxation 
factor of 1 (momentum and pressure combined). A second order upwind method was 
applied to the transient simulations. A time step was set to 1. The tolerances of (temporal) 
convergence for the continuity, x-velocity and y-velocity were set to 1 x 10
-3
.  Appendix 





4.2.3  Assessment of Changes in Bulk Flow within the Phantom 
A simulation study was performed on the efficiency of passive mixing of CA and SBF 
downstream of the T-junction. Streamline data was collected for two-phase flow 
introduced through the two inlets of the system. The distributions of CA and SBF before 
and after the static mixer were assessed to determine the overall mixer performance. The 
input mass flow to the vascular tree was set to the value of outlet mass flow rate from the 
T-junction. The mass flow rate at the outlets, after the fourth-level of bifurcation were 
measured and used as the inlet mass flow rate in compartment simulations. In addition, 
the uniformity of flow across the scaffold compartments was evaluated, as these changes 
affect intensity values analyzed during image post-processing. Flow parallel (profile near 
center, and right and left offset from center) and perpendicular (top, middle and bottom 
profile) to the direction of flow across the porous compartment was qualitatively assessed 
via visual inspection to identify hot spots (velocities more than two standard deviations 
greater than the average velocity across the 6 planes) and dead zones (velocities more 
than two standard deviations less than the average velocity across the 6 planes) within the 
compartment. The mass flow rate across the network was measured to determine the DF 
across the scaffold (see Fig. 4.2) and to compare flow rates against theoretical flow rates 
predicted by Eq. 4.2. Two planes were drawn perpendicular to the direction of flow in the 
porous and scaffold geometry models. For the porous geometry model, the top and 
bottom planes were slightly offset inward of the boundary edges (perpendicular to the 
direction of flow) of the porous scaffold within the compartment. For the porous jump 
model, the top and bottom planes were slightly offset outward of the jump interface (Fig. 
4.4c) (perpendicular to the direction of flow). The mass flow rate was calculated across 
the plane to attain CFD-based DF values. The DF (%) across the scaffold compartment 
was calculated by the following Eq. 4.9 
 
   
       
   




where MFi is the mass flow rate across plane 1 (g/s) and MFf was the mass flow rate 
across plane 2 (g/s). 
The CFD-calculated DF values were compared to the experimentally measured values for 
spherical pore scaffolds previously reported [18]. The DF values calculated from the 
scaffold geometry models were compared to values from the porous jump model for SBF, 
to assess the closeness of the models’ results. Based on simulations with the mixture of 
SBF and CA as the fluid, the DF values were calculated and compared to DF values 
calculated for SBF only, in order to determine the influence of CA. 
  
4.2.3.1 Accuracy of Experimental Hydraulic Permeability Measurement 
To evaluate the accuracy of the experimentally measured hydraulic permeability values, a 
benchmark comparison of the permeability output provided by the custom-designed flow 
meter was performed against another system previously published on by Sanz-Herrera et 
al. [27]. Sanz-Herrera et al. reported permeability values for Sponceram® carriers 
(Zellwerk, Oberkraemer, Germany) based on their in-house, Darcy-based permeability 
chamber (listed in Table 4.3). Their experimental permeability values were confirmed by 
homogenization theory-based numerical results. Three Sponceram® (30-
90)/Hydroxyapatite (HA) discs were acquired from Zellwerk. The discs were porous, 
zirconium dioxide based ceramic scaffolds. The height and diameter of each disc was 
measured to estimate the average dimensions of the samples. Micro-CT scans of each 
scaffold were acquired and processed using MicroView to calculate each specimen’s 
porosity. An average porosity was calculated for each scaffold type. The hydraulic 
permeability of the each scaffold was measured by water perfusion within the flow meter 
system [28]. To position the discs in the chamber, plastic tubes were custom-made (Objet 
Connex 500 using Accura® 60 plastic) to tightly fit the scaffold diameters. Each disc was 
run five times through the permeability chamber. Statistical values of the intrinsic 




4.2.3.2  Statistical Analysis 
A two-tail one-sample t-test was performed to determine whether there was a significant 
difference between the expected and observed DF values. The expected values were 
those computationally derived. The representative DCE imaging data served as the 
observed value. Statistical significance was defined as a P-value of less than 0.05. 
 
4.3  RESULTS 
The SBF rheology exhibited non-Newtonian, shear thinning characteristics. The shear 
stress increased and viscosity decreases, with increasing shear rate. The fitted data was 
compared to widely-accepted blood viscosity curves (Fig. 4.5a). The Carreau model 
coefficients, which provided the best fit were n = 0.23, a = 2, µ0 = 0.076 kg/m·s, µ∞ = 
0.004 kg/m·s and λ = 22.06 seconds. The SBF viscosity was Newtonian for shear rate 
values greater than 100 s
-1 
(Fig. 4.5b). For large shear rates values the dynamic viscosity 
was 3.64 x 10
-3
 ± 3.0 x 10
-3







Figure 4.5 (a) The SBF mixture was fitted by nonlinear least squares to Carreau model and 
compared to published findings for a similar SBF [29] and human blood fluid [30]. (b) Log-log scale 
plot of the SBF flow behavior for shear rates greater than 100 s-1 illustrate an approximately 
constant viscosity. 
 
Fig. 4.6 illustrates the path of the fluids through the stopcock then mixer 1 second after 
the bolus enters the system. The yellow and blue streamlines in Fig. 4.6 are intertwined 
proximal to the outlet. The discharge mass flow rate from the T-junction/mixer increased 
from 0.00248 kg/s to 0.00362 kg/s, with the addition of the bolus into system. As the 
fluid entered the “arterial” vascular tree the mass flow rate decreased after each level of 
bifurcation, closely matching theoretical estimations that were based on the conservation 












across offspring vessels within the same level is approximately ±0.01 g/s. The percent 
difference in mass flow across all bifurcations is less than 3%.  
 
 
Figure 4.6 (a) Flow conditions within the T-junction/mixer model, where the mass flow rate from the 
contrast injector is 0.00273 kg/s for CA and fluid from the peristaltic pump delivers a continuous 
stream SBF at 0.0014 kg/s. The blue and yellow streamlines show velocity trajectories for the SBF 






Table 4.2 Decrease in the average mass flow across the levels of bifurcation. The computational 
values closely match the expected theoretical values. 
Bifurcation Theoretical Mass Flow CFD-measured Mass Difference 
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Level (g/s) Flow (g/s) (%) 
0 3.62 3.59 -0.7 
1 1.81 1.79 -0.9 
2 0.91 0.89 -2 
3 0.45 0.44 -3 
4 0.23 0.23 0.003 
 
Using the porous jump model, the DF was estimated for the intrinsic permeability values 








. Lower intrinsic permeabilities produced increased 
resistance that resulted in a larger pressure drop across the compartment. Fig. 4.9 shows 
the DF measured across the porous jump, dependent on the applied intrinsic permeability.  
 
 
Figure 4.7 Porous Jump Model. Calculated DF based on the prescribed intrinsic permeability into 
the porous jump model.  
 
The measured average porosity, calculated experimental hydraulic permeability and 
estimated intrinsic permeability of the Sponceram® (30-90)/HA scaffolds are represented 
in Table 4.3. The measured intrinsic permeability was roughly one order smaller than that 
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of the published value. Based on these results and those reported Appendix D.2, a 
correction factor (roughly three times the original value) was applied to the experimental 
intrinsic permeability. An exponential curve was fitted to the data in Fig. 4.7 (DF = -0.9e
-
2E+07k
, where k = intrinsic permeability). The low intrinsic permeability value increased 




 (hydraulic permeability = 6.3 x 10
-6 









 (hydraulic permeability = 
7.5 x 10
-6 




. The porous jump-derived DFs for the low and high 
permeability compartments were -89% and -54%, respectively. Based on the porous jump 
model, the corrected intrinsic permeability generated DFs of -82% and -21%, for the low 
and high permeability scaffolds, respectively. 
 
Table 4.3 The benchmark experimentally measured permeability values (mean value ± standard 
deviation) for Sponceram®(30-90)/HA scaffolds [27] are compared to in-house experimental 
measurements. 
 In-house (n=3) Published  (n=5) 
Porosity (%)       78.8 ± 1.2 79.81 ± 2.18 
Experimental Permeability  (m
4
/N·s) 1.7 x 10
-6 





)  1.7 x 10
-9 
± 5.7 x 10
-10
 1.79 x 10
-8




The computational estimations of the DF across the low and high permeability 
compartments from the porous geometry model were -77% and -21%, respectively. Fig. 
4.8 compares the experimental results from Chapter 3 to the porous geometry simulation 
measurements. The porous geometry and porous jump-corrected DF measurements were 
not significantly different from the experimental measurements (p > 0.05).  The porous 
jump-corrected DF was slightly greater than the porous geometry DF for the high 





Figure 4.8 Comparison of measured DF between experimental and computational (porous geometry). 
There was no statistical difference (p > 0.05) between the simulation and experiment measurements. 
 
For the high permeability compartment, the average velocity was 0.067 m/s ± 0.033 m/s, 
with hot zones occurring for velocities greater than 0.098 m/s and dead zones for 
velocities less than 0.035 m/s. The contour maps in Fig. 4.9a illustrate the range of 
velocities across the high permeability compartment for the transverse and longitudinal 
planes. Fig 4.9b shows the velocity contour maps for the low permeability compartment. 
In the low permeability compartment, the average velocity was 0.015 m/s ± 0.007 m/s, 
with hot zones occurring for velocities greater than 0.022 m/s and dead zones for 
velocities less than 0.008 m/s. In Fig. 4.9a-b, the maximum velocity was set to the 
represent hot zones and the minimum velocity to dead zones. The four-inlet designed 
fully perfused both compartments. Zero velocities only occurred at the walls of the 
design. For the high permeability compartment, along the transverse and longitudinal 
planes the center of the pore (cylindrical core) received the greatest velocities. While for 
the low permeability compartment, a larger fraction of the pore was perfused at a high 
velocity along the transverse plane. Along the longitudinal planes, the lowest velocities 
were experience at the middle of the compartment. For both compartments, non-spherical 
pores (quarter or half of a pore) at the edges of the cylindrical compartment received the 





Figure 4.9 Contour map illustrates velocity profile across (a) high permeability and (b) low 
permeability compartment along the longitudinal (top row, from left to right: left offset, near center 






4.4  DISCUSSION 
The implementation of the proposed dynamic flow phantom into routine quality 
assurance of clinical CT systems can provide hemodynamic behavior across bifurcating, 
arterial-like, vessel structures with differential flow across scaffold compartments. 
Experimental and computational characterization of the physical system is important to 
realize the benefits of a physical, dynamic quality assurance tool in the clinic or as a 
research tool. CFD uses numerical methods to solve fluid mechanics equations and 
analyze fluid flow through a construct. This paper used the CFD software FLUENT to 
assess flow conditions of the bifurcating tree and porous media flow within the phantom 
system illustrated in Fig. 4.1. The system was evaluated piecewise — T-junction/mixer, 
“arterial” vascular tree and porous compartment — in order to customize the mesh for 
each complex geometry and to reduce the computational cost of the simulations. The 
mesh quality was optimized to maintain the contours of the original volume geometry, to 
have sufficient element quality (specifically, in terms of skewness) and to balance the 
number and size of elements in order to be computational feasible (balancing accuracy 
and convergence). Appendix D.1 provides the mesh independence data for each model. 
CFD is often used to examine wall shear stress, pressure and velocity profiles within 
arteries and porous media [31-36]. Computational evaluation of the physical phantom 
investigated in Chapter 3 [18] can support the previously reported experimental data, as 
well as address phantom design or setup concerns, such as signal enhancement variations 
caused by inadequate mixing/dispersion of the bolus. As such, both the fluid and 
geometry of the phantom were modeled. The aggregation of red blood cells along the 
center axes of small blood vessels in vessels of decreasing diameter (less than 800 μm) 
cause blood to exhibit non-Newtonian behavior due to the shear-dependent (less than 
100/s) changes in viscosity [37-41]. The SBF composed of 65% glycerine and 0.0075% 
Xanthan gum at 25˚C achieved the viscous properties of human blood and demonstrated 
shear-thinning, non-Newtonian behavior that was fit to the Carreau model (Fig. 4.5). The 
determination of an appropriate SBF at 25˚C eliminated the need for temperature 
regulation of the phantom device, beyond the controls of the imaging room. The warmed 
CA that was introduced to the system had a density and viscosity similar to that of human 
blood. In vivo, the iso-osmolality of CA compared to plasma reduces the potential for the 
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increased disaggregation of red blood cells with increasing concentration of contrast 
medium [42-43]. Thus, the resultant viscosity of the combined solution is assumed to not 
be affected by mixing in CA. As such, models downstream of the contrast injection 
assume the viscosity and density of the SBF.  
It was important integrate a mixer into flow phantoms in order to provide adequate 
mixing, similar to the diffusion that occurs in vivo, downstream of the CA injection site. 
Non-homogenous mixing can lead to variability in the extracted flow rates. Table 4.1 
demonstrates that the CA and SBF flow conditions entering the stopcock/mixer (shown in 
Fig. 4.2) were laminar. Fig. 4.6 illustrates that the CA and SBF fluid layers were stratified 
prior to entry into the helical mixer. The stream path after the mixer demonstrated 
increased mixing of the fluids, with a reduced layering effect.  
DCE post-processing techniques delineate the high intensity voxels within VOIs located 
in the input arterial structure (aorta or major artery) and parenchyma of interest, in order 
to extract signals used to estimate blood flow rates. As such, the flow in the “arterial” 
vascular tree (Fig. 4.3) and discharge flow within the porous compartments (Fig. 4.4a-b) 
were qualitatively and quantitatively evaluated. Given the maximum output flow rate 
from the mixer, simulations of the vascular tree (Fig. 4.3) demonstrated that the flow rate 
decreased across the bifurcation levels (Table 4.2), as expected, closely matching 
theoretical predictions (less than 2% difference). A uniform distribution of fluid entered 
the porous compartments. The velocities exhibited at the inlet (1.5 x 10
-3 
m/s) and outlet 
(3 x 10
-4 
m/s) of the vascular tree fall in the range found in vivo, within small human 
arteries and arterioles, respectively [44].  
The flow resistance experienced within the compartment was characterized using the 
intrinsic permeability of the porous scaffold. A porous jump model (Fig. 4.4c) was used 
to simulate flow at intrinsic permeability within a reasonable range attainable using 
scaffolds (i.e. selective laser sintering and solvent casting/salt leaching). Fig. 4.7 shows 
the exponential relationship between measured DF and prescribed intrinsic permeability. 
Compared to the published permeability values for Sponceram® scaffolds, the designed 
in-house permeability measurement system was determined to underestimate the 
permeability of measured samples (Table 4.3). Based on the observed underestimation of 
119 
 
permeability by the in-house permeability setup, additional studies carried out to 
understand the influence of the Reynolds number and fluid viscosity on the measured 
hydraulic permeability for different scaffold geometries (see Appendix D.2). A correction 
factor was applied to the intrinsic permeabilities to estimate the DF. 
The results of the computational simulations, demonstrated that flow rate in the porous 
compartments decreased as the SBF moved across the scaffold compartments. These 
changes in DF mimicked the decrease in blood flow associated with the pressure drop 
exhibited in vivo as blood flows from arterioles down to capillaries. For the low 
permeability compartment, the DF was less than that of the high permeability 
compartment, likely due to the increased tortuosity in the pore architecture. Fig. 4.8 
showed that the simulation measurements for the porous geometry and porous jump-
geometry closely matched (± 5%), for the estimated correction factor (given the 
viscosity-dependent variability of the experimentally measured hydraulic permeability). 
The experimental results were not significantly different from the either of CFD models.  
By visual inspection, the flow across both compartments’ transverse planes was 
determined to be uniform based on the symmetry of the contour shown in Fig. 4.9a-b. 
Similarly, the flow across the longitudinal plane of the high permeability compartment 
was uniform, with the greatest flow rates occurring at the center of the spherical pore. 
However, for low permeability scaffolds, the longitudinal planes showed non-uniform 
flows, where the highest flow rates were experienced closer to the edges of the 
compartment.  
An improvement to the physical phantom and simulations would give the SBF a 
physiological flow waveform. As well, the simulation assumed that the vessel walls were 
motionless, due to the rigidity of the polymer used to manufacture the physical phantom. 
However, small arteries are elastic and small veins are highly compliant, with the visco-
elastic properties of their walls modulated by oscillatory flow. Future generations of the 
system and an associated CFD model would incorporate a dynamic motion model. Along 
with these additions, a coefficient of friction can also be incorporated to account for the 
fluid’s interaction with the polymer construct and tubing. This realistic frictional force 
model would dampen the fluid behavior and increase the complexity of the CFD model 
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along with the accuracy of results. The porous jump model provides a prediction tool to 
identify other scaffolding techniques or spherical pore geometries that can generate 
porous media within the range of -5% to -95%, in order to represent low and high 
differential flows within the system. 
 
4.5  CONCLUSION 
New dynamic imaging phantoms seek to maximize the benefits of rapid prototyping 
techniques to manufacture a validation tool that closely mimics the anatomical features 
and hemodynamic properties characteristics of distributed blood flow at the organ-level. 
This chapter demonstrates the use of CFD and experimental data to confirm flow 
characteristics (rate or differential flow) within a flow phantom that enclosed either low 
or high permeability compartments. Velocity flow rates from the artery-level down to 
arteriole-level were mimicked within the dynamic phantom. These results indicate that 
CFD can be reliably used to design phantoms to better mimic a range of DFs, for further 
development and testing of dynamic phantom for quality assurance for DCE imaging. 
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CHAPTER 5  
 
 
Comparative Computational Fluid Dynamics Study of Flow-Induced Shear Stress 
on Bone Scaffold Designs for a Perfusion Angiogenesis Bioreactor 
 
Abstract  
Pore geometries for bone scaffolds are optimized to enhance bone tissue in-growth into 
the scaffold. In this study, the distribution of flow-induced shear stress across large 
spherical and orthogonal cylindrical pore scaffolds (67 - 68% porosity) was examined 
using a computational fluid dynamics model. The scaffolds were embedded within a 
vascular-like perfusion angiogenesis bioreactor to identify the range of inlet velocities 
that achieved a stimulatory shear stress range between 1 to 10 dynes/cm
2
. The results of 
the simulations demonstrate a tradeoff between shear stresses within the target range and 
at the extremes (less than1 dynes/cm
2
 and greater than 10 dynes/cm
2
), in order to achieve 
flow within the confines of a laminar flow regime. The spherical geometry exhibit greater 
uniformity of shear stress across the scaffold and realized more than 50% of the large 
scaffold surface experiencing shear stresses within the desired range. These findings will 
aid in the development of thick scaffolds for perfusion angiogenesis bioreactors and the 
determination of optimal bioreactor operating conditions to be used in future in vitro 
angiogenesis co-culture or pre-vascularization implantation studies.  
 
5.1  INTRODUCTION 
Angiogenesis is critical for tissue viability [1-2] To date, clinically successful tissue 
replacement therapies have been limited to avascular tissues (the epidermis of skin and 
nasal septae cartilage [3]) and thin tissues less than 2 mm thick (adipose tissue [4] and 
smooth muscle [5]). Oxygen diffusion is a limiting factor to cell viability within tissues 
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greater than 2 mm thick, with necrosis normally occurring when oxygen must diffuse 
over a distance greater than 100 μm [3,6]. Oxygen depletion can occur within hours of 
implantation, due to inadequate pre-vascularization of the implant and a slow rate of 
angiogenesisv [7]. Several pre-vascularization strategies have been investigated to 
expedite angiogenesis [8-20]. Among them, perfusion angiogenesis bioreactors offer a 
continuous controllable dynamic in vitro environment for supporting endothelial cell 
proliferation and differentiation across engineered porous scaffolds under optimized 
growth conditions [17, 21-24].  Table E.1 in Appendix E summarizes recently reported 
studies of angiogenesis within perfusion bioreactors. The optimization of bioreactor 
parameters is a critical step in the promotion of physiological phenomena (i.e. 
osteogenesis [25-28], chondrogenesis [29-30] and angiogenesis) that are influenced by 
varied levels fluid-imposed shear stress (SS). 
 
Co-culture studies of endothelial cells (or their progenitors) with osteoblasts or 
mesenchymal stem cells have illustrated the potential of the in vitro three-dimensional 
pre-vascularization strategy, as a tool for accelerating vessel in-growth and enhancing 
osteogenic differentiation during implantation [31-33]. There have been extensive 
reviews on the design and viability of bone tissue engineering bioreactors [34-36]. 
Previous analytical and computational studies have demonstrated that the distribution of 
shear stress (ss) imposed by the flow rate across engineered constructs is dependent on 
pore geometry (random versus well-defined), pore diameter, anisotropy, permeability, 
diffusivity and porosity [37-43]. As such, the goal of the study was to quantitatively 
evaluate the local ss distribution within two distinct engineered constructs with 
commonly adopted controlled pore geometries (spherical and orthogonal) in bone tissue 
engineering [44-47]. Williams et al.[44] and Mitsak et al.[46] demonstrated that bone in-
growth representative of trabecular bone was evident within 4 weeks of subcutaneous 
implantation for the examined orthogonal and spherical pore geometries seeded with 
bone morphogenetic protein-7 (BMP-7) transduced human gingival fibroblasts, 
respectively.  
Mechanical stress is a modulator of cell physiology and morphology [48-50]. The 
literature demonstrates the role of mechanical stimulus, specifically fluid-imposed SS, 
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imposed by variable flow rates on EC proliferation and function during angiogenesis, 
both in two-dimensional and three-dimensional in vitro studies [22, 51]. Both high and 
low ss have implications on EC viability, elongation and alignment [52]. SS values below 
1 dyne/cm
2
 exhibit negligible shear force, comparable to static environments, while high 
values ranging from 1 to 15 dyne/cm
2
 have been reported to stimulate EC realignment 
along the direction of flow and EC proliferation on biocompatible substrates in vitro [53-
54]. SS from laminar flow above 20 dynes/cm
2 
and turbulent flow have been shown to 
alter cell morphology, as well detach cells from the construct [55]. Table E.2 in Appendix 
E summarizes the effects of ss on ECs and delineates ss levels that have been shown to 
promote EC growth and/or function.  
Existing angiogenesis perfusion bioreactors have primarily supported EC growth on thin 
hydrogels (1 - 5 mm; collagen or fibrin) (Appendix Table E.1). Predictive ss studies of 
natural scaffolds or scaffolds with random architectures are limited by the inherent 
variability of these constructs. Lesman et al. presented computational results on the flow-
induced shear rates on vascular cells seeded on porous sponges with 200-600 micron pore 
diameters [37]. Their computational fluid dynamic (CFD) model assumed a 500 micron 
diameter across the sponge scaffold for a given thickness of 1.2 mm. The transition to 
thick scaffolds for larger defect sites requires the consideration of uniform perfusion in 
order to avoid necrosis at the core of the scaffold. Koch et al. and Arano et al. have 
presented bioreactor studies that employed larger scaffolds for thick tissue generation 
[56-57]. Koch et al. demonstrated osteoblast proliferation on large engineered Poly-
95L/5DL-lactic acid (PLA)-calcium composite scaffolds (6 - 12 mm diameter) in a 
perfusion bioreactor and Arano et al. examined the efficiency of perfusion seeding for 
osteoblast-like cells onto 10 - 12 mm-thick scaffolds in a radial-flow bioreactor. There 
have been no similar studies published for ECs cultured on well-organized large 
scaffolds. 
In this study, a CFD model is used to estimate the local ss imposed on the walls of a large 
cylindrical scaffold embedded in a recently developed implantable vascular-like 
angiogenesis bioreactor (discussed in Chapter 6 [58]). For each geometry, the input flow 
rate was varied to determine which architecture and velocity at the inlet produces the 
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most uniform distribution of the imposed ss across the large scaffold, within a range of 1-
10 dynes/cm
2
 for a physiologically relevant input flow rate. 
 
5.2  MATERIALS AND METHODS 
5.2.1 Design of Perfusion Bioreactor System 
The analyzed closed-loop bioreactor system consisted of a pump that circulated EC 
culture media through a vessel-like network, which perfused adjoined EC-seeded 
scaffolds. The “venous” end of the vessel-like network shunted media towards a reservoir 
for re-circulation. Fig. 5.1a illustrates the implantable component of the bioreactor, which 
housed the scaffolds. The cylindrical scaffolds (11mm x 11 mm) were located at the 
center of the vascular construct, enclosed in a cylindrical holder 11 mm in diameter and 
10 mm in length. Within the compartment, a 500 micron guidance inlet was positioned 
before and after the scaffold. A holder tightly secured the scaffolds, in order to ensure 
perfusion through the scaffolds. Each compartment enclosed a single scaffold perfused 
with media by four 0.79 mm outlets from the preceding vascular tree. The outlets were 
aligned in parallel at the center of the compartment. Fig. 5.1b depicts the bioreactor set-
up. Flow from a peristaltic pump is dampened to produce constant flow prior to passing 
through a flowmeter, which monitored the dispensed flow rate entering the vascular 
construct (see Fig. 5.1b). The inlet and outlet diameter of the vascular construct had a 2.2 





Figure 5.1 (a) Vascular PCL construct which fed four porous scaffolds (12.0 cm length x 5.6 cm 
width). (b) Schematic diagram of bioreactor containing vascular network construct seeded with 
endothelial cells. 
 
5.2.2  PCL Scaffolds: Architecture and Fabrication  
Three-dimensional cylindrical scaffolds with periodic porous architectures were designed 
using Computer Assisted Design (CAD) design software (Solidworks, Waltham, MA, 
USA). The scaffold geometries included (i) a spherical unit cell enclosing a sphere with a 





5.2. illustrates the CADs for the spherical and orthogonal scaffold geometries. For the 
spherical scaffold designs, the unit cell was repeated every 2 mm to fill a cylindrical 
construct with an 11 mm height and 11 mm diameter. The 0.9 mm cylinders that formed 
the orthogonal lattice were repeated every 1.5 mm to fill a cylindrical construct with an 
11 mm height and 11 mm diameter.  
Triangulated surface renderings of the scaffolds were generated in the CAD software. 
The renderings were used to fabricate the scaffolds on an SLS system (EOS FORMIGA 
P100, EOS GmbH, Munich, Germany) using a mixture of polycaprolactone (PCL) with a 
small percentage of hydroxyapatite (HA). The SLS system was set to 49.5°C, with a 450 
mm focused laser beam diameter at 4.5W power and 1.257 m/s scan speed. The system 
used a 0.08 mm layer thickness. Three fabrications for each pore geometry were 
MicroCT scanned with an isotropic resolution of 15 μm (μCT 100, Scanco Medical AG, 
Bassersdorf, Switzerland). Diameter and porosity measurements for each MicroCT 
dataset were collected in a three-dimensional image analysis tool (MicroView, General 
Electric Healthcare, Waukesha, Wisconsin, USA). Measurements of the pore diameter 
and porosity for the designed scaffolds were collected in (Magics, Materialise, Leuven, 
Belgium) (Fig. 5.2c). Based on a comparison of the designed and fabricated scaffold pore 
and throat diameters, a correction factor was applied to the modeled CAD design 





Figure 5.2 (a) Top view of CAD and (b) trimetric cross-sectional view of CAD of bone scaffolds. (c) 
Axial (leftmost) and coronal slices (right) of three-dimensional renderings of spherical and 
orthogonal scaffold from Micro-CT scans. For the spherical geometry, a cross-section of the middle 
of a pore is shown. Red lines indicate measured pore. Scale bar = 1 mm. 
 
5.2.3  Bio-Fluid Characterization 
The endothelial cell culture media was modeled as a homogenous, incompressible fluid. 
The dynamic viscosity of the EC media was acquired using a rheometer (AR1000 
 heometer, TA Instruments, New Castle, DE) at 37˚C for shear rates ranging between 90 
to 1000 s
-1
. The fluid behavior of the EC media was characterized. The average of the 
collected viscosities was calculated. The density was calculated as an average of three 
repeated weighings of a known volume of the EC media on an analytical balance (37˚C). 
The estimated viscosity and density served as input to the CFD simulation. 
 
5.2.4  Formulation of CFD Model and Simulation Conditions 
For each geometry, flow through the scaffold compartment was evaluated for a single 
representative scaffold compartment, since Chapter 4 demonstrated uniform flow through 
the vascular network, which perfuses the four compartments in the system [59]. The 
vessels at the last level of bifurcation in the vascular tree were 2 mm long. Thus, a single 
scaffold compartment connected to four 2-mm-long inlets and outlets was designed in 
(a) (b) (c)
mid-pores ide view









CAD design software (Solidworks, Waltham, MA, USA) to represent the bioreactor. The 
generated fluid volume (Fig. 5.3a) was meshed with tetrahedral elements (ANSYS 
Meshing, Lebanon, NH, USA). Mesh independence tests were conducted to improve the 
accuracy of the solution. Mesh refinement was performed until the number of meshing 
elements reduced the sensitivity in the average shear stress to less than 5% (see Appendix 
E.2). Based on the evaluation of the spatial resolution, approximately 3 million elements 




Figure 5.3 CAD of the inverse geometry of compartment illustrates the fluid volume modeled in 
CFD, with vascular network outlets shunting EC media into the (a) spherical and (c) orthogonal 
scaffold compartment. The transverse planes (red) and longitudinal planes (blue) along which the ss 













CFD simulations were carried out using the commercial CFD package, Fluent (ANSYS 
Fluent, Lebanon, NH, USA). Each CFD simulation assumed the scaffold to be a rigid 
solid object, receiving constant, non-pulsatile flow. Simulations were solved using a 
steady-state Navier-Stokes equation, pressure-based solver, and laminar flow model, 
under the assumption of constant viscosity, constant density and continuity 
(incompressible flow). The solved Navier-Stokes equations for momentum 5.1 and 




              Equation 5.1 
    , Equation 5.2 
where   was the fluid density (kg/m3),   was the dynamic viscosity (kg/m·s),   was the 
fluid velocity,   was the pressure (Pa) and   was acceleration due to gravity (m/s2) [60]. 
The velocity-pressure coupling was solved using the SIMPLEC (Semi-Implicit Method 
for Pressure Linked Equations - Consistent) algorithm [61] (momentum and pressure 
under-relaxation factors summed to 1). Spatial discretization was achieved with the least 
squares cell based gradient algorithm, standard pressure algorithm and second order 
upwind algorithm for momentum. To reduce numerical diffusion, a second order upwind 
was performed. A no-slip boundary condition was imposed on solid walls. Convergence 






 for continuity and residuals, respectively. 
Each volume was meshed with tetrahedral elements. The mass flow rate (kg/s) at the 
inlets was set along the primary direction of flow, y-direction relative to the orientation of 
model. The outlets were defined as outflow boundaries, which assumed a zero normal 
gradient for all flow variables except pressure. Due to the symmetry of the vascular 
phantom design, there were no pressure variations assumed among the outlets. Inflation 
layers were added to the four inlets and outlets. The fluid entering the network and 
compartment were modeled as isothermal and laminar. Laminar flow at the inlets was 
confirmed by computation of a Reynolds number that was less than 2300 for relevant 
mass flow rates, based on the following equation 5.3 
   
    
  




where   was the density of given fluid (kg/m3), Q was the volumetric flow rate (m3/s),    
was the hydraulic diameter (m) and   was the dynamic viscosity (Pa·s) [62]. For the 
vascular tree and compartment,    was based on the inlet diameters, while for the 
orthogonal geometry,    was set to the pore diameter. For the spherical geometry, the 
throat diameter (smallest pore within geometry), which connected two adjacent spherical 
units, was used to estimate the maximum Re. 
 
5.2.5  Shear Stress Analysis 
The ss across the scaffold was determined along 6-7 planes (3-4 transverse and 3 
longitudinal) located at the middle and peripheral (1.4 mm below/above and left/right of 
edges) of the structures (Fig. 5.3b). The orthogonal scaffold has two transversal middle 
planes located 1.1 mm from the middle of the scaffold. Histograms were generated to 
evaluate the frequency of ss values along each plane. The maximum and average wall ss 
were computed. The median absolute deviation (MAD) was calculated using equation 5.4 
to evaluate the dispersion of induced SS.  
           (|    ̃|),  Equation 5.4 
where    is an indexed ss value and   is the median of the ss values within the given 
plane. Hotspots and dead zones were quantified by the relative frequency of ss values 
greater than 10 dynes/cm
2
 and less than 1 dynes/cm
2
, respectively.  
 
5.3  RESULTS 
Table 5.1 summarizes the scaffold properties for the spherical and orthogonal scaffolds. 
The void space within both designs is roughly the same, at 67 - 68%. Based on the pore 
diameter measurements collected from the μCT (Fig. 5.2c), the CAD designs were 
changed to the actual fabrication diameters. The spherical scaffold CAD designed pore 
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diameter was reduced to 2.13 mm and the orthogonal pore diameter was decreased from 
1.50 mm to 1.46 mm. Table 5.2 provides the measured designed, CAD and fabricated 
pore diameters for both pore geometries.  
 
Table 5.1 Summary of the pore diameter measurements for the designed and fabricated scaffolds: 
spherical and orthogonal geometries. 
Pore Design 
 Designed Pore 
Diameter [mm] 
Surface Area [mm2] Porosity [%] 
 
Spherical  2.22  1583 67 
Orthogonal  1.5 1255 68 
 
Table 5.2  Pore diameter measurements for the designed and then fabricated scaffolds. 





(n = 15) 
 Fabricated  
(n = 24) 
Spherical  2.22  2.20 ± 0.004 2.13 ± 0.07 
Orthogonal  1.50  1.50 ± 0.001 1.46 ± 0.14 
 
Using the modified scaffolds, the EC media flow conditions within the bioreactor 
compartment were analyzed. The relationship between the ss and shear rate of the EC 





 Pascal-seconds and the density was 957 ± 2 kg/m
3
. Table 5.3 summarizes the 
inlet velocities needed to generate laminar flow within the system. Based on these 
theoretical measurements, compartment inlet velocities less than 0.61 m/s generate 




Table 5.3  Upper limit of the flow conditions required to satisfy laminar flow within the bioreactor, 
for the vascular tree and bone scaffold geometry within each compartment. 
Component Maximum Reynolds Number Inlet Velocity (m/s) 
Vascular Tree 2300 1.27 
Compartment 400 0.61 
Orthogonal Scaffold 867 0.72 
Spherical Scaffold* 594 – 1,726 0.34 – 2.85 
* Reynolds number and velocity through the pore and throat (connection between two 
pores) within the scaffold provided. 
 
Simulations were performed for compartment inlet velocities of 0.11 - 0.86 m/s and 0.32 
- 1.2 m/s for the spherical and orthogonal geometry, respectively. The inlet velocities 
achieved an average ss between 1.9 - 15 dynes/cm
2 
and 0.79 - 18 dynes/cm
2
 for the 
spherical (Fig 5.4a) and orthogonal (Fig 5.4b) geometry, respectively. The minimum ss 






. The ss peaked at 74 - 
1900 dynes/cm
2
 and 310 - 2300 dynes/cm
2
 for the spherical and orthogonal geometry, 
respectively. The plot in Fig. 5.4 illustrates the increased ss imposed on the scaffold for 
higher inlet velocities. For the overlapping inlet velocity range between 0.32 - 0.86 m/s, 
the average ss imposed on the spherical scaffold were higher in comparison to the 
orthogonal scaffold. The MAD of the ss for the spherical and orthogonal scaffold ranged 
from 0.5 - 3.5 dynes/cm
2
 and 0 - 1 dynes/cm
2
, respectively, for the overlapping inlet 




   
Figure 5.4 Linear relationship between the average and maximum ss and the inlet velocity within the 
(a) spherical and (b) orthogonal scaffold compartments. 
 
Fig. 5.5 illustrates the dependence of the distribution of the imposed ss on the inlet 
velocity. Across all inlet velocities, the low (less than 1 dynes/cm
2
) and very high (more 
than 20 dynes/cm
2
) ss imposed on the scaffolds geometries was at least 21% and at most 
15% of their surface areas (SA), respectively. Fig. 5.5a and 5.5c show the ss distribution 
across the spherical and orthogonal scaffold, respectively, for the different flow rates. 
Fig. 5.5b and 5.5d categorizes the imposed ss into low (less than 1 dynes/cm
2












































































































































































































































) and high (more than 10 dynes/cm
2
) for the spherical and orthogonal 
geometry, respectively. For the spherical scaffold, the percentage of SA that experienced 
the low, target and high ss ranges was 21-91%, 9-64% and 1-15%, respectively. While 
for the orthogonal scaffold, the percentage of SA was 43-84%, 14-45% and 2-12% for the 
low, target and high ss ranges. Particularly, within the overlapping inlet velocity range, 
the percentage of SA that achieved the target ss for the spherical geometry was 35 - 64%, 
which was higher compared to the 14 - 40% that was imposed on the orthogonal 
geometry. 
Fig. 5.6 illustrates the average ss along the transverse and longitudinal planes for both 
geometries. The top planes experienced 4-5 and 2-3 times higher average ss than the 
middle and bottom planes for the spherical (Fig. 5.6a) and orthogonal (Fig. 5.6c) 
geometries, respectively. The average ss imposed on the lower half of the spherical 
scaffold was uniform along the transverse direction (Fig. 5.6a), but for the orthogonal 
geometry (Fig. 5.6c) the middle planes experienced twice as much average SS, in 
comparison to the bottom planes. For overlapping velocities, along the top plane, the 
spherical geometry experienced an average ss 5 times higher than along middle or bottom 
plane, whereas the orthogonal was 2-3 times higher. For both geometries, the average 
imposed ss along left and right planes were approximately equal. As the inlet velocity 
increased, the difference between the average ss along the middle plane and the left and 
right planes decreased for both geometries. For the spherical geometry, the average ss 
along the middle plane was 57 times higher than along the left and right planes at the 
lowest velocity and 4 times higher at the highest velocity (Fig. 5.6b).  For the orthogonal 
geometry, at the lowest and highest inlet velocity, the average ss imposed along the 
middle plane was 28 and 3 times higher than along the left and right planes, respectively 
(Fig. 5.6d). For overlapping velocities, the spherical geometry exhibited a lower 
difference in average ss in the longitudinal direction than the orthogonal geometry. 
Overall, for both geometries, the average ss imposed in the direction of the longitudinal 
planes and transverse direction was uniform, for all inlet velocities. 
For both geometries, across all planes, the imposed ss and its respective MAD increased 
as the inlet velocity increased. For inlet velocities greater than or equal to 0.47 m/s, the 
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spherical geometry achieved a ss between 1 - 10 dynes/cm
2
 along all planes. The 
orthogonal geometry achieved a ss between 1 - 9 dynes/cm
2
 along all planes for velocities 
greater than or equal to 0.67 m/s. Fig. 5.7 shows that distribution of low, target and high 
ss for each inlet velocity across the spherical and orthogonal scaffold. For the spherical 
scaffold, only the top and middle planes experienced high ss (Fig. 5.7a). In the orthogonal 
geometry, the left, right, longitudinal middle 2 and transversal middle planes experience 
high SS. For the orthogonal scaffold, the dominant ss range was low, with a slight 
decrease for inlet velocities greater than or equal to 0.92 m/s (Fig 5.7c-d). However, for 
the spherical geometry, the percentage of SA that experienced 1-10 dynes/cm
2
 was only 
greater than 1 dynes/cm
2
 across the scaffold for the maximum inlet velocity of 0.67 m/s 
(Fig 5.7a-b). Otherwise, the low ss was dominant. Fig. 5.8 illustrates that for both 
geometries, as the inlet velocity increased, the difference in ss across the transverse and 
longitudinal planes decreased. For the spherical geometry, the percentage of SA that 
experienced 1-10 dynes/cm
2
 along the transverse planes was greater than 50% for a 0.86 
m /s inlet velocity and greater than or equal to 0.73 m/s along the longitudinal planes (Fig 
5.8a-b). Collectively, across the whole scaffold, Fig 5.5b shows that 1 - 10 dynes/cm
2 
of 
ss was imposed on more than 50% of the SA for inlet velocities greater than or equal to 
0.54 m/s. However, the orthogonal geometry did not achieve 1 - 10 dynes/cm
2
 over 50% 
of its SA along any of the planes (Fig 5.8c-d). Similarly, the target ss was not achieved 
for 50% or more of the whole orthogonal scaffold (Fig 5.5d). Table 5.4 summarizes the 
benefits and drawbacks between the computational ss results for the spherical and 
orthogonal geometries. Fig. 5.9 illustrates the ss and the velocity distributions across the 
spherical compartment, for an inlet velocity of 0.54 m/s along the transverse and 
longitudinal planes. In Fig. 5.9a and Fig. 5.9d, the highest wall shear stress and 
corresponding fluid velocity were experienced in the middle of the scaffold along the 
direction of flow. Fig. 5.9b and Fig. 5.9d shows that for the edge (top and bottom) 
regions of the scaffold where there were higher fluid velocities, the ss stress imposed on 
the scaffold surface was also high. The ss was moderately uniform across the scaffold, 








       
Figure 5.5 Distribution of imposed ss on the (a) spherical and (c) orthogonal scaffold compartment for the given inlet velocities. Summary of the 

































































































































































































0.32 m/s 0.39 m/s
0.47 m/s 0.54 m/s
0.60 m/s 0.67 m/s
0.73 m/s 0.80 m/s
0.86 m/s 0.93 m/s
0.99 m/s 1.06 m/s











Figure 5.6 Average ss along the (first column) transverse and (second column) longitudinal cross-sectional planes of the (a and b) spherical and (c and 




































































































































Figure 5.7  Distribution of ss along the (first column) transverse and (second column) longitudinal planes of the (a-b) spherical and (c-d) orthogonal 
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Figure 5.8 Percentage of (a-b) spherical and (c-d) orthogonal scaffold SA that experienced 1-10 dynes/cm2 along the (a,c) transverse and (b,d) 



















































































































































Table 5.4 Upper limit of the flow conditions required to satisfy laminar flow within the bioreactor, 
for the vascular tree and bone scaffold geometry within each compartment. 
Geometry Benefits Drawbacks 
Spherical 
•  Lower maximum ss 
•  Higher average ss 
•  Target ss imposed over larger % of SA 
•  More than 50% of SA experienced target 
ss for inlet velocities  0.54 m/s 
•  Inlet velocity of 0.47 - 0.86 m/s required to 
achieve target ss (laminar flow regime 
realizable) 
•  Greater ss uniformity in longitudinal 
direction 
•  Average ss below top plane largely 
uniform 
•  Higher variation in average ss  
 
Orthogonal 
•  Smaller variation in average ss along 
transversal direction 
 
•  Inlet velocity of 0.67 - 1.2 m/s 
required to achieve target ss (non-
laminar flow) 
•  Low ss dominant across scaffold 
•  Larger % of SA experienced 
high ss (greatest potential for EC 
detachment) 
Conclusion: For inlet velocities between 0.54 – 0.61 m/s, the spherical geometry provides the 









      
Figure 5.9 Contour maps of ss along (a) longitudinal and (b) transversal cross-sections of the spherical scaffold. The velocity distribution along the (c) 
longitudinal and (d) transversal planes are shown. Left to right, the left, middle and right plane cuts are shown for the longitudinal cuts. Left to right, 





























5.4  DISCUSSION 
To solve the thick tissue challenge, which hinders the translation of bench top tissue 
engineering successes to practical clinical therapy, bioreactors have been employed as a 
pre-vascularization strategy and technique to study in vitro angiogenesis. Dynamic 
bioreactors provide a three-dimensional platform that offers efficient mass transfer and a 
tunable stimulant mechanical environment. The controlled growth of capillary-like 
structures from endothelial cells on a matrix under dynamic in vitro bioreactor conditions 
provides a platform for studying angiogenesis and can also serve as a precursor step to 
efficiently generate pre-vascularized large constructs (greater than 2 - 4 mm) for 
implantation. The presented vascular-like bioreactor allows for an in vitro setup to be 
transferred to an in vivo environment to support bone tissue growth, with or without 
scaling to meet the constraints of the defect site. Existing bioreactors assume that a defect 
site can provide a large inflow of nutrients directly into the scaffold. This vascular-like 
bioreactor provides a structure for the anastomosis of an artery and vein to the structure 
in order to shunt blood towards the thick scaffold upon subcutaneous implantation. 
Tanaka et al. and Asano et al. demonstrated that a vein graft anastomosed to a femoral 
artery and femoral vein supported new vessel in-growth towards the core of the avascular 
tissue [63-64]. Asano et al. suggested that the increased shear stress within the loop 
construct stimulated a pro-angiogenic cell response (expression of growth factors and 
stimulatory proteins) [64]. Using an in vivo approach, Laschke et al. implanted a three-
dimensional poly-lactic-glycolic (PLGA) scaffold into a host mouse for 20 days, then 
removed it and it placed into a recipient mouse [65]. A significant increase in blood 
perfusion and wall ss was observed over the 14 day study, with reperfusion of the implant 
occurring within 3-6 days. 
Optimized pore architectures for bone scaffolds enhance bone tissue in-growth into the 
scaffold, possess mechanical properties characteristic of trabecular bone (i.e. compressive 
strength) and allow for the adequate exchange of cell signaling molecules, nutrients and 
waste (i.e. high interconnectivity and pore diameters greater than 100 microns [66-67]) 
[68-69]. The co-culture of osteogenic and angiogenic lineages can enhance bone 




been demonstrated to support in vivo bone growth based on their optimized designs (in 
terms of porosity, permeability or pore size) for smaller dimensions between 3 – 4.5 mm 
in thickness and 5 – 6.4 mm in diameter [44,46]. The spherical and orthogonal scaffolds 
can be reliably fabricated by selective laser sintering (SLS) of the polyester, 
polycaprolactone (PCL), which is a biodegradable polymer commonly used for in vivo 
EC studies [71-73]. The rapid prototyping technique allows for the repetition of pore 
shape and size. The scaffold dimensions were corrected to account for the fabrication 
inconsistencies that typically narrow the pore diameter.  
Based on the performed simulations, spherical scaffolds were determined to achieve more 
uniform ss within the desired EC stimulation range of 1-10 dynes/cm
2
 for inlet velocities 
between 0.47 - 0.86 m/s. Although the ss across the spherical and orthogonal scaffolds 
was evaluated for the inlet velocity range 0.11 - 0.86 m/s and 0.32 - 1.2 m/s in order to 
characterize the system, velocities greater than 0.60 m/s generated turbulent flow regimes 
within the system. Based on the literature, EC viability, morphology, attachment and 
directionality are maintained for ss ranges within 1-10 dynes/cm
2 
under laminar flow 
conditions. The spherical scaffold demonstrated that 52 - 57% of scaffold surface 
experienced a ss between 1 - 10 dynes/cm
2
 for the inlet velocities between 0.54 - 0.60 
m/s, compared to the orthogonal scaffold that only achieved a distribution between 14 - 
31% for inlet velocities between 0.32 - 0.6 m/s (Fig. 5.8). Both low and high ss ranges 
were dominant across the orthogonal scaffold (Fig. 5.7). As such, the spherical scaffold 
was determined to be a better design choice for future in vitro angiogenesis studies, as it 
realized the optimal ss range with moderate uniformity (Fig 5.5). The optimal inlet 
velocity was determined to be the lower limit of the range, 0.54 m/s, to reduce the 
likelihood of falling within the transitional flow region. For this given inlet velocity the 
spherical geometry achieved an average ss of 8.6 ± 1.5 dynes/cm
2
 across the scaffold, 
with a maximum shear stress of 900 dynes/cm
2
 occurring over 7% of the scaffold (Fig. 
5.4 and Fig. 5.5). For both scaffolds, EC detachment was likely for surfaces that 
experienced ss greater than 20-25 dynes/cm
2
, as seen for extracellular matrix and glass 
substrates [74-75]. There is a clear tradeoff between the stimulation of attached scaffolds 
and the detachment of cells, particularly at the top and middle planes (transversal and 




outs in hot spots (high fluid velocities), cell apoptosis in dead zones (low fluid velocities) 
or non-uniform growth across the scaffold. In vitro cell studies will be required to 
determine the impact of the high ss along these planes. The ss imposed over the 
transverse middle/bottom and left/right planes were approximately the same, with the 
greatest spike in ss occurring along the middle and top planes (Fig 5.6). However, Fig. 
5.9 illustrates that these high ss ranges are primarily at the top and bottom edges along 
the fluid direction. 
The performed study did not account for the surface roughness (underestimation of 
surface area) of the PCL scaffold, as CFD implemented a no-slip boundary condition on 
the model. As such, the acquired results may be an overestimation of the imposed fluid 
velocities and ss on the surface of the scaffold. Nonetheless, the identified inlet velocity 
serves as a useful initial condition for beginning an in vitro bioreactor study. Further 
studies are required to understand the changes in ss distribution as the EC monolayer 
extends with the formation of tubules. These changes will decrease the size of the void 
space within the scaffold. 
Given the constraints of the proposed vascular-like perfusion bioreactor and the limits of 
computational models, the identified boundary conditions for the spherical scaffold are 
predicted to support and stimulated EC proliferation. After the formation of a vascular 
monolayer on the surface of scaffold, the vascular-like bioreactor may be implanted into 
a pig (2.1 - 2.9 mm; 99.4 ± 5.0 ml/min) [76] and anastomosed to a peripheral artery for 
the continuation of a pre-vascularization in vivo study. The inlet flow into the bioreactor 
would impose an average ss of 2.1 ± 0.5 dynes/cm
2
 and 73-78% of the scaffold surface 
would receive less than 1 dyne/cm
2
. Flow-induced ss levels between 0.001 - 0.1 
dynes/cm
2 
have been used in three-dimensional osteogenic studies, while higher levels 




 have been utilized in two-dimensional studies [35]. 
 
5.5  CONCLUSION 
Orthogonal and spherical scaffold geometries are commonly adopted in tissue 




scaffolds with a well-organized spherical pore (2.22 mm diameter) lattice imposed ss 
within the desired ss range to stimulate EC proliferation. Compared to an orthogonal 
design (1.46 mm), the spherical pore achieved better ss uniformity across the scaffold 
under a laminar flow regime. These results provide guidance on the appropriate inlet 
velocity for an in vitro vascular-like perfusion bioreactor construct. Furthermore, this 
study demonstrates the utility of computational models in understanding the distribution 
of flow for larger scaffolds and within angiogenesis bioreactors, at the start of a culture.  
The presented study can readily be extended to other pore geometries (i.e. hexagonal and 
cubical) in order to assess shear stress across the scaffold and to identify an optimal bone 
scaffold design for future EC co-culture studies. 
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CHAPTER 6  
 
 
The Effect of Polycaprolactone (PCL) Surface-Modifications on Endothelial 
Cell Proliferation, Function and Spatial Distribution In Vitro 
 
6.1  INTRODUCTION 
Several studies have highlighted the biomechanical influence of three-dimensional 
extracellular matrices (and adhering components) and shear stress on the growth of tissue 
and vascularization [1-2]. As an in vitro pre-vascularizations strategy, perfusion 
bioreactors sustain endothelial cell (EC) proliferation and promote tubulation across an 
embedded natural or engineered matrix, thereby imposing fluid shear stress and eliciting 
mechanotransduction. Existing angiogenesis bioreactors incorporate hydrogels (i.e. 
collagen, alginate and fibrin) for guided three-dimensional EC growth and migration [3-
6]. Numerous co-culture studies of endothelial with osteogenic cell lineages have shown 
accelerated vessel in-growth and enhanced osteogenic differentiation post-implantation, 
using this pre-vascularization strategy [7-9]. The next generation of angiogenesis 
bioreactors should support co-cultures with osteogenic or chondrogenic lineages for the 
development of in vitro and/or implantable in vivo bone regeneration models. However, 
promulgated investigations of angiogenesis bioreactors employ hydrogels, which lack the 
mechanical (stiffness and strength) properties characteristic of bone, particularly 
trabecular bone for load-bearing applications [10-11]. These hydrogels are typically less 
than 2 mm thick [12-15]. Larger scaffolds would allow for the generation of thick tissue 
for larger defect sites. Large constructs can be readily fabricated with polymers, such as 
polycaprolactone (PCL) using numerous rapid prototyping techniques, such as selective 
laser sintering (SLS) [16]. The biodegradable polymer, PCL has been well documented in 
its application to benchtop tissue engineering and translational clinical applications [17]. 




scaffolds to be scaled up to larger dimensions. Although versatile, in terms of the 
diffusion, permeability and mechanical properties it offers, the hydrophobic surface 
properties of PCL diminish its cytocompatibility. The functionalized groups at the surface 
of PCL are critical to the interaction with cells, in terms of cell attachment and 
proliferation. As such, several surface modification methods have been investigated in 
recent years: protein adhesion, growth factor immobilization, hydrolyzation and the 
incorporation of natural extracellular matrix molecules [18]. Gel-based cell attachment 
methods introduce flow constraints to a bioreactor and can be washed away with 
continual perfusion. Typically, angiogenesis bioreactor studies perform a static pre-
culture on the scaffolds for roughly 2 - 72 hours or until confluence is reached, prior to 
the introduction of the fluid shear stress. Therefore, the attachment and uniform 
proliferation of ECs onto the surface of a large scaffold during the first 3 days is 
important for incorporation into a bioreactor. In the following study, endothelial cell 
response with respect to cell proliferation, cell function and spatial distribution were 
quantitatively assessed for three PCL surface modifications: sodium hydroxide (NaOH) 
hydrolyzation, Arg-Gly-Asp (RGD) conjugation and vascular endothelial growth factor 
(VEGF) immobilization. 
PCL constructs strongly hydrolyzed with NaOH have been shown to increase the surface 
hydrophilicity and surface roughness of the constructs (wettable polymers), thereby 
improving cell interaction[19-20]. In a co-culture study of human bone marrow cells and 
human bone marrow endothelial cells (HBMEC-60), Choong et al. [19] reported 
increased attachment and proliferation of HBMECs-60 for strongly hydrolyzed PCL 
films (5 M NaOH for 48 hours), compared to weakly hydrolyzed (0.1 M NaOH for 48 
hours) or untreated PCL films. Similarly, Serrano et al. [20] demonstrated that the NaOH-
treated  PCL films (2N for 2 hours) resulted in cell proliferation rates comparable to 
cultures on tissue culture polystyrene (TCPS). The untreated films supported EC cell 
viability, but did not promote similar proliferation rates. 
A more commonly adopted surface modification is the attachment of extracellular matrix 
(ECM) components or their derived synthetic peptides. Arg-Gly-Asp (RGD) has been 
cited as a highly effective peptide sequence for improving cell attachment onto polymer 




activate signal transduction between the ECM and cell [21-22]. A previous study by 
Zhang et al. [23-24] immobilized RGDC on PCL two-dimensional film surfaces and on 
3D PCL scaffold surfaces via sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-
carboxylate (sulfo-SMCC) crosslinking. For both PCL constructs, the adhesion of rat 
bone marrow stromal cell (BMSC) to the polymer was significantly increased and 
initiated  integrin-mediated signal transduction that regulates subsequent increases in cell 
survival and growth [23-24]. Wang et al. enhanced endothelial cell (EC) attachment and 
proliferation on PEGyLated polymers surfaces with the incorporation of N- 
hydroxysuccinimide (NHS) coupled RGD [25].  
VEGF is another common modification, which is either adsorbed or conjugated onto the 
surface of a construct. It is a potent mitogen that stimulates the migration and 
proliferation of ECs [26] and has been cited as an important growth factor acting in the 
initiation of angiogenesis [27]. When immobilized onto a scaffold, VEGF has been 
shown to lengthen and localize cell stimulation, resulting in increased EC proliferation 
[28-37]. Several groups have used VEGF’s affinity for heparin to immobilized the 
growth factor on to polymer surfaces [38-39]. Amino groups are introduced to the PCL 
surfaces by a reaction with 1,6-hexanediamine, wherein one amino group reacts with the 
polymer ester group to form a covalent amide bond [40]. Heparin then binds to the other 
unreacted, free –NH2 groups. Heparin is a naturally occurring polysaccharide composed 
of alternating units of sulphated glucuronic acid and glucosamine derivatives. At 
sufficient low concentrations, heparin can potentiate VEGF binding, while at higher 
concentrations can inhibit VEGF binding [41]. As well, researchers have suggested that 
there is an optimum dose of VEGF to be loaded onto scaffolds, and have noted this 
window as a critical factor in promoting angiogenesis [34,36,38,42]. Based on the 
literature, a constant release concentration of approximately 70 - 100 ng/day produces 
favorable conditions for angiogenesis in vitro (see Appendix F, Table F.1).   
Numerous polymer surface modifications have been investigated to improve EC 
attachment, viability and proliferation within in vitro studies. The goal of this study was 
to optimize the growth conditions for human umbilical vein endothelial cells (HUVECs) 




determine the most effective surface modification that elicits the best cell response in 
terms of cell proliferation and function.   
 
6.2  MATERIALS AND METHODS  
6.2.1  PCL Vascular Network and Scaffold Design and Fabrication  
The two-dimensional discs (2.1 mm height and 15 mm diameter) and three-dimensional 
cylindrical scaffolds (11 mm height and 11 mm diameter) were fabricated using the same 
SLS protocol. Sections 2.3.1.1 and 2.3.2.2 detail the SLS fabrication and the scaffold 
design process, respectively. After fabrication, the discs and scaffolds were sonicated for 
2 hours in ethanol to remove excess powder. (Henceforth, the collective of discs and 
scaffolds may be referred to as constructs.)  
 
Figure 6.1 (a) Side view of scaffold. (b) Top view of scaffold. (c) Top view of disc. Surface area for 
each construct is provided. 
 
6.2.2  Heparin Immobilization and VEGF Conjugation 
Amine groups were introduced to the constructs based on a protocol established by Zhu 
et al. [40]. Each construct first underwent aminolysis. Constructs were submerged in a 
10% (w/v) 1,6-hexanediamine solution (Fluka Chemie AG, Buchs, Switzerland) in 
isopropanol (Reagent ACS, Fisher Scientific) for 4-5 hours at 37˚C. The constructs were 
initially pulled under a vacuum for 1 hour to allow for solution penetration. The 
constructs had an NH2 density of approximately 0.21 μmol/cm
2 
[40]. Then, the constructs 




vacuum. The constructs were washed in phosphate buffered saline (Gibco, Inc., Grand 
Island, NY) and 2-morpholinoethane sulfonic acid (MES, pH 5.40, Thermo Scientific, 
Waltham, MA). Thereafter, the activated carboxylic acid groups of unfractionated 
sodium heparin (Sigma-Aldrich, St Louis, MO) were immobilized on the constructs (see 
Fig. 5.2) by a chemical crosslinking of amino end-functionalized PCL with 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide/N-hydroxysulfosuccinimid (EDC/Sulfo-NHS) 
(Thermo Scientific, Waltham, MA) . 0.05 M MES buffer, 10 mg/ml heparin, 4 mg/ml 
EDC and 11 mg/ml Sulfo-NHS were allowed to react for 15 minutes. The reaction was 
quenched by 14 µl/ml 2-mercaptoethanol (Sigma-Aldrich, St Louis, MO). The pH of the 
heparin solution was adjusted to 7.2-7.5 using NaOH. The constructs were immersed in 
the heparin solution for 24 hours at 37˚C. Thereafter the constructs were washed twice in 
deionized water, for twenty minutes each time. The constructs were sterilized in ethanol 
for 24 hours at room temperature. Table 6.1 summarizes the respective heparin 
concentrations loaded onto the scaffolds and discs. 
 





6.3  VEGF IMMOBILIZATION 
Table 6.1 outlines the three experimental groups for which a conjugation efficiency and 
release study were completed. Groups 2 and 3 were used in cell culture studies. After 
each construct was aminated, then functionalized with heparin, VEGF (VEGF 165 
Protein, Novus Biologicals, Littleton, CO) was conjugated onto the PCL surface. The 
constructs were washed in deionized distilled water for thirty minutes. 1 ml of VEGF 
(10µg/ml) was added to each scaffold and 0.5 ml of VEGF (20µg/ml) to each disc. The 
discs were reacted in low-attachment 24-well plates and the scaffolds in 5 ml centrifuge 
tubes coated with 1% bovine serum albumin (Sigma-Aldrich, St Louis, MO). The VEGF 
reacted for two hours at room temperature. 
 
Table 6.1 Experimental groups in VEGF conjugation and adsorption study. 
  
 
6.3.1.1  VEGF Release  
Following conjugation, in vitro VEGF release studies (n = 3) were performed in triplicate 
over five days for Group 2 and 3 outlined in Table 6.1. The discs were incubated in 1 ml 
of EC media, while the scaffolds were incubated in 2 ml of media. The discs and 
scaffolds were incubated in low attachment 24-well plates at 37ºC with gentle shake. On 
days 1, 3 and 5, the supernatant in each well was collected and replaced with fresh EC 
media of equal volume. The concentration of VEGF in the collected samples was 





6.3.1.2  VEGF Quantification 
After conjugation or adsorption, the constructs were washed for ten minutes with sterile 
water to remove unconjugated VEGF. The washes were collected, along with the residual 
from the VEGF loading solution. The conjugation or adsorbed efficiency was calculated 
indirectly, as the amount initially in the conjugation solution minus the amount washed 
off following the conjugation, which remained in the assayed fluid. For the release study, 
the media was gently suspended in the wells to remove unconjugated VEGF. The 
released amount of VEGF was calculated as the direct measurement of VEGF collected 
in the fluid samples on day 1, 3, 5 and 7.  
To quantify the amount of conjugated VEGF on the treated constructs, enzyme-linked 
immunosorbent assay (ELISA) was performed using an optimized version of a general 
double antibody sandwich ELISA protocol (Thermo Scientific and Invitrogen’s Antibody 
Pairing Kit). VEGF standards (Invitrogen) were reconstituted and prepared: 1500 pg/ml, 
750 pg/ml, 375 pg/ml, 188 pg/ml, 93.8 pg/ml, 46.9 pg/ml, 23.4 pg/ml and 0 pg/ml. The 
assay buffer (pH 7.4) consisted of sodium chloride, potassium chloride, disodium 
phosphate., monopotassium phosphate, Tween 20 and bovine serum albumin diluted in 
deionized distilled water. Aqueous Tween 20 was used as the wash buffer (pH 7.4). 
VEGF Purified, Mouse Monoclonal Antibody Unconjugated was diluted to 3 µg/ml in 
aqueous sodium bicarbonate to prepare a coating buffer (pH 9.4). The incubation buffer 
(pH 7.4) consisted of sodium chloride, potassium chloride, Disodium hydrogen 
phosphate, monopotassium phosphate, EDTA and bovine serum albumin diluted in 
deionized distilled water. VEGF Rabbit Anti-human-Biotin Conjugated (Invitrogen) was 
diluted to 0.3125 µg/ml in a detection antibody solution (pH 7.4) that consisted of sodium 
chloride, sodium dihydrogen phosphate, disodium phosphate, mouse serum and bovine 
serum albumin. A stock solution of Streptavidin HRP solution (ELISA Grade) 
(Invitrogen) was dissolved in assay buffer to prepare a 0.24 µg/ml solution. 
Tetramethylbenzidine stabilized chromagen (Invitrogen) was used as the substrate 
solution. 0.9 M (1.8N) sulfuric acid was used as the stop solution. The absorbance of the 
samples was measured in 96-well plates at 450 nm by microplate reader (Multiskan 
Spectrum, Thermo Electron Corporation). Based on a derived calibration curve, the 




amount of retained VEGF from each respective 0 µg sample group was subtracted from 
the average of each sample within that group to remove the baseline absorbance.  
 
6.3.2  RGD Conjugation 
The discs and scaffolds were modified with RGDC peptide following the protocol 
previously established by Zhang et al. [24] (based on published bioconjugation 
techniques [43]). Aminolysis was performed identical to the methods outlined in section 
5.2.2. Then, the aminated constructs were thoroughly washed for 24 hours in deionized 
distilled water under a vacuum at 37˚C. Then the constructs were washed three times in 
activation buffer (0.1 M phosphate-buffered saline containing 0.15 M NaCl pH 7.2). 
RGDC peptides were conjugated onto the surface of the constructs using the 
heterobifunctional crosslinker sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-1- 
carboxylate (sulfo-SMCC) (Pierce Biotechnology, Rockford, IL).  Each construct was 
submerged in a 4 mg/ml solution of the sulfo-SMCC and incubated for one hour at room 
temperature. Thereafter, each construct was washed twice in activation buffer and once in 
the conjugation buffer (activation buffer containing 0.1 M EDTA, pH 7.0). The RGDC 
peptide (Bachem California, Inc., Torrance, CA) was dissolved in conjugation buffer at a 
concentration of 0.125 mg/ml. 0.5 ml of the peptide solution was added to the sulfo-
SMCC-treated discs and 1 ml to the sulfo-SMCC-treated scaffolds. All constructs were 
incubated overnight at 4
o





[24]. The peptide-conjugated scaffolds were washed conjugation 
buffer twice and in PBS three times, then dried under a vacuum at room temperature 
overnight.  
 
6.3.3  Sodium Hydroxide Hydrolysis 
The discs and scaffolds were submerged in 5 M NaOH (Certified A.C.S, Fisher 
Scientific) at room temperature on a shaker for 72 hours. Thereafter, the constructs were 
soaked in distilled water and 90% ethanol for 3 hours. The pH of the resultant supernatant 




scaffolds was recorded. After treatment, the scaffolds were dried and their dry weights 
were recorded. The percent weight loss was calculated using Equation 6.1. 
            ( )   
               
        
     , Equation 6.1 
where          and        are the weights of the dried untreated and treated samples, 
respectively. 
 
6.3.4  Surface Wettability 
The wettability of the control and modified PCL surface was determined by 
measurements of the water contact angle made on the surface of the flat disc (see Fig 6.3) 
(n = 3) using a goniometer (Rame-Hart Instrument Co., Netcong, NJ). The discs were 
dried for 24 hours prior to measurement. The measurements were made at room 
temperature. A digital camera (Net GmbH 1394 Digital Camera) captured the series of 
advancing sessile water drops for 30-35 samples. The contact angles were extracted from 
the collected series using image processing software (Advanced DROP Image Software, 
Rame-Hart Instrument Co., Netcong, NJ). Surfaces with smaller contact angles were 
characterized as less hydrophobic.  
 
 
Figure 6.3 Look how we measure the wettability of a surface. 
 
6.3.5  Static Cell Culture  
Human Umbilical Vein ECs were isolated from harvested umbilical cords and acquired 
from the Stegmann Lab. The HUVECs were used at Passage 8 or 9. The initial seeding 
density was between 2,500 - 5,000 cells/cm
2
. The cells were cultured until 70-80% 
confluence (4-6 days after plating). The HUVECs were cultured in EC media (EBM-2®, 
Lonza, Walkersville, MD) consisting of fetal bovine serum, ascorbic acid, 




θ = contact angle




gentamicin/amphotericin-B, VEGF, hydrocortisone, human epidermal growth factor, 
human Fibroblast growth factor-basic, heparin, and human recombinant analog of 
insulin-like growth factor-I. Cell culture studies were performed in 24-well TCPS (discs) 
and 48-well TCPS (scaffolds) under static incubation (humidified atmosphere, 37°C, 5% 
CO2) conditions. Prior to cell seeding, all constructs were sterilized under an ultraviolet 
(UV) lamp for one hour, equilibrated in PBS (Dulbecco) for 30 minutes, and then 
submerged in EC media once for 30 minutes. Heparinized constructs were sterilized by 
UV prior to the addition of VEGF.  
The seeding densities were 1.2 x 10
4
 cells/disc for discs with a surface area of 1362 mm
2
 
and 9.0 x 10
4
 cells/scaffold for scaffolds with a surface area of 177 mm
2
. A cell 
suspension of known cell density was added to the top of each disc. Similarly, the top of 
the scaffolds was seeded, then incubated for 30 minutes, before they were flipped to 
expose the bottom of the scaffold for seeding. Fig. 5.4 illustrates the drop-wise seeding 
technique used. The media was changed every other day. The ten experimental groups 
are shown in Table 6.2. The effect of sodium hydroxide treatment, bound VEGF and 
bound RGD on cellular behavior was investigated by seeding cells onto PCL discs and 
scaffolds modified with the respective treatments (to be referred to as PCL-N, PCL-HV 
and PCL-R, respectively). Untreated PCL served as the control. Heparinized constructs 
with no VEGF present (to be referred to as PCL-H) were compared to Group 2 and 3 
from Table 6.1. The cells were cultured for up to four days.  
 







Figure 6.4 Drop-wise seeding method used for discs and scaffolds. 
 
6.3.6  Cell Viability 
Cell attachment, proliferation and spatial distribution across the disc and/or scaffold were 
determined by a MTT assay. Prior to the conducting the assay, the culture medium was 
aspirated and the discs and scaffolds were washed in PBS three times to remove 
unattached cells. The colorimetric MTT assay used a 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfonphenyl)-2H-tetrazolium (MTS tetrazolium) 
compound (Cell-Titer 96 Aqueous One Solution Cell Proliferation Assay; Promega, 
Madison, WI). The seeded ECs were incubated for three hours with the 20% MTS 
solution in serum-free culture medium in 48-well paltes. The metabolically active ECs 
reacted with the of MTS reagent to produce soluble formazan product. From each 
scaffold-well, three aliquots of the reagent were pipetted into a 96-well plate then placed 
into a microplate reader (Multiskan Spectrum, Thermo Electron Corporation). The 
absorbance was measured at 490 nm.  
Cell attachment was assessed within 24 hours (Day 1) of initial attachment. Cell 
proliferation was evaluated after 72 hours (Day 3) of static culture. The spatial 
distribution was evaluated on Day 1 and 3. The three-dimensional scaffolds were 
sectioned in three parts with a razor. The distribution of seeded cells on scaffolds was 
determined over the three sections: top (20% of surface area), center (60% of surface 
area) and bottom (20% of surface area). Comparisons between edge and center cell 






6.3.7  Von Willebrand Factor (vWF) Assay 
On day 3, the amount of vWF released into the medium was determined using the 
standard protocol from a commercially available vWF ELISA kit (AssayPro, St Charles, 
Missouri).  
 
6.3.8  Statistical Analysis 
Each assay was performed in triplicate for three independent samples. The results were 
expressed as means ± standard deviations. In Minitab (Minitab Inc., State College, PA), 
Pairwise comparisons between the treatment groups was performed with the ANOVA 
procedure, followed by Tukey's post hoc test at a significance level of P-value < 0.05 or 
P-value < 0.01. Two-tail Student’s t-test assuming equal variance was used to determine 
whether there was significant difference between two groups. P-values below 0.05 were 
considered significant. 
 
6.4  RESULTS 
6.4.1  Effect of Surface Modifications on PCL Wettability 
The surface charge of untreated PCL was largely neutral due to the prevalence of ester 
groups (-COO-) in PCL molecules, which made it weakly acidic. The negatively charged 
residue from the RGD peptide and the strong negative charge of heparin deposited a 
negative charge onto the PCL surface. Hydrolyzation broke down the ester groups 
present in PCL molecules and formed carboxylic and alcohol by-products, which created 
a negative surface charge. Figure 6.5 shows the range of contact angles measured for the 
four surface treatments. The untreated PCL exhibited the largest contact angle and was 
significantly different from all other groups (P-value < 0.01). All groups were 
signficantly different from one another (P-value < 0.01). The average degree of the 
contact angle increased as follows: PCL-N (14° ± 8°) < PCL-R (29° ± 19°) < PCL-H (59° 
± 11°) < PCL (87° ± 12°). The chemical modification produced a significantly lower 






Figure 6.5 Contact angles (ascending) for surface modified PCL surfaces (n = 3).  Illustrates 
statistical significant difference between each group (p-value < 0.01). PCL – untreated; PCL-H – 
Heparinized; PCL-R – RGD immobilization; PCL-N – NaOH-treated. 
 
6.4.2  Effect of Surface Modifications on HUVEC proliferation 
After day 1, HUVECs cultured on PCL-HV discs and scaffolds exhibited the greatest 
average number of cells than all other groups (Fig 6.6a). On PCL-HV discs, the average 
number of cells was 4 times higher, and on scaffolds, seven times greater than the control 
group. For both discs and scaffolds, PCL-HV groups were statistically different from the 
untreated control group. All scaffold surface modified groups exhibited greater 
proliferation than the control group (Fig 6.6a). On the scaffolds, the average number of 
cells on PCL, PCL-R, PCL-N, PCL-HV were 5,183 ± 2,951, 49,999 ± 10,541, 28,517 ± 
6,018 and 37,421 ± 6,786, respectively. All groups were statistically different from the 
control group. For discs, the PCL-N proliferation was comparable to the PCL control 
group (Fig 6.6a). The mean percent degradation for NaOH-treated PCL scaffolds (at 
room temperature, 25°C) was 8.5 ± 1.2% and 0.43 ± 0.38% for PCL disks (n = 3). On 
day 3, the trends remained the same (Fig 6.6b). For the scaffolds, there was no statistical 
difference between PCL-R (51,385 ± 4,974), PCL-N (50,537 ± 7,324) and PCL-HV 
(56,391 ± 5,085) scaffolds. On PCL-R, PCL-N and PCL-HV discs, the average number 









Figure 6.6 The average amount of HUVECs proliferated at (a) day 1 and (b) day 3 for discs and 
scaffolds (n = 3). Statistically significance shown between groups with * (p < 0.01). 
 
6.4.3  Effect VEGF conjugation on HUVEC proliferation 
Both PCL-HV discs and scaffolds demonstrated an increase in proliferation on day 1 and 




promoted slightly higher cell proliferation. After day 1, on discs, the presence of VEGF 
results in an average cell amount of three times as much as the heparinized discs with no 
VEGF present. However the two groups, PCL-H and PCL-HV were not statistically 
different on day 1 or 3, the relationship between PCL-H to PCL-HV was roughly one to 
one. Based on the VEGF conjugation efficiency study, 8.7 ± 0.01 μg (87% of initial 
loaded amount) of VEGF was immobilized on to untreated scaffolds and 8.1 ± 1.2 μg (81 
% of initial loaded amount) to heparinized scaffolds. 8.5 ± 0.23 μg (85% of initial loaded 
amount) of VEGF was immobilized on to untreated discs and 7.9 ± 0.22 μg (79% of 
initial loaded amount) to heparinized discs. Over seven days, there was less than 10 
ng/day (0.1% of initial loaded amount) release of VEGF from either group (PCL or PCL-
HV), for discs or scaffolds (Fig 6.8a-b). Table 6.3 summarizes the release of VEGF over 
7 days. There is negligible release (less than 10 ng/day) for untreated and heparinized 
scaffolds over the entire duration of the study. After day 1, the untreated discs 
demonstrated negligible release. The heparinized discs demonstrated stimulating (greater 
than 10ng/day) release levels from day 1-3, with a slight drop on days 5 and 7. 
 
 
Figure 6.7 Average amount of HUVECs at day 1 and 3 on heparin immobilized PCL discs and 
scaffolds without (PCL-H) and with 10μg of VEGF loaded (PCL-HV). No statistical significance 







(b)        (c) 
Figure 6.8 VEGF retention over 7 days for (a) heparinized and untreated discs and (b) untreated 
scaffolds and (c) heparinized scaffolds (n=3). 10 μg of VEGF loaded and heparin (based on values in 









6.4.4  Effect of Surface Modifications on the Localization of HUVECs 
Sectioning and MTT analysis of the three-dimensional scaffolds revealed that the initial 
distribution of HUVECs on each treatment group had high variability at the edge and 
center of the scaffold (Fig. 6.9a). By day 3, the PCL-N (average number of HUVECs: 
27,310 ± 9,880) and PCL-R (average number of HUVECs: 61,946 ± 22,390) group 
showed higher HUVEC densities at the edge of the scaffold, compared to the control 
group (average number of HUVECs: 14,675 ± 8,762). While PCL-HV (average number 
of HUVECs: 36,486 ± 13,913) demonstrated at a higher density at the center compared to 
the control group (average number of HUVECs: 29,549 ± 2,218) (Fig 6.9b). There was 
no statistical difference among the groups, in terms of the edge density. At day 3, the 
edge-to-center ratios for PCL, PCL-R, PCL-N and PCL-HV were 2.3 ± 1.5, 1.0 ± 2.0, 1.3 
± 1.6 and 0.2 ± 0.3 respectively. PCL and PCL-N showed more uniform distribution, 
with PCL-N promoting greater cell proliferation. 
 
Heparinized Untreated Heparinized Untreated
Day 1 254 754 5 0.4
Day 3 40 1 2 0.4
Day 5 8 1 2 0










Figure 6.9 Average number of HUVECs at (a) day 1 and (b) day 3 at the edge and center of a 
sectioned scaffold. There was no statistical significance between localization of HUVECs on day 1 
across surface treatments or regions of the scaffold (p-value > 0.05) (n = 3). By day 3, there was no 
statistical signficance at the edges between the PCL surface treatments associated with **, but RGD-
modified scaffold showed the largest edge attachment and the VEGF-loaded scaffold showed the 
greatest attachment at the center of the scaffold (p-value > 0.05). PCL – untreated; PCL-H – 
Heparinized; PCL-R – RGD immobilization; PCL-N – NaOH-treated. 
 
6.4.5  Effect of Surface Modifications on vWF release 
The cell response to the treatment groups showed that PCL-N, PCL-R and PCL-HV 
released significantly lower levels of vWF than the control group (Fig. 6.10). For discs, 




than the respective control groups. However, there was no statistical difference among 
the release amounts among the surface modified groups. For discs, the vWF 
concentrations for PCL, PCL-R, PCL-N and PCL-HV were as follows 5.3 ± 0.16 
IU/10,000 cells, 3.4 ± 0.14 IU/10,000 cells, 3.1 ± 0.17 IU/10,000 cells and 2.3 ± 0.03 
IU/10,000 cells. For scaffolds the vWF concentrations were 6.0 ± 0.11 IU/10,000 cells, 




Figure 6.10 Relative amount of vWF released by surface modified discs and scaffolds into media over 
48 hours, at day 3 (n = 3). Normalized to the amount of HUVECs at day 3. PCL – untreated; PCL-H 
– Heparinized; PCL-R – RGD immobilization; PCL-N – NaOH-treated. 
 
6.5  DISCUSSION AND CONCLUSIONS 
Within a three-dimensional in vitro bioreactor, each component of the system plays a 
critical role in recreating appropriate conditions for chemical and mechanical stimulation 
of cells. In particular, the following factors are critical: (i) scaffold composition and 
biocompatibility, (ii) scaffold architecture and associated properties, (iii) cell line and 
culture type, (iv) perfusion source and hydrodynamic conditions, (v) oxygen exchange / 




cell distribution. The work presented in this chapter is an initial step to a larger study that 
would systematically evaluate each of these parameters. Chapter 5 evaluated the 
influence of architecture on the adherent cells under constant, non-pulsatile flow 
conditions, within the designed bioreactor. In this chapter, the results have demonstrated 
the effect of surface modified PCL discs (two-dimensional) and scaffolds (three-
dimensional) on the proliferation and activity of HUVECs in an initial static culture. 
These static cultures are a typical precursor step to dynamic bioreactor cultures. 
Among the four groups (PCL, PCL-V, PCL-R, PCL-N), the hydrolyzed scaffolds exhibited 
the largest wettability (Fig. 6.5). Each of the surface modifications showed improved 
wettability compared to the control group. Each contact angle range 
(minimum/maximum) was statistically different from all other groups. Based on its low 
contact angles, PCL-N had the most hydrophilic surface, followed by PCL-R and lastly 
PCL-H.  
For discs and scaffolds, PCL-HV demonstrated significantly higher proliferation levels 
than the control, at day 1 and 3 (Fig. 6.6a-b). Day 1 proliferation on PCL and PCL-N 
discs were similar contrary to what would be expected based on their respective 
wettabilities (Fig. 6.6 and Fig 6.6a). For all scaffolds, more cells proliferated on the 
treatment groups than on the control, with PCL-R demonstrating the largest average 
number of cells (Fig. 6.6a-b). The NaOH degradation to discs was lower than for 
scaffolds. This decrease in degradation may have affected the degree of surface 
roughness and surface area achieved on the discs. For both discs and scaffolds, PCL-R 
and PCL-HV demonstrated the highest levels of proliferation and were not statistically 
different from one another (Fig. 6.6a-b). For both constructs, the average number of cells 
peaks at day three indicating that cell quiescence may have occurred between 24-72 
hours, once the ECs reach a high confluence on the constructs (Fig. 6.6b). By day 3, there 
is no statistical difference in viable ECs among the PCL-R, PCL-N and PCL-HV discs or 
scaffolds (Fig. 6.6b). All scaffold treatment groups had more viable cells than the control 
group. The uniform proliferation across treatment groups may indicate that although 
PCL-R and PCL-HV promoted greater attachment (or initial proliferation during the 
initial attachment period), for scaffolds and discs, the critical factor in proliferation may 




The investigation on dose effect of 10μg of loaded VEGF revealed that PCL-HV 
demonstrated approximately the same average number of viable cells in comparison to 
PCL-H at day 1 and day 3 (Fig. 6.7). There was no significant difference in the number of 
proliferated cells between the two groups. There was no statistical difference in 
proliferation at day 1. The results indicate that a larger amount of VEGF must be loaded 
to produce a cell response. The VEGF release study showed that there was negligible 
release across all constructs, except for the heparinized disc group (Fig. 6.8 and Table 
6.3). The VEGF content that remains on the scaffold may be bound too tightly for 
gradual release or adequate exposure of functional end groups. Further investigations 
should compare PCL-H to PCL-R proliferation over 72 hours. As well, the dose of effect 
of VEGF should be investigated to determine if larger doses can elicit a distinctive 
response compared to PCL-H, in less than 72 hours.  
Heparin dosage can be increased in effort to improve VEGF binding and reduce 
opportunities for VEGF adsorption onto the scaffold. As such, in a second proliferation 
study (data not shown), designed to evaluate the heparin dose cell response to increased 
heparin, the PCL, PCL-R and PCL-N treatment groups were cultured over 72 hours, with 
the addition of a high dose heparin group (5 mg on discs and 10 mg on scaffolds) with 10 
μg of VEGF loaded. PCL-HV (high heparin content) had less and statistically different 
average number viable cells than PCL-R, on both scaffolds and discs. However, the 
increase in dose invoked a negative cell response, which made cell proliferation 
comparable to the control group. The heparin dose effect should be further evaluated, to 
determine an optimal dosage of VEGF needed to counteract potential heparin inhibition. 
The decrease in cumulative vWF released over 48 hours was roughly the same for all 
treatment groups on discs and scaffolds. They were all significantly lower than the 
control group. Starke et al. reported that a decrease in vWF was linked to increase in vitro 
angiogenesis [44]. Based on this finding, all surface modifications demonstrated greater 
angiogenic function: PCL-HV > PCL-N > PCL-R.  
Simulations in chapter 5 showed that for in vitro perfusion bioreactor, apoptosis is greater 
at the edges of a scaffold, where the largest shear stresses are experienced. As such, a 




core would provide the ideal spatial distribution for both in vitro and long-term in vivo 
application. The edges of PCL-R supported the highest average number of ECs among all 
groups (Fig. 6.9b). The average cell viability at the edges of PCL-R was higher than all 
other groups, although not statistically different. There was also no statistical difference 
between the viability of cells at the core of the scaffold. 
Overall, the implications to a bioreactor study were (i) each surface modification 
improved the hydrophilicity and as a result the cytocompatibility of PCL (Fig. 6.5), (ii) 
there was no significant difference in EC proliferation among modifications over three 
days (Fig. 6.6b), (iii) ECs should be cultured for less than 72 hours to avoid quiescence, 
but promote attachment/proliferation (Fig. 6.6b), (iv) there was no significant difference 
in EC function, in terms of vWF release, among the modified surfaces, making the 
cheaper modification (PCL-R compared to PCL-HV) advantageous (Fig. 6.10), and (v) 
the high edge density of RGD-modified scaffolds after 72 hours makes it ideal for 
bioreactor studies, without compromising EC density at the core of the scaffold (Fig. 
6.9b). In a preliminary assembly and run of the bioreactor enclosing a PCL-R scaffold 
(after 72 hour static culture), after 1 hour of perfusion, at room temperature, there was 
approximately a 30% retention of ECs on the scaffolds (n = 3). Further studies are 
required to determine the viability and maturation of cells with time within an incubator. 
Most three-dimensional bioreactor studies employ translucent matrices, such as alginate, 
Matrigel or collagen, which can be readily imaged to assess EC migration and the 
formation of tubules during angiogenesis. However, given the proposed bioreactor 
design, further studies are needed to determine the ideal method of evaluating cell and 
vessel form and function within this PCL bioreactor. Cumulative and cyclic protein/factor 
production (i.e. vWF) may be used to assess changes, but typically vessel morphology is 
the standard metric for evaluation of angiogenesis. Chapter 7 discusses imaging 
opportunities for non-translucent biomaterials. 
Tissue engineering often focuses on the treatment and restoration of damaged tissue sites 
to normal function and/or morphology. However, given its toolbox of biomaterials, 
computational models, bioengineering approaches and cell culture systems, the field of 
tissue engineering inherently lends itself to the development of disease systems [45].  As 




two-dimensional to three-dimensional in vitro platform has been the focus of 
interdisciplinary work between cancer researchers and tissue engineers [46-48]. Recent 
studies have highlighted the biomechanical influence of three-dimensional extracellular 
matrices (and adhering components) on the growth of normal tissue and solid tumors [49-
50]. The practical implementation of a cell bioreactor (with the addition of other 
signaling factors) for the growth of cancerous tumor models remains to be further 
explored. A localization of HUVECs on the scaffold that provides a higher density at the 
edges versus the center, may favor necrosis typical of tumorigenesis, in a co-culture with 
tissue cell lines. 
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CHAPTER 7  
 
A Review of Three-dimensional Imaging Methods for Assaying Tubule Formation 




The structure and function of blood vessels is a key determinant of the viability and 
proliferation of cells in both healthy and diseased tissue. In vivo imaging of angiogenesis 
is a routine procedure to monitor treatment responses and disease progression, in both 
animal research studies and clinical practice. Two-dimensional microscopy is often 
implemented in biomedical research to visualize cell monolayers. Recently, 
investigations of physiologically-relevant in vitro three-dimensional culture models have 
heightened the need for three-dimensional, non-invasive methods to evaluate vessel 
formation and function within tissue. In order to garner real-time, structural and/or 
functional information from these models, various imaging techniques were modified to 
track angiogenesis within in vitro studies that employ synthetic or natural matrices. 
Advances in medical imaging systems and image processing make multi-scale imaging 
from the tissue-level down to molecular-level, a viable tool for the qualitative assessment 
or quantification of angiogenesis within in vitro three-dimensional culture studies. Static 
and dynamic image series acquired using imaging systems offer valuable temporal 
insight on the proliferation, migration and tubule anatomy of ECs involved in 
angiogenesis. Tissue properties, such as elasticity are also extracted from these images. In 
this article, we review the recent literature to demonstrate the utility and potential of 
imaging technologies when adapted to in vitro three-dimensional culture models. 
Magnetic resonance, optical, nuclear and ionizing radiation imaging systems are among 




7.1  INTRODUCTION 
Angiogenesis is a critical step to the sustainment of healthy regenerative tissue and to the 
growth of solid cancerous tumors. The determination of whether three-dimensional in 
vitro angiogenesis models can successfully re-create favorable environments for 
endothelial cell (EC) tubulation is key to their practical application to angiogenesis or 
tumor angiogenesis research. Recent studies explored the utility of physiologically-
relevant angiogenesis and tumor angiogenesis culture models that provided 
biomechanical stimulus (via an extracellular matrix or flow): three-dimensional gel 
embedded matrices (collagen, fibrogen, alginate and Matrigel), three-dimensional 
biocompatible polymers and microfluidic models [1-10]. The success of these three-
dimensional in vitro angiogenesis models in terms of their potential to sustain tissue 
viability (normal or pathological) is often qualitatively and quantitatively characterized 
by the structure and function of newly formed blood vessels [11-12]. The physical 
phenomenon of capillary sprouting, termed angiogenesis, is the process by which new 
capillary blood vessels are created, either as offshoots or as splits from existing vessels 
[13]. Tumor angiogenesis is the rate limiting stage of tumorigenesis, marked by initiation 
and sprouting of new vessels from existing neighboring vessels [14-15].
 
This stage 
encourages the survival and uncontrolled proliferation of cancerous cells by providing the 
cancerous site with access to nutrient and waste exchange [14]. Under healthy conditions, 
angiogenesis is marked by EC migration, initiation, formation, maturation, network 
remodeling, differentiation, and regression stages as cells grow into tubules and networks 
[14]. During tumor angiogenesis, the basement epithelial layer of the extracellular matrix 
(ECM) thins, the altered cells’ mechanics allow for cell crowding and anchorage-
independent growth, and the sensitivity to growth stimuli increases for neighboring cells 
[14-16]. The new vascular networks are markedly more tortuous and leaky, compared to 
a normal capillary network [17]. The vascular network created via tumor angiogenesis 
lacks the organization and maturation of vessels characteristic of normal vascular 
networks
 
[17-18]. The formation of the vascular networks can be characterized in terms 
of EC biology (i.e. gene expression), EC proliferation, EC migration, EC differentiation 
and tubule formation [19]. Imaging techniques have increasingly been adapted to track 




vascular networks (comprised of 4-10 micron vessels). These imaging techniques 
facilitate the evaluation of blood vessel development and/or regression within 
angiogenesis and tumor angiogenesis [20-22]. 
Commonly, static (well plates and natural/engineering constructs) and dynamic 
(microfluidics and in vivo) angiogenesis and tumor angiogenesis models are characterized 
based on results of histology and two-dimensional microscopy. These models are 
evaluated based on hypoxia distribution, epithelial proliferation, extracellular matrix 
composition, angiogenic factor secretions, the presence of transmembrane adhesion 
proteins, EC proliferation, blood vessel density, blood vessel diameter, tumor weight and 
tumor volume. Quantification of the tubule formation usually involves an estimation of 
the total or average number of tubules, lengths and area based on scaled measurements 
from a portion of the area of tubule growth. The presence and function of tubules is also 
quantitatively evaluated via enzyme-linked immunosorbent assays (ELISAs) that 
estimate the amount of EC surface glycoproteins that promote cell-cell adhesion, 
respectively, cluster of differentiation 31 (CD31) and von Willebrand factor (vWF).  
Imaging-based tubule formation assays of two-dimensional in vitro systems evaluate 
properties visible from the top or bottom surface of a Petri dish or well plate. As such, 
quantification of cell behavior, specifically EC migration or formation into tubules during 
angiogenesis is easily discernible in static images captured from a camera, or light or 
electron microscope [23], as illustrated in Fig. 7.1a. Techniques such as histology 
(hematoxylin and eosin staining), and immunostaining for CD31 and vWF are used to 
visualize tubules [23-25], as shown in Fig. 7.1b. Microscopy techniques that yield two-
dimensional topographic data, such as phase contrast and fluorescence imaging offers 
visualization and monitoring of in vitro vessel growth in translucent constructs, such as 
Matrigel. In a study of human umbilical vein endothelial cells (HUVECs) cultured on a 
Matrigel basement membrane matrix, Mezentsev et al. performed topological analysis on 
captured time-lapse microscopy data. The imaging data was qualitatively and 
quantitatively to evaluate the growth and regression of capillary-like networks over time 
in response to potential markers of EC dysfunction (endothelial microparticles) that were 






Figure 7.1 Two-dimensional tubule formation assays. Representative images of (A) in vivo 
immunohistochemical images of hematoxylin and eosin-stained fibrin implant sections showing the 
presence of red blood cells within anastamosed lumenal structures and (B) in vitro 
immunofluorescent images of capillaries formed within a fibrin tissue. Images courtesy of S. 
Grainger and A. Putnam, Cell Signaling in Engineered Tissues Lab, Department of Biomedical 
Engineering, University of Michigan. 
 
However, the complexity in geometry of three-dimensional engineered constructs renders 
assessments based on two-dimensional, surface imaging uninformative. Three-
dimensional constructs encompass pores, crevices, and other tortuous paths that are 
hidden from a top or bottom orthogonal view. Three-dimensional assays on tubule 
formation can be thwarted by light impenetrable synthetic polymer scaffolds and by the 
dissection of tubules in preparation for histology or microscopy. In addition, assessment 
in terms of structure (i.e. volume) and function (i.e. perfusion characteristics) of un-
mineralized tissue/blood vessels, non-calcified tissue/blood vessels are useful parameters 
in the characterization of engineered three-dimensional constructs. Quantification via 
CD31 and vWF remains a feasible assessment of vessel presence and function, 
respectively. However, the localization of ECs requires the cryosectioning of scaffolds, 
which introduces error to the measurement from the inevitable displacement and damage 
to cells and tubules. Thus, in order to better capture the information available in three-
dimensional angiogenesis models, three dimensional imaging methods are needed to 
qualitatively and quantitatively characterize tubule formation under in vitro conditions in 
three-dimensional constructs. At the sub-cellular level, microscopy studies of kinetochore 
microtubule cell division dynamics have demonstrated that trajectories observed in two-
dimensional imaging may significantly differ from those visualized in three-dimensional 




complete and accurate representation needed to characterize cellular processes and 
outcomes during in vitro angiogenesis and tumor angiogenesis studies [27]. 
Since the late 1890s, the challenge of non-invasive penetration of the human body has 
been achieved through medical imaging systems. These imaging systems generate 
datasets from which informative quantitative vascular metrics are extracted based on 
image voxel intensity values. In clinical radiology and oncology practice, static imaging 
(mainly, Magnetic Resonance Imaging and Computed Tomography) provides a 
qualitative and quantitative method to localize large vessel structures and assess their 
microvascular density. In addition, Radiation Oncology teams in therapeutic assessments 
of radiation treatment use dynamic perfusion imaging (via Magnetic Resonance Imaging, 
Computed Tomography, Positron Emission Tomography and Single-Photon Emission 
Computed Tomography) to capture image datasets over a given period of time (1-2 
minutes) in order to quantify tumor perfusion and angiogenesis. In whole-body and 
animal studies, static and dynamic imaging techniques have been employed to study 
xenograft, allograft and tissue engineered graft post-implantation [28-33]. Increasingly, 
tissue engineers have adopted whole-body and small animal imaging systems, such as 
Magnetic Resonance (MR) imaging techniques, Computed Tomography (CT) and 
Nuclear Imaging to evaluate in vitro normal and tumor angiogenesis. Several groups have 
capitalized on the strengths of the different imaging modalities to evaluate angiogenesis, 
despite some of the system’s limitations for practical cell-level biological application: 
low penetration depth (microscopy), low spatial resolution (MR), use of ionizing 
radiation (CT and x-ray) or lengthy imaging time (MR). Several molecular imaging 
modalities have also been investigated, particularly optical fluorescence imaging, 
targeted MR imaging and bioluminescence imaging.  
Utilized at fixed endpoints, these static and dynamic imaging methods provide 
observations of single-cell responses and bulk property changes (i.e. microvessel density) 
that are directly and indirectly related to normal and/or pathological angiogenesis and the 
resultant altered microenvironment. Existing imaging modalities used in angiogenesis 
research examine the structure and/or function of tubules and their local environment in 
terms of cellular composition, local environment (i.e. presence of biomarkers), stiffness 




branching. Direct metrics evaluate the structural characteristics of tubule formation, while 
indirect metrics assess changes caused by angiogenesis, such as construct stiffness and 
vascular permeability. 
In this paper, the methodologies available for noninvasive, in vitro imaging of tubules 
created during angiogenesis are explored. As well, their experimental requirements, 
potential benefits and inherent limitations are explored from the vantage point of 
applying these tools to the nascent explorations on in vitro three-dimensional 
angiogenesis models. This paper primarily focuses on the image-based characterization 
of tubule formation in terms of structural, mechanical and/or functional properties 
extracted from imaging methodologies, since angiogenesis studies commonly use the 
extent of vascularization as an end marker of tissue viability and tumor therapy. There is 
also brief mention of cell seeding and migration visualization. 
 
7.2  MEDICAL IMAGING MODALITIES  
7.2.1  Optical Imaging 
7.2.1.1  Phase Contrast and Fluorescence Microscopy 
Microscopy provides an assay method to capture live-cell kinetics. Specifically, phase-
contrast microscopy uses the fact that denser mediums transmit light at slower rates, than 
do less dense mediums. The change in this optical path of light allows for the 
visualization of living and otherwise transparent biological tissue and sub-cellular 
components, without the use of fixation or dyes [34]. Fluorescence microscopy offers 
enhanced contrast using near-monochromatic illumination to excite fluorescent-labeled 
biomolecules within a biological sample [35] to visualize structure and function of 
molecular or cellular components [35]. The stimulated fluorescent molecules emit a 
lower energy light (in the presence of light, biological parameters or gradients) that is 
used to produce an image that enhances the excited features [36], as shown in Fig. 7.2c. 
To visualize the distribution of a molecule within a sample, immunofluorescence 
employs antibody-antigen pairings tagged with fluorescent dyes to localized biomolecule 
targets [37]. Biological compounds, such as hemoglobin, nicotinamide adenosine 




during metabolic processes can be indirectly measured [38-40]. McDonald and Choyke 
[41] summarized a list of available markers to labeling ECs.  Each of these microscopy 
methods can be used to acquire a two-dimensional surface image of section sample (sub-
millimeter field of view).  
 
 
Figure 7.2 Example of three-dimensional phase-contrast microscopy coupled with fluorescent optical 
imaging. (A) Schematic of the fibrin/bead assay. Endothelial cells (red) are coated onto Cytodex 
beads and embedded into fibrin gels. (B) Phase contrast image of branching vascular sprouts 
emerging from a bead. Scale bar is 500um. (C) Endothelial cells were transduced with retrovirus 
expressing mCherry and sprouts were visualized under epifluorescence. (D) Confocal image of a 
sprout stained with phalloidin (actin) and DAPI (nuclei), demonstrating the presence of a lumen in 
the trunk of the vessel and a non-lumenized tip cell at the head of the sprout. Scale bar 10um. Images 
courtesy of C. W. Hughes and M. N. Nakatsu, Department of Molecular Biology and Biochemistry, 
University of California Irvine, Irvine, California. 
 
In a study that evaluated the distribution and survival of fibroblasts seeded onto a 
poly(lactic-co-glycolic acid) (PLGA) salt-leached scaffold, Thevenot and Tang [42] 
imaged 20-micron sections of the scaffold from top to bottom, using phase-contrast, and 
red and green fluorescence imaging. A three-dimensional rendering in NIH Image J (U. 
S. National Institutes of Health, Bethesda, MD) allowed for the direct quantification of 




In time-lapse microscopy, the dynamic and transient behavior of cells is captured within a 
given two-dimensional (x-y) field of view determined by the contrast mode (i.e. phase or 
fluorescence) adopted using an inverted microscope, at discrete intervals, for a given 
period of time [43]. Typically, time-lapse experiments comprise of hundreds of images 
that are analyzed by an automated post-processing method [43]. The visual output offers 
limited, quantitative information, since only a few vessels are visible in the small region 
imaged— a function of the required magnification (approximately 40-200 times). As 
well, the assay is subject to the selection of the field of view and the inherent variability 
within the network. Time-lapse microscopy is commonly used to track cell migration and 
growth, and can be combined with phase contrast microscopy [44-45].  
 
7.2.1.2  Confocal Microscopy 
In contrast to phase contrast and fluorescence microscopy, confocal microscopy 
generates three-dimensional volume reconstructions of scanned optical sections of a 
translucent three-dimensional sample. Three-dimensional confocal microscopy improves 
the quality of the image and offers a slighter higher resolution improvement (by roughly a 
factor of 1.4 [46]) over other microscopy techniques, making it useful for observations of 
three-dimensional structures thicker than 2-3 micrometers [47-48]. Image formation in a 
confocal microscope is achieved through point by point, serial reconstructions (i.e. 0.1-30 
Hz frame rate for a 512 x 512 image) of three-dimensional (z-series) data collected from 
the illuminated volumes [49-50]. The volume reconstructions are assembled from the 
series of thin vertical slices collected. Within confocal microscopy, a laser emitting 
monochromatic, coherent light is focused at a motor-driven dichromatic mirror(s) that 
scans the sample and then selectively excites thin sections of the sample [47,51]. 
Fluorescence emitted from the excited volumes is transmitted back through the mirror(s); 
low frequencies are reflected by the mirror(s), while higher frequencies are transmitted 
through the mirror, and then focused through a pinhole aperture. Only light in confocal 
(along a conjugate plane) with the source and pinhole passes through the aperture and is 
detected by a single photodiode or photomultiplier tube. The confocal pinhole or single-
mode fiber restricts the scanned volume confocal to the source and pinhole, thereby 




would otherwise contribute to the detected signal. A barrier filter is employed to ensure 
that none of the excitation light is detected in the final signal [51]. Confocal microscopy 
achieves roughly a 1 micron resolution, and submillimeter field of view and depth of 
penetration [52]. 
Similarly, two-photon confocal microscopy uses the simultaneous absorption of two 
infrared photons to excite section of a sample, in the same manner as previously 
described in confocal (one-photon) microscopy [53-54]. The two-photon method utilizes 
longer excitation wavelengths (higher frequency), which produce less scatter and out-of-
focus fluorescent background (at depths of about 1 mm) [53-55]. The longer wavelengths 
improve depth penetration and provide greater spatial confinement of light-matter 
interactions to reduce the absorption of excitation light outside the focal plane. The 
resulting biological implications are decreased phototoxicity and photobleaching on 
scanned cells [52-54,56].  
Dawood et al. used z-stack three-dimensional image reconstruction of images from 
immunofluorescent confocal microscopy to evaluate the number of HUVEC cells and 
tubule formation in multichanneled hydrogels (collagen VI and Matrigel) [57]. In the 
evaluation of translucent fibrogen gels, Nakatsu and Hughes stained the vessel walls 
within their construct with vimentin, and the EC nuclei with 4',6-diamidino-2-
phenylindole (DAPI) to visualize the three-dimensional hollow lumens recently sprouted 
in their in vitro angiogenesis study. They coupled phase-contrast microscope images with 
fluorescent (optical) images to generate a z-sliced image dataset, in order to confirm the 
presence of intercellular lumens and the polarity of HUVEC cell orientation relative to 
the collagen IV basement membrane and fibrin gel. Nakatsu and Hughes captured 
fluorescent images using a two-photon Carl Zeiss MicroImaging LSM 510 Meta 
microscope, then generated three-dimensional renderings [58]. Fig. 7.2a illustrates the 
setup of their fibrin/bead assay and Fig. 7.2b shows results from their phase contrast. Fig. 
7.2c-7.2d shows the results of three-dimensional renderings of fluorescent optical image 
stacks.  
Within a microfluidic device, volume renderings of tubule formation within individual 
channels were realized in a study by Chau et al., using z-stack image reconstructions and 




evaluation of capillary morphogenesis within a microfluidic system, generated three-
dimensional reconstructions of confocal images to visually confirm the patency of newly 
created fluorescent marked lumen structures [60]. Other investigations using microfluidic 
devices have combined fluorescent, confocal and/or time-lapse microscopy to optimize 
their set-up to monitor soluble chemicals such as oxygen tension [6,61].  
In an evaluation of engineered capillary networks, Grainger and Putnam co-cultured 
human lung fibroblasts and micro-carrier beads coated with HUVECs in a fibrinogen gel 
for 14 days [62]. The seeded gels were immersed in a fluorescent dextran tracer to allow 
for tracer perfusion into the luminal space of newly formed vessels.  The technique 
evaluated the permeability of the networks, as immature early sprouts are highly 
permeable, while mature networks possess mature cell-cell cadherin junction that are less 
permeable to the tracer. Confocal microscopy images were collected to quantify the total 
network length and to estimate a pixel intensity-based permeability measurement, which 
illustrated a decrease in tracer uptake over the 14 days. Although, the Grainger and 
Putnam, performed the study using Matrigel, the technique may be adapted to other 
three-dimensional in vitro models and the pixel intensity-based permeability algorithm 
could be expanded to a three-dimensional volume rendered from confocal images. As 
well, the technique provided a useful analytical tool to distinguish normal vascular 
networks from leaky, cancerous networks. 
Song and Munn illustrated the effects of positive and negative localized vascular 
endothelial growth factor (VEGF) gradients and fluid forces (approximately 0 - 3 
dynes/cm
2
) on in vitro angiogenic sprouting in microchannels [63]. Vascular endothelial-
cadherins were stained with a cyanine (Cy3) dye and HUVECs with 5’bromo-2’-
deoxyuridine (BrdU) in a microfluidic device fabricated with poly(dimethylsiloxane) 
(PDMS) and containing a localized coating of collagen gel. Phase constrast and 
fluorescent images were collected with an epifluorescence microscope, then processed to 
quantify EC proliferation and to qualitatively and quantitatively evaluate EC invasion 
into the collagen gel. Z-stacks of confocal images were also acquired to count the number 
of filopodia formation in sprouting HUVECs in a given area. The combined use of phase 




combining microscopy techniques to further understand angiogenesis and to assess tubule 
formation within a dynamic in vitro model. 
Meijering et al. [43] highlights that living cells are sensitive to photodamage due to 
excessive light exposure, such as that received during time-lapse microscopy. As such, 
before using these imaging protocols, validation studies should be performed to confirm 
that neither the light nor fluorescent probes alter cell physiology. Experimental set-ups 
should include controls and treatments that evaluate the sensitivity of cell-types under 
different culture conditions to light exposure and probes. 
 
7.2.1.3  Bioluminescent imaging (BLI) 
Bioluminescent imaging (BLI) provides a high sensitivity and specificity imaging 
technique to track cell viability/proliferation and localize neovascularization, using a cool 
charge-coupled device (CCCD) camera. In vitro BLI of cells is another noninvasive 
imaging technique that is useful in the evaluation of angiogenesis. It offers a colorimetric 
evaluation of the hypoxia levels of cells. Within BLI, energy in the form of light that is 
emitted from a chemical reaction within a biological sample is captured to form an 
image. Luciferins, light-emitting biological pigments, can be introduced to a sample to 
react with oxygen [64]. The light emission from these reactions is transient, and may be 
influenced by factors that are not controllable in the study. Liu demonstrated the viability 
of the assay for three-dimensional scaffolds by effectively visualizing oxygen gradients 
across cylindrical engineered agarose gels (4.8 mm x 4.8 mm), seeded with transfected 
Chinese hamster ovary A4-4 cells, and then subcutaneously implanted into nude mice 
[65]. Wang and El-Deiry [66]
,
, Wang et al. [67] and Jenkins et al. [68] performed in vitro 
BLI imaging on wells seeded with mesenchymal stem cells, ECs and/or tumor cells that 
were transfected with the firefly luciferase gene. In each study, image intensity was 
directly correlated with cell counts in order to quantify viability and proliferation. BLI 
has mainly been limited to in vivo whole body imaging and ex vivo imaging of excised 
tissue. Nadella et al. [69] and Xie et al. [70] tracked disease progression, in terms of 
tumor volume, through the delineation of tumor boundaries volumes using BLI. 




dynamic bioreactor. In the study, chitosan scaffolds (13 mm × 13 mm × 25 mm) were 
embedded in a bone perfusion bioreactor and imaged over 11 days with BLI to monitor 
cell viability and bone morphogenetic protein 2 (BMP-2) expression of both MB-Luc and 
MC3T3-E1 cells. 
For a three-dimensional engineered scaffold or dynamic construct, the sensitivity of the 
BLI technique may be diminished as the material properties of the 3-D construct can 
produce high scatter and attenuation causing a low transmission of the bioluminescence 
signal at increased depths. BLI does not resolve depth, instead produces a two-
dimensional image representation of the visualized activity in the sample, whereby 
overlapped signals from the structure sum to form the final image. In a study by Logeart-
Avramoglou et al. [72], the cell counts for tagged murine stem (C3H10T1/2) cells in a 
known cell suspension were correlated to the number of cells adherent to a hydrogel (6 
mm diameter x 2 mm height) and ceramic (3 mm x 3 mm x 3 mm) scaffold. Logeart-
Avramoglou et al. suggested that the degree of signal attenuation and corresponding 
linear decrease in cell count were a material constant dependent on the scaffold properties 
(i.e. size, shape and porosity).  
As well, it should be noted that sources closest to the imaging source may appear brighter 
than those towards the bottom or at the core of the engineered scaffold. Initial studies 
should determine the percent loss of signal with increased depth for a given in vitro three-
dimensional model. Multiple CCCD cameras could be configured to capture multiple 
views of the construct in order to provide depth information. The sensitivity of the CCCD 
camera (and filters), along with spectral analysis techniques used to acquire and evaluate 
data can greatly enhance the sensitivity and resolution of BLI images. Along with an 
evaluation of signal loss, the potential inherent physiological changes that may be 
induced by the introduction of the luciferins should be assessed in a control study. 
Similarly, the transduction efficiency of the retroviral vectors for EC lines should be 
optimized. As an imaging modality for examining network formation, BLI fails to 
visualize anatomical changes, but can indirectly monitor tubule formation through the 
assessment of bulk changes in vessel formation, and the correlation between cell 





7.2.1.4  Additional Optical Imaging Techniques 
Investigations of optical imaging techniques, such as optical coherence tomography 
(OCT) and photoacoustic microscopy (PAM) have shown their utility in to monitor cell 
migration, spatial distribution, proliferation and morphology within three-dimensional 
culture models. OCT forms an image based on the indirect measurement of intensity from 
an interference pattern generated by reflected broad bandwidth, near-infrared that was 
focused light onto a given sample [73-74]. The echo time-of-flight produced from the 
scattered light is used to resolve the depth dimension. The axial and transversal 
resolutions of the system are governed by the spectral bandwidth and incident beam 
focusing, respectively [73-74]. OCT can image up to several millimeters deep, dependent 
on the optical properties of the sample, to form either two-or three-dimensional images. 
A variation of OCT, whole-field optical coherence microscopy (WFOCM, also referred 
to as full-field OCT) provides greater depth penetration than confocal microscopy [73-
75]. OCM provides high sensitivity and contrast in scattering (non-transparent) and non-
scattering (translucent) samples. Yang et al. [75] rendered three-dimensional cell 
distributions from volumetric WFOCM data for bone cells seeded on poly(l-lactic acid) 
(PLLA) scaffolds (9 mm diameter x 4 mm height) using WFOCM (resolution on order of 
0.8 μm x 0.9 μm x 0.7 μm) for 250 micrometer field of view. Coupled with multiphoton 
microscopy, OCM can be used to simultaneously acquire structural and functional 
information at the cell level [76]. 
PAM is a modified photoacoustic tomography technique, which forms an image by 
ultrasonically detecting pressure waves induced by the absorption of photons by local 
molecules irradiated by a pulsed laser beam [77-78]. The axial and lateral resolutions are 
determined by the dual detection/excitation focusing and the acoustic travel time, 
respectively [77]. The final is speckle-free image can have a resolution of few hundred 
nanometers to about a millimeter and a depth of a few millimeters [77-78]. Zhang et al. 
[79] generated three-dimensional renderings of fibroblasts which were allowed to 
proliferate on poly(D,L-lactide-co-glycolide) (PLGA) scaffolds (approximately 5 mm 
diameter). A depth penetration of 1.2 mm was achieved. However, EC studies of 




increases in temperature, as well as their response to pressure changes during imaging 
should be considered. 
 
 
Figure 7.3 (A) Photoacoustic microscopy (PAM) maximum amplitude projection (MAP) image and 
(B) the corresponding three-dimensional volume rendering of the MAP image illustrate the spatial 
distribution of fibroblast seeded on PLGA scaffold.  (C) and (D) are three-dimensional renderings 
generated from optical coherence tomography (OCT) data. Reprinted from Cell Imaging, 50, Zhang, 
Y., et al., Noninvasive photoacoustic microscopy of living cells in two and three dimensions through 
enhancement by metabolite dye, 7359-7363, 2011, with permission from Wiley-VCH Verlag GmBH 
& Co. Reprinted from Physics in Medicine and Biology, 51, Yang, Y., et al., Investigation of optical 
coherence tomography as an imaging modality in tissue engineering, 1649-1658, 2006, with 
permission from IOP Science [75,79]. 
 
In vivo small animal studies have illustrated the successful application of various optical 
imaging techniques, e.g. PAT [77-78] , OCT [80-81], multiphoton microscopy [82] and 
laser speckle imaging [83-84] to imaging functional vasculature (normal and diseased) in 






computed tomography), where the relative transient motion of fluorescence labeling, 
hemoglobin gradients, reporter genes, dyes or nanoparticles were detected. These 
dynamic imaging methods have not been applied to in vitro three-dimensional culture 
models, wherein the function of nascent vasculature is typically not assessed.  
 
7.2.2  Magnetic Resonance Imaging 
Magnetic Resonance Imaging (MRI) generates high contrast between different types of 
soft tissues (resolution of about 1 mm) [85]. The magnetization of hydrogen atoms 
present in the water within soft tissue causes the atoms to align their spin states, either 
with or against the applied magnetic field [85]. The image created by MRI is a function 
of how quickly the hydrogen atoms return to their original orientation (termed the 
relaxation time, T1 and T2), after the application of a radiofrequency pulse [85]. These 
variances in relaxation times are highly dependent on the water content of the tissue, and 
thus are used to distinguish tissues in the body. References to T1 and T2-weighted images 
indicate that most of the contrast between tissues is due to differences in the specified 
relaxation value [86]. In T1-weight images fat appears brighter than water, while in T2-
weight images water appears brighter than fat (typically pathological tissue has a high 
water content) [86]. T2*-weighted images offer greater contrast in tissue or lesions with 
hemorrhaging, calcification, and iron deposition [87]. Before image acquisition, a 
contrast agent that is impenetrable to the cell membrane is often administered to enhance 
the appearance of blood vessels in a particular region of tissue. The contrast agents 
reduce the T1 or T2 relaxation times [88]. MR studies have primarily evaluated the 
material stiffness of tumors and three-dimensional spatial distribution of microvessels 
grown on engineered tissue constructs, using contrast techniques such as, T1-weighting, 
T2-weighting, paramagnetic particles, magnetization transfer, perfusion and elastography 
[89-94].  
Clinically, the studies are limited in spatial resolution since regions of interest deeper 
than about 2 cm are poorly targeted by MRI, due to the rapid decrease of field strength 




dimensional culture models are typically between 0.3 - 1 cm, with “thick tissue” 
constructs extending the range beyond 1 cm. 
 
7.2.2.1  Magnetic Resonance Elastography (MRE) 
Recent developments in MRE have taken advantage of the remodeled and stiffened ECM 
that is evident during tumorigenesis. Animal and human (breasts, aorta, brain and liver) 
studies have demonstrated that MR elastography is sensitive to these stromal (ECM, 
MMPs, ECM glycoproteins) changes and can offer an evaluation of stiffness, in terms of 
shear modulus and shear elasticity estimations [94-96]. MRE involves the propagation of 
mechanical waves, at a controlled frequency (100-1000 Hz [95]) and amplitude (less than 
100 µm [95]), through a target sample via a wave driver, which is positioned as close as 
possible to the sample [96-97]. The MR image acquisition is synchronized with the 
periodic vibrations. The mechanical excitation induces a shear stress on the sample, 
which results in a displacement captured by the real (elasticity) and imaginary (viscosity) 
components of the shear modulus of the scanned sample [98]. From the visco-elastic MR 
data, quantitative elasticity maps are generated [96-97]. These changes are inherent to the 
multistep process of tumorigenesis (and tumor angiogenesis), which is characterized by a 
thinned basement epithelial layer of the ECM, and cell crowding and anchorage-
independent growth [16-18]. Transmembrane protein function is diminished for integrins 
that regulate cellular shape and for adheren proteins that hold epithelial cells onto the 
basement membrane together [99]. The interstitial fluid pressure is amplified with the 
increased volume of inefficient, dense ECM within the tumor [100]. The increased cell 
tension and ECM-remodeling contribute to the stiffened ECM during tumorigenesis [100-
102]. 
Although performed in vivo, the study conducted by Jugé et al. [89,103] compared 
immunostained histology (CD 31 and KI67) to acquired MRE data to draw conclusions 
about tumor behavior. Jugé et al. concluded that the blood vessel density (based on 
cellularity and number of vessels) (mm
-2
) and elasticity (based on number of vessels and 
elasticity) (kilopascals) measurements from the respective techniques, both showed 




phase of tumorigenesis. Fig. 7.4 illustrates the MRE data that was collected from a 
colorectal mouse cancer model using T2-weighting on a 7 Telsa scanner over the course 
of 18 days. However, no comparable in vitro studies using engineered constructs have 
been published.  
 
 
Figure 7.4 In vivo MRE mapping. T2-weighted images (top row) and Gd maps (bottom row) of 
selected ectopic tumors (outlined in red) as a function of colorectal mouse tumor evolution. Gd 
measurements showed an increase of the mechanical properties when the tumor switched from its 
early stage (3.8 ± 0.6 kPa) to its angiogenic and late stage (6.5 ± 0.8 kPa to 5.8 ± 0.5 kPa). White 
arrow indicates region of interest. Images courtesy of L. Jugé and R. Sinkus, Centre de Recherche 
Biomédicale Bichat-Beaujon, INSERM U773, Clichy, France [104]. 
 
MRE is an emerging area that can offer an indirect method to evaluate the progression or 
regression of tubule formation during tumor angiogenesis, particularly when vessels may 
be too leaky or nonfunctional for perfusion methods of evaluation (i.e. DCE-MRI).  The 
shear modulus changes captured by MRE may be a biomarker indicative of changes 
induced by increased microvessel density. The model would be most applicable to a 
natural or engineered matrix with a low stiffness that may be altered during 
tumorigenesis, under the conditions of an in vitro tumor angiogenesis model. However, 
additional studies would be required to understand the role of the composition and 





7.2.2.2  Dynamic Contrast Enhanced - MRI 
Dynamic Contrast Enhanced (DCE) - MRI, a method of perfusion imaging, involves the 
acquisition of a time series of images after the injection of a bolus of paramagnetic 
contrast agent (i.e. iodinated radiographic contrast material or radionuclides) into the 
bloodstream [105]. The presence of contrast agent allows for the temporal and spatial 
localization of blood in a region of interest. DCE-MRI receives these transient changes in 
the local magnetic field as temporal changes in the collected signal. Data is typically 
collected for 1-10 minutes, for each time point over some study period dependent on the 
time course of the transient activity being observed. DCE-MRI offers voxel resolution on 
the order of millimeters and a temporal resolution of less than five seconds when 
optimized MR imaging sequences are employed. DCE-MRI data can be performed on a 
standard 1.5 Tesla MR system [106]. Perfusion metrics (i.e. flow rate, microvessel 
density and volume) indicative of the extent and functionality of the vasculature are 
extracted from the collected image datasets [105]. These metrics are based on the 
conversion of the temporal signal data to tissue contrast concentration data.  
In an ex vivo study by Buschmann et al. [90] on the endothelialization of DegraPol® 
foam scaffold, quantitative contrast enhanced MRI (T1-weighted) perfusion analysis was 
performed. First, the scaffolds were seeded with ECs and cultured in vitro to allow for 
tubule formation. Subsequently, gadolinium (Gd)-DTPA dimeglumin salt (contrast agent) 
was used to outline the in-growth of new vascular networks into scaffolds assayed ex 
vivo, in a chorioallantoic membrane (CAM). MR image analysis of the scaffolds, 
saturated with contrast intravenously, demonstrated low contrast uptake by the scaffold. 
There was significant distinction between the vascular network and the background 
scaffold. The uptake of Gd was evaluated across the scaffold and used as a metric of 
microvessel density. As often seen across scaffolds, the greatest uptake was seen at the 
periphery and the least at the center of the scaffold. Buschmann et al. also evaluated three 
seeding methods to determine if the distribution of these capillaries was a function of 
whether ECs, osteoblasts or a co-culture were seeded on the scaffold. MRI showed 
insignificant differences in relative relaxation times based on the seeding method. The ex 
vivo model angiogenesis assay demonstrated the utility of DCE-MRI to evaluate 




Although not yet extended to a completely in vitro study, the work by Buschmann et al. 
showed that saturation of a contrast agent on the surface (not intravenously) of a scaffold 
implanted in CAM still produced an increase in the relaxation rate, but with less 
sensitivity to changes in perfusion. These findings demonstrated the potential for DCE-
MRI technique to provide a visualization and quantification method for observing gross 
changes in tubule formation (surface area covered and vasculature permeability). Future 
studies may employ the technique to evaluate the presence or the function of newly 
formed vessels in dynamic in vitro angiogenesis models (i.e. microfluidic device or 
bioreactor). The three-dimensional dynamic culture models offer a flow source thru 
which contrast agent can be injected for uptake by permeable sprouting capillary-like 
structures. The degree of contrast agent uptake by tubules can be an indicator of 
vasculature function. Key parameters that should be optimized to ensure the credibility of 
extracted perfusion metrics include the image’s signal-to-noise ratio and contrast-to-noise 
ratio, and the length of contrast agent retention in new formed vessels. 
 
7.2.2.3  Targeted MRI 
The application of targeted MRI to cellular and molecular imaging was first introduced as 
an alternative to MRI contrast agents [107]. Highly negatively charged 
superparamagnetic iron oxide nanoparticles (SPIONs), such as ferumoxides, shorten MRI 
T2 and T2* relaxation times to produce contrast enhanced images from which useful 
metrics, such as tubule volume and area, can be extracted [108]. The ability to estimate 
tubule properties, in terms of length or number of tubules using enhanced or unenhanced 
MRI is otherwise limited by its low spatial resolution of 200 - 400 micrometers [109]. 
Cell uptake of the nanoparticles occurs via phagocytosis, but intake by nonphagocytic 
methods can also be facilitated by cationic compounds that interact with the negatively 
charged cell surface to promote endosomal uptake [110-111]. SPIONS tag biological 
molecules such as antibodies, peptides and hormones [112]. They can also be 
functionalized to localize cells or subcellular structures.  
In an in vitro targeted MRI study, Terrovitis et al. [91] cultured iron-labelled 




1.5 Tesla MRI scanner, T2-weighted scans were performed and resulting images 
demonstrated that iron-labelled MSCs on a collagen scaffold could be visualized using 
MRI. This study also illustrated that the biocompatibility of ferumoxide and its lack of 
adverse effects on the viability and proliferation of MSCs. The study methodology 
demonstrated by Terrovitis et al. could be applied to ECs in a three-dimensional tumor 
angiogenesis model. 
In the design of an in vitro method to control endothelial progenitor cell (EPC) migration, 
Wilhelm et al. [93] tagged EPCs with iron oxide magnetic nanoparticles. The tagged 
EPCs were cultured in Matrigel for 18 hours, then imaged using a high resolution MRI 
(29 micron x 29 micron) and videomicroscopy (12,000 - 24,000 times real-time). Using 
videosmicroscopy, individual vessel structures were visible. The MRI images were 
acquired with a 9.4 Tesla horizontal MRI system, using gradient echo sequences (T2* 
sensitive). The magnetic nanoparticles induced changes in the MR contrast agent 
properties, which led to visible changes in local magnetic susceptibility within images. 
Tagged EPCs appeared as black voids on a brightened Matrigel structure. In this study 
however, no quantitative metrics were used. Nonetheless, the study by Wilhelm et al. has 
implications that can be extended to tumor angiogenesis tube formation assays, since 
EPC recruitment was linked to tumor angiogenesis in both  patient studies [113-114] and 
preclinical models [115-116]. In mouse models, EPCs have been shown to control the 
angiogenic switch in lung mouse metastasis [117].  
Gimi et al. [118] tagged HUVECs with superparamagnetic iron oxide T2 contrast agent 
and cultured them in vitro for five days adjacent to MDA-MB-231 breast cancer cells 
seeded onto an ECM gel. After 24 hours of culture, a vascular network was present. The 
migration and subsequent tubule formation of the HUVECs within the gel was observable 
using an 11.74 Telsa MRI, fluorescence microscopy and phase-contrast microscopy. The 
light microscopy techniques were used to confirm that no observable physiological 
differences occurred between the tagged and untagged HUVECs. Three-dimensional 
reconstruction of the MRI data and post-processing produced an isolated volume 
rendering of the HUVEC vessel network. The volume renderings are shown in Fig. 7.5. 
The rendered volume was used to determine the fractional area of the gel occupied by 




Similarly, other macromolecular contrast media have been used in cellular imaging to tag 
biomarkers of tumor aggressiveness and to monitor normal angiogenesis [119-121]. Gimi 
et al. demonstrated how multiple imaging modalities can be simultaneously used to 
garner the additional information on tubule formation within an in vitro model.  
 
 
Figure 7. 5 Representative image and volume renderings from targeted MR imaging of endothelial 
cells 24 hours post-seeding in ECM gel. (A) Axial image of 0.5-mm-thick slice, obtained using a T2-
weighting, contains HUVECs labeled with 9 µg/ml Feridex.  (B) Three-dimensional reconstruction of 
images from multi-slice MRI data, orthogonally sliced in the axial direction to visualize network 
structure. (C) Volume rendering produced from segmented three-dimensional reconstruction, which 
illustrates intricate HUVEC network (red). Reproduced from Gimi et al. with permission [118]. 
 
In another study, although carried out in a subcutaneous xenograft mouse model, the 
potential use of paramagnetic 
19
F perfluorocarbon (PFC) nanoparticles was explored to 
quantify (in terms of the number of enhanced voxels) and visualize the extent of 
neovascularization at the periphery of tumors, using small animal MRI [122]. Bound PFC 
nanoparticles can be directly detected with high specificity once the threshold of 
detection is achieved, using MRI or MRS [123]. In addition to improvements in 
nanoparticles, advances in magnetic resonance microscopy may also provide nanometer 
resolution to visualize the mechanisms involved in tubule formation [124].  
The application of target MRI to in vitro three-dimensional angiogenesis models provides 
tool for the assessment of temporal and spatial cell migration and gene expression (via 
green fluorescent protein marker) [125] over a three-dimensional spatial distribution. 
Many studies have demonstrated the biocompatibility of these particles in terms of cell 
apoptosis rates, differentiation and proliferation for specific cells types. However, cell 
exposure to SPIONs may induce DNA damage, mitochondrial disfunction, apoptotic 
bodies, membrane leakage of lactate hydrogenase, or generate reactive oxygen species 




vitro three-dimensional angiogenesis models, an investigation of the particle-EC uptake 
efficiency, retention, dose effect, detection threshold, and biocompatibility should be 
explored for the particular cell line. In addition, for surface-modified nanoparticles, the 
shelf-life, by-products of degradation, aggregation and precipitation of particles under in 
vitro conditions should be investigated prior to use in the model. Zhang et al. noted that 
the ability to track SPIONs over 5 days diminishes due to cell’s release of the iron 
particle [129]. 
 
7.2.3 Ionizing Radiation Imaging Systems 
7.2.3.1  X-ray, Fluoroscopy and Computed Tomography (CT) 
In X-ray imaging system (wavelength of 10 to 0.010 and energy range of 120eV to 
120keV), X-rays emitted from a source penetrate a tissue, then attenuate at different 
levels dependent on the density of the material. The X-rays which penetrate the tissue are 
received by scintillation detectors [130]. From these readings, a grayscale two-
dimensional image is generated. Fluoroscopy provides a real-time continuous video of X-
ray images. The technique is useful for viewing whole-body motions, and contrast agent 
or instrument motion in tissue or bloodstreams [131]. Computed Tomography (CT) 
imaging (sub-millimeter spatial resolution) involves the reconstruction of a three-
dimensional volume from a collection of two-dimensional X-ray projections taken about 
a central axis of rotation [131].  
Imaging techniques, such as X-ray, fluoroscopy and CT (including MicroCT), which emit 
ionizing radiation offer useful structural information regarding a construct’s porosity, 
strut/throat size, mineralization and overall architecture of tissue-engineered constructs 
with high-attenuation. To visualize low-attenuation structures such as blood vessels, 
MicroCT (spatial resolution 1-50 microns [132]) has been used in experimental animal 
studies to characterize structural properties [133-134]. Rai et al. [135] used Micro-CT to 
quantify vascular in-growth into poly(ε-caprolactone)-tricalcium phosphate (PCL-TCP) 
composite scaffolds implanted in rats, in terms of a vascular volume fraction.  The 
animals were anesthetized, then injected with the contrast medium, Microfil, to enhance 




for poly(propylene fumarate) (PPF) scaffolds coated with vascular endothelial growth 
factor (VEGF) to measure changes in blood vessel volumes in rats over a four week 
study. Fig. 7.6 provides an example MicroCT images produced in a similar study by 
Schmidt et al. [137]. In the study by Schmidt et al., Microfil was injected into a rat to 
quantify the ingrowth of vasculature into a porous polyurethane construct. Vessels 
between 6 - 144 micron were visualized using MicroCT. However, the well-documented 
anti-angiogenic effect of ionizing radiation, even at low doses, abrogates its use in an 
ongoing study of angiogenesis [138-140]. There is potential use for these methods in 
static imaging of non-living constructs with patent vessel structures large enough to have 






Figure 7.6 MicroCT of Microfil-injected vessels. Representative volume renderings generated from 
MicroCT datasets of neovasculature within polyurethane construct, 10 days after delivery of 
vascular endothelial growth factor growth factor. (A) Longitudinal center slice through volume 
rendering. (B) Horizontal slice. Red color represents microvascular network and gray represents the 
construct. (C) Color-coded distribution of vessel diameter distribution across construct. Reprinted 
from publication Rapid three-dimensional quantification of VEGF-induced scaffold 
neovascularisation by microcomputed tomography, 30/5959, Schmidt, C., Bezuidenhout, D., Beck, 






Conversely, radiation exposure has been shown to induce tumorigenesis [142-143]. 
Accordingly, X-ray and CT could be used to introduce radiation to an experimental set-
up to investigate or control the response or rate of tumor angiogenesis or cell death in the 
presence of drugs or other factors [144-145].  
 
7.2.3.2  Nuclear Imaging 
Positron Emission Tomography (PET) imaging introduces a low radiation dose to the 
body using short-lived radionuclide tracers. The system then detects gamma rays emitted 
indirectly by the positrons released from the injected radionuclides. Scintillation crystals 
in the gamma ray detectors covert the emitted gamma rays to photons, which are then 
amplified and converted to electrical signals by photomultiplier tubes to form PET 
images [146]. A second nuclear imaging system, Single-Photon Emission Computed 
Tomography (SPECT), detects these emitted gamma rays directly to generate images 
[147]. Both systems can create clinically relevant three-dimensional volume 
visualizations of functional and metabolic processes (i.e. glucose metabolism) [148]. In 
spite of the sensitivity of radionuclides to highlight physiological effects on the level of 
100 picomolar, compared to other modalities, nuclear imaging techniques offer an 
inferior spatial resolution [148]. The clinical resolution of PET ranges between 3-5 mm
 




small animal PET imaging [149]. Clinical SPECT resolutions 
are typically greater than 1 cm, with decreased sensitivity than PET systems [150]. Both 
systems’ poor resolution outweighs its potential benefit in the evaluation of bulk 
properties characteristic of tubule formation in angiogenesis. MRI-compatible PET 
scanners are currently under investigation as a method for fusing complementary 
capabilities in small animal imaging: high sensitivity, good spatial resolution and high 
contrast [151]. There is currently no literature to support the use of nuclear imaging 
radioligands (molecules bound to radionuclides) or radiotracers to evaluate in vitro tubule 





7.3 IMAGE PROCESSING  
Five major steps are involved in the quantification of tubulation from three-dimensional 
images. Fig. 7.7 details these steps: image acquisition, image reconstruction, image 
segmentation, feature identification, and feature measurement. The appropriate imaging 
system to be used should be based on the experimental setup and constraints, and desired 
output measures. Post-processing of acquired images requires image processing and 
analysis software. The image analysis freeware, NIH Image J [152] (and derivative 
software, Scion Image) is often cited as the tool used to stack, reconstruct, render or post-
process network formations.  
 
 
Figure 7.7 Stages of image processing. Flowchart of image analysis process required to qualitatively 
and/or quantitatively evaluate angiogenesis. 
 
Rendered volumes are subjected to a threshold (automated image segmentation) to 
contrast the desired luminal features from the background larger tissue volume. In the 
evaluation of vessel diameter, length or area, threshold values can influence final 




lumen is defined. Boundary detection between the tubule and background construct 
requires the optimization of a fixed or adaptive, local or global threshold algorithm. 
Semi-automatic methods of image segmentation implement snakes or splines for 
boundary delineation or edge detection. Manual and semi-automated methods of 
processing imaging data require visual inspection of image by a trained eye. The human 
reader performs ‘feature identification’ based on a set of pre-determined characteristics. 
Sarkanen et al. [153] employed a grading scale from 0 to 8 using visually inspection of 
microscopy images, to quantify the number of tubules and branching achieved for a co-
culture of HUVEC and foreskin fibroblasts. Along with boundary detection, the number 
of tubules estimated is dependent on the shape and dimensional threshold parameters 
(feature identification and measurement) set either manually or by the software package. 
The cylindricality and contrast (produced by fluorophore, dye or contrast agent) of the 
tubule may be variable in given regions of the volume, and may potentially influence 
final measurements. Similarly, the length and diameter of a tubule may vary dependent 
on the level of bifurcation. Tubules may be faint, partially stained/tagged or clustered. 
Segmentation and the definition of its rubric are subjective and sensitive post-processing 
elements that are biased by the biomaterial (scaffold), cell type (and resultant vascular 
network properties) and imaging system adopted. Measurements are also subject to 
variance and user-based error incurred during manual or semi-automated segmentation 
methods. Several freeware and commercial software programs that perform automated 
and semi-automated image analysis produce output parameters such as, the number of 
tubules, branching point statistics, tube length statistics and tube size statistics [154-158].  
Many automated and semi-automated quantification algorithms directly measure 
perfusion metrics (i.e. surface area) based on two-dimensional analysis of collected two-
dimensional sectional data [159-161]. Rytlewski et al. [162] proposed a new algorithm to 
perform three-dimensional morphological analysis on two-dimensional sectional data, in 
order to increase the accuracy of output metrics. Initial evaluations of the algorithm were 
performed on an in vitro model, in which HUVECs were cultured within a PEGylated 
fibrin gel and allowed to sprout tubules. Rytlewski et al. performed confocal imaging on 
the in vitro model and then extracted morphological data, which included estimations of 




that measurements based on three-dimensional models were significantly different than 
those based on two-dimensional planar data for multi-plane anisotropic tubule formation.  
In the post-processing of DCE images acquired for indirect measures of perfusion, 
segmentation should be performed, and then followed by the application of perfusion 
algorithms adopted or specifically developed to evaluate flow characteristics of the newly 
formation vasculature. In the evaluation of stiffness, using MRE, the acquired three-
dimensional images provide phase and amplitude maps that are modeled using an 
inversion algorithm that yields an elastogram. The generated elastogram indicates the 
spatial distribution of stiffness within the imaged construct. For each of the imaging 
methods used to acquire direct or indirect measures, the final angiogenesis metrics are 
compared across several time points within the duration of the study (minutes or days),  
in order to assess angiogenesis within the in vitro construct. For metrics that assess 
spatial deviations, image registration of the two-dimensional images across time points 
should be performed before feature isolation or other post-processing algorithm are 
applied. Image registration aligns the spatial overlay of the constructs coordinate systems 
for the given points, in order to facilitate the tracking of temporal changes. 
 
7.4 CONCLUSION  
The in vitro studies described above confirm the practical application of imaging to 
characterize blood vessel formation and function within natural or synthetic constructs. 
At the cellular level, the tracking of EC motility and alignment in the formation of 
tubules is best resolved using optical imaging, MRI or CT. The rendering of three-
dimensional volumes provides a non-invasive method to observe the structure and 
distribution of blood vessels, which may otherwise be compromised or lost through 
histology sectioning. BLI, contrast enhanced MRI, MRE and microscopy coupled with 
fluorescent tracers can provide temporal and functional information (i.e. metabolic 
activity, permeability, proliferation and stiffness) on neo-vasculature and/or the 
surrounding extracellular matrix.  
New techniques in molecular imaging (for MR, optical and nuclear imaging) that tag 




to further improve achievable resolution limits. As well, nascent imaging techniques such 
as magnetic particle imaging (MPI) may offer a more reliable or precise method of 
dynamic perfusion imaging through the quantitative detection SPIONs [163-164]. 
Although some of the techniques (i.e. MRE) have published findings only under in vivo 
conditions, the techniques still lend themselves to an in vitro environment.  
Initial implementations of these techniques require validation studies to assess toxicity 
and to identify any adverse effects caused by the introduction of light, magnetic 
resonance, particles or ionizing radiation to the given cell and cell environment. As well, 
the incorporation of an imaging modality into an experimental set-up requires a careful 
consideration of the hardware and software choices made, in terms of processor needs, 
frame rates, threshold algorithms, among other parameters that may reduce the reliability 
of quantitative estimations. In the determination of an appropriate imaging modality, the 
scaffold architecture (shape and dimension), scaffold material characteristics (physical, 
optical, mechanic and acoustic properties), and the features of interests (subcellular or 
bulk property) should be considered. Dependent on the set-up conditions and scaffold 
architecture, multi-modality imaging can be leveraged to take advantage of the respective 
features of the systems to provide more spatial, depth, structural and/or functional 
information about the imaged features.  
Future applications of imaging techniques to in vitro three-dimensional angiogenesis 
studies will provide more reliable, robust methods for comparison of the vascular 
properties exhibited within these in vitro models to animal models. Correlation of 
changes in between the two models has the potential to outline the advantages and/or 
limitations of three-dimensional angiogenesis and tumor angiogenesis culture models as 
practical tools for the investigation of mechanisms or pathophysiology acting at the 
cellular level in engineered tissue and tumors, respectively. 
 
7.5  ACKNOWLEDGEMENTS 
This work was supported by the graduate fellowships awarded to Auresa Thomas. Auresa 
was funded by Ruth L. Kirschstein National Research Service Awards for Individual Pre-





7.6  REFERENCES 
[1] Szot, C.S., Buchanan, C.F., Freeman, J.W., and Rylander, M.N. 3D in vitro 
bioengineered tumors based on collagen I hydrogels. Biomaterials 32, 7905, 2011. 
[2] Kievit, F.M., Florczyk, S.J., Leung, M.C., Veiseh, O., Park, J.O., Disis, M.L., and 
Zhang, M.Q. Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor 
microenvironment. Biomaterials 31, 5903, 2010. 
[3] Khoo, C.P., Micklem, K., and Watt, S.M. A Comparison of Methods for Quantifying 
Angiogenesis in the Matrigel Assay In Vitro. Tissue Engineering Part C-Methods 17, 
895, 2011. 
[4] Yates, C., Shepard, C.R., Papworth, G., Dash, A., Stolz, D.B., Tannenbaum, S., 
Griffith, L., and Wells, A. Novel three-dimensional organotypic liver bioreactor to 
directly visualize early events in metastatic progression. Advances in Cancer 
Research 97, 225, 2007. 
[5] Wlodkowic, D., and Cooper, J.M. Tumors on chips: oncology meets microfluidics. 
Current Opinion in Chemical Biology 14, 556, 2010. 
[6] Stroock, A.D., and Fischbach, C. Microfluidic Culture Models of Tumor 
Angiogenesis. Tissue Engineering Part A 16, 2143, 2010. 
[7] Verbridge, S.S., Chandler, E.M., and Fischbach, C. Tissue-Engineered Three-
Dimensional Tumor Models to Study Tumor Angiogenesis. Tissue Engineering Part 
A 16, 2147, 2010. 
[8] Peyton, S., Ghajar, C., Khatiwala, C., and Putnam, A. The emergence of ECM 
mechanics and cytoskeletal tension as important regulators of cell function. Cell 
Biochemistry and Biophysics 47, 300, 2007. 
[9]  Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J., 





[10] van Moorst, M., and Dass, C.R. Methods for co-culturing tumour and endothelial 
cells: systems and their applications. Journal of Pharmacy and Pharmacology 63, 
1513, 2011. 
[11] Staton, C.A., Reed, M.W.R., and Brown, N.J. A critical analysis of current in vitro 
and in vivo angiogenesis assays. International Journal of Experimental Pathology 
90, 195, 2009. 
[12] Khoo, C.P., Micklem, K., and Watt, S.M. A Comparison of Methods for Quantifying 
Angiogenesis in the Matrigel Assay In Vitro. Tissue Engineering Part C-Methods 
17, 895, 2011. 
[13] Risau, W. Mechanisms of angiogenesis. Nature. 386, 671, 1997. 
[14] Nussenbaum, F., and Herman, I.M. Tumor angiogenesis: insights and innovations. J 
Oncol 2010, 132641, 2010. 
[15] Carmeliet, P., and Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 
249, 2000. 
[16] Mbeunkui, F., and J., J.D.,Jr. Cancer and the tumor microenvironment: a review of 
an essential relationship. Cancer chemotherapy and pharmacology 63, 571, 2009. 
[17] Bergers, G., and Benjamin, L.E. Tumorigenesis and the angiogenic switch. Nature 
Reviews Cancer 3, 401, 2003. 
[18] Payne, S.J, and Jones, L. Influence of the tumor microenvironment on angiogenesis. 
Future Oncology 7, 395, 2011. 
[19] Auerbach, R., Lewis, R., Shinners, B., Kubai, L., and Akhtar, N. Angiogenesis 
assays: A critical overview. Clinical Chemistry 49, 32, 2003. 
[20] Folkman, J. Angiogenesis-dependent diseases. Seminars in Oncology 28, 536, 2001. 
[21] Hlatky, L., Hahnfeldt, P., and Folkman, J. Clinical application of antiangiogenic 
therapy: Microvessel density, what it does and doesn't tell us. Journal of the 
National Cancer Institute 94, 883, 2002. 
[22] Folkman, J. What Is the Evidence That Tumors Are Angiogenesis Dependent. 




[23] Staton, C.A., Reed, M.W.R., and Brown, N.J. A critical analysis of current in vitro 
and in vivo angiogenesis assays. International Journal of Experimental Pathology 
90, 195, 2009. 
[24] Sun, H.C., Qu, Z., Guo, Y., Zang, G.X., and Yang, B. In vitro and in vivo effects of 
rat kidney vascular endothelial cells on osteogenesis of rat bone marrow 
mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds. 
Biomedical Engineering Online 6, 2007. 
[25] Yan, S., Zhang, H.F., Xie, Y.F., Sheng, W.H., Xiang, J., Ye, Z.M., Chen, W.C., and 
Yang, J.C. Recombinant Human Interleukin-24 Suppresses Gastric Carcinoma Cell 
Growth In Vitro and In Vivo. Cancer Investigation 28, 85, 2010. 
[26] Dorn, J.F., Jaqaman, K., Rines, D.R., Jelson, G.S., Sorger, P.K., and Danuser, G. 
Yeast kinetochore microtubule dynamics analyzed by high-resolution three-
dimensional microscopy. Biophysical journal 89, 2835, 2005. 
[27] Stephens, D.J., and Allan, V.J. Light microscopy techniques for live cell imaging. 
Science 300, 82, 2003. 
[28] Hathout, E., Chan, N.K., Tan, A., Sakata, N., Mace, J., Pearce, W., Peverini, R., 
Chinnock, R., Sowers, L., and Obenaus, A. In vivo imaging demonstrates a time-
line for new vessel formation in islet transplantation. Pediatric transplantation 13, 
892, 2009. 
[29] Cartwright, L., Farhat, W.A., Sherman, C., Chen, J., Babyn, P., Yeger, H., and 
Cheng, H.M. Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-
engineered bladder graft neovascularization: Pilot study. Journal of Biomedical 
Materials Research Part A 77A, 390, 2006. 
[30] Cao, M., Liang, Y., Shen, C., Miller, K.D., and Stantz, K. M. Developing DCE-CT 
to Quantify Intra-Tumor Heterogeneity in Breast Tumors With Differing 
Angiogenic Phenotype. IEEE Trans Med Imaging 28, 861, 2009. 
[31] Ungersma, S.E., Pacheco, G., Ho, C., Yee, S.F., Ross, J., van Bruggen, N., V., 
P.F.,Jr, Ross, S., and Carano, R.A. Vessel imaging with viable tumor analysis for 




journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic 
Resonance in Medicine 63, 1637, 2010. 
[32] Ehrhart, N., Kraft, S., Conover, D., Rosier, R.N., and Schwarz, E.M. Quantification 
of Massive Allograft Healing with Dynamic Contrast Enhanced-MRI and Cone 
Beam-CT: A Pilot Study. Clinical Orthopaedics and Related Research 466, 1897, 
2008. 
[33] Haubner, R., Wester, H.J., Weber, W.A., Mang, C., Ziegler, S.I., Goodman, S.L., 
Senekowitsch-Schmidtke, R., Kessler, H., and Schwaiger, M. Noninvasive imaging 
of alpha(v)beta(3) integrin expression using F-18-labeled RGD-containing 
glycopeptide and positron emission tomography. Cancer Research 61, 1781, 2001. 
[34] Davidson, M.W., and Abramowitz, M. Optical Microscopy. In: Anonymous 
Encyclopedia of Imaging Science and Technology. : John Wiley & Sons, Inc., 2002. 
[35] Lang, P., Yeow, K., Nichols, A., and Scheer, A. Cellular imaging in drug discovery. 
Nature reviews. Drug discovery 5, 343, 2006. 
[36] Bradbury, S., and Evennett, P. Contrast Techniques in Light Microscopy. : Bios 
Scientific Publishers, 1996. 
[37] Ntziachristos, V. Going deeper than microscopy: the optical imaging frontier in 
biology. Nature Methods 7, 603, 2010. 
[38] Chance, B. Near-infrared images using continuous, phase-modulated, and pulsed 
light with quantitation of blood and blood oxygenation. Advances in Optical Biopsy 
and Optical Mammography 838, 29, 1998. 
[39] Sokolov, K., Aaron, J., Hsu, B., Nida, D., Gillenwater, A., Follen, M., MacAulay, 
C., Adler-Storthz, K., Korgel, B., Descour, M., Pasqualini, R., Arap, W., Lam, W., 
and Richards-Kortum, R. Optical systems for In vivo molecular imaging of cancer. 
Technology in Cancer Research & Treatment 2, 491, 2003. 
[40] Faber, D.J., Mik, E.G., Aalders, M.C.G., and van Leeuwen, T.G. Light absorption of 
(oxy-) hemoglobin assessed by spectroscopic optical coherence tomography. Optics 




[41] McDonald, D.M., and Choyke, P.L. Imaging of angiogenesis: from microscope to 
clinic. Nature medicine 9, 713, 2003. 
[42] Thevenot, P.T., and Liping Tang. Novel Method to Monitor Cell Survival and 
Distribution in PLGA Degradable Scaffolds. Engineering in Medicine and Biology 
Workshop, 39, 2007. 
[43] Meijering, E. Time-lapse imaging. In: Anonymous Microscope Image Processing. , 
2008, pp. 401. 
[44] Errington, R.J., Marquez, N., Chappell, S.C., Wiltshire, M., and Smith, P.J. Time-
lapse microscopy approaches to track cell cycle progression at the single-cell level. 
Curr Protoc Cytom Chapter 12, Unit 12 4, 2005. 
[45] Celis, J.E. Cell Biology: A Laboratory Handbook. : Elsevier Academic, 2006. 
[46] Cox, G. Biological confocal microscopy. Materials Today 5, 34, 2002. 
[47] Claxton, N.S., Fellers, T.J., and Davidson, M.W. Laser scanning confocal 
microscopy. Olympus. Available online at 
www.olympusconfocal.com/theory/LSCMIntro.pdf, 2006. 
[48] Fujimoto, J.G., and Farkas, D. Biomedical Optical Imaging. : Oxford University 
Press, USA, 2009. 
[49] Prasad, V., Semwogerere, D., and Weeks, E.R. Confocal microscopy of colloids. 
Journal of Physics-Condensed Matter 19, 2007. 
[50] Webb, R.H. Confocal optical microscopy. Reports on Progress in Physics 59, 427, 
1999. 
[51] Wnek, G.E., and Bowlin, G.L. Encyclopedia of Biomaterials and Biomedical 
Engineering: L-Z. : Marcel Dekker, 2004. 
[52] Niesner, R.A., and Hauser, A.E. Recent advances in dynamic intravital multi-photon 
microscopy. Cytometry A 79, 789, 2011. 
[53] Diaspro, A., Bianchini, P., Vicidomini, G., Faretta, M., Ramoino, P., and Usai, C. 




[54] Diaspro, A., Chirico, G., and Collini, M. Two-photon fluorescence excitation and 
related techniques in biological microscopy. Quarterly reviews of biophysics 38, 97, 
2005. 
[55] Huang, B., Bates, M., and Zhuang, X. Super-resolution fluorescence microscopy. 
Annual Review of Biochemistry 78, 993, 2009. 
[56] Isherwood, B., Timpson, P., McGhee, E.J., Anderson, K.I., Canel, M., Serrels, A., 
Brunton, V.G., and Carragher, N.O. Live Cell in Vitro and in Vivo Imaging 
Applications: Accelerating Drug Discovery. Pharmaceutics 3, 141, 2011. 
[57] Dawood, A., Lotfi, P., Dash, S., Kona, S., Nguyen, K., and Romero-Ortega, M. 
VEGF Release in Multiluminal Hydrogels Directs Angiogenesis from Adult 
Vasculature In Vitro. Cardiovascular Engineering and Technology 2, 173, 2011. 
[58] Nakatsu, M.N., and Hughes, C.C. An optimized three-dimensional in vitro model for 
the analysis of angiogenesis. Methods in enzymology 443, 65, 2008. 
[59] Chau, L.T., Rolfe, B.E., and Cooper-White, J.J. A microdevice for the creation of 
patent, three-dimensional endothelial cell-based microcirculatory networks. 
Biomicrofluidics 5, 2011. 
[60] Vickerman, V., Blundo, J., Chung, S., and Kamm, R. Design, fabrication and 
implementation of a novel multi-parameter control microfluidic platform for three-
dimensional cell culture and real-time imaging. Lab on a Chip 8, 1468, 2008. 
[61] Chung, S., Sudo, R., Vickerman, V., Zervantonakis, I.K., and Kamm, R.D. 
Microfluidic platforms for studies of angiogenesis, cell migration, and cell-cell 
interactions. Sixth International Bio-Fluid Mechanics Symposium and Workshop 
March 28-30, 2008 Pasadena, California. Annals of biomedical engineering 38, 
1164, 2010. 
[62] Grainger, S.J., and Putnam, A.J. Assessing the Permeability of Engineered Capillary 
Networks in a 3D Culture. PLoS ONE 6, e22086, 2011. 
[63] Song, J.W., and Munn, L.L. Fluid forces control endothelial sprouting. Proc Natl 




[64] Hastings, J.W. Biological diversity, chemical mechanisms, and the evolutionary 
origins of bioluminescent systems. Journal of molecular evolution 19, 309, 1983. 
[65] Liu, J., Barradas, A., Fernandes, H., Janssen, F., Papenburg, B., Stamatialis, D., 
Martens, A., van Blitterswijk, C., and de Boer, J. In vitro and in vivo bioluminescent 
imaging of hypoxia in tissue-engineered grafts. Tissue engineering. Part C, Methods 
16, 479, 2010. 
[66] Jenkins, D., Oei, Y., Hornig, Y., Yu, S., Dusich, J., Purchio, T., and Contag, P. 
Bioluminescent imaging (BLI) to improve and refine traditional murine models of 
tumor growth and metastasis. Clinical and Experimental Metastasis 20, 733, 2003. 
[67] Wang, W., and El-Deiry, W. Bioluminescent Molecular Imaging of Endogenous and 
Exogenous p53-Mediated Transcription In Vitro and In Vivo Using an HCT116 
Human Colon Carcinoma Xenograft Model. Cancer Biol Ther 2, 194, 2003. 
[68] Wang, J., Najjar, A., Zhang, S., Rabinovich, B., Willerson, J.T., Gelovani, J.G., and 
Yeh, E.T.H. Molecular Imaging of Mesenchymal Stem Cell / Clinical Perspective. 
Circulation: Cardiovascular Imaging 5, 94, 2012. 
[69] Nadella, M.V., Kisseberth, W.C., Nadella, K.S., Thudi, N.K., Thamm, D.H., 
McNiel, E.A., Yilmaz, A., Boris-Lawrie, K., and Rosol, T.J. NOD/SCID mouse 
model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: 
cytokine gene expression profiling and in vivo bioluminescent imaging. Veterinary 
and comparative oncology 6, 39, 2008. 
[70] Xie, Y., Yin, T., Wiegraebe, W., He, X.C., Miller, D., Stark, D., Perko, K., 
Alexander, R., Schwartz, J., Grindley, J.C., Park, J., Haug, J.S., Wunderlich, J.P., 
Li, H., Zhang, S., Johnson, T., Feldman, R.A., and Li, L. Detection of functional 
haematopoietic stem cell niche using real-time imaging. Nature 457, 97, 2009. 
[71] Lapp, S.J. Bioluminescence Imaging Strategies for Tissue Engineering Applications 
[Master's Thesis]. Blacksburg: Virginia Polytechnic Institute and State University, 
2010. 
[72] Logeart-Avramoglou, D., Oudina, K., Bourguignon, M., Delpierre, L., Nicola, M.A., 




quantification of viable stem cells in engineered constructs. Tissue engineering Part 
C, Methods 16, 447, 2010. 
[73] Liang, X., Graf, B.W., and Boppart, S.A. Imaging engineered tissues using structural 
and functional optical coherence tomography. J Biophotonics 2, 643, 2009. 
[74] Graf, B.W., and Boppart, S.A. Imaging and analysis of three-dimensional cell 
culture models. Methods Mol Biol 591, 211, 2010. 
[75] Yang, Y., Dubois, A., Qin, X.P., Li, J., El Haj, A., and Wang, R.K. Investigation of 
optical coherence tomography as an imaging modality in tissue engineering. Physics 
in medicine and biology 51, 1649, 2006. 
[76] Tan, W., Vinegoni, C., Norman, J.J., Desai, T.A., and Boppart, S.A. Imaging cellular 
responses to mechanical stimuli within three-dimensional tissue constructs. Microsc 
Res Tech 70, 361, 2007. 
[77] Wang, L.V., and Hu, S. Photoacoustic tomography: in vivo imaging from organelles 
to organs. Science 335, 1458, 2012. 
[78] Yao, J., and Wang, L.V. Photoacoustic tomography: fundamentals, advances and 
prospects. Contrast Media Mol Imaging 6, 332, 2011. 
[79] Zhang, Y., Cai, X., Wang, Y., Zhang, C., Li, L., Choi, S.W., Wang, L.V., and Xia, 
Y. Noninvasive photoacoustic microscopy of living cells in two and three 
dimensions through enhancement by a metabolite dye. Angew Chem Int Ed Engl 
50, 7359, 2011. 
[80] Jia, Y., Bagnaninchi, P.O., Yang, Y., Haj, A.E., Hinds, M.T., Kirkpatrick, S.J., and 
Wang, R.K. Doppler optical coherence tomography imaging of local fluid flow and 
shear stress within microporous scaffolds. J Biomed Opt 14, 034014, 2009. 
[81] Vakoc, B.J., Lanning, R.M., Tyrrell, J.A., Padera, T.P., Bartlett, L.A., 
Stylianopoulos, T., Munn, L.L., Tearney, G.J., Fukumura, D., Jain, R.K., and 
Bouma, B.E. Three-dimensional microscopy of the tumor microenvironment in vivo 
using optical frequency domain imaging. Nat Med 15, 1219, 2009. 
[82] Kamoun, W.S., Chae, S.S., Lacorre, D.A., Tyrrell, J.A., Mitre, M., Gillissen, M.A., 




velocity, flux, hematocrit and shear rate in vascular networks. Nat Methods 7, 655, 
2010. 
[83] Rege, A., Murari, K., Seifert, A., Pathak, A.P., and Thakor, N.V. Multiexposure 
laser speckle contrast imaging of the angiogenic microenvironment. J Biomed Opt 
16, 056006, 2011. 
[84] Rege, A., Thakor, N.V., Rhie, K., and Pathak, A.P. In vivo laser speckle imaging 
reveals microvascular remodeling and hemodynamic changes during wound healing 
angiogenesis. Angiogenesis 15, 87, 2012. 
[85] Webb, S. The Physics of Medical Imaging. : Hilger, 1988. 
[86] Haacke, E.M. Magnetic Resonance Imaging: Physical Principles and Sequence 
Design. : J. Wiley & Sons, 1999. 
[87] Chavhan, G.B., Babyn, P.S., Thomas, B., Shroff, M.M., and Haacke, E.M. 
Principles, Techniques, and Applications of T2*-based MR Imaging and Its Special 
Applications. Radiographics 29, 1433, 2009. 
[88] Rummeny, E.J., Reimer, P., and Heindel, W. MR Imaging of the Body. : Thieme, 
2009. 
[89] Jugé, L., Doan, B.T., Seguin, J., Albuquerque, M., Larrat, B., Scherman, D., 
Vilgrain, V., Paradis, V., Van-Beers, B. and Sinkus, R. MR-Elastography, a new 
biomarker of the tumor vascularization in a colon cancer mice model. International 
Society for Magnetic Resonance in Medicine 19, 3485, 2011. 
[90] Buschmann, J., Welti, M., Hemmi, S., Neuenschwander, P., Baltes, C., Giovanoli, 
P., Rudin, M., and Calcagni, M. Three-Dimensional Co-Cultures of Osteoblasts and 
Endothelial Cells in DegraPol Foam: Histological and High-Field Magnetic 
Resonance Imaging Analyses of Pre-Engineered Capillary Networks in Bone Grafts. 
Tissue Engineering Part A 17, 291, 2011. 
[91] Terrovitis, J.V., Bulte, J.W.M., Sarvananthan, S., Crowe, L.A., Sarathchandra, P., 
Batten, P., Sachlos, E., Chester, A.H., Czernuszka, J.T., Firmin, D.N., Taylor, P.M., 




Mesenchymal Stem Cells Seeded on Collagen Scaffolds Relevance to Tissue 
Engineering. Tissue engineering 12, 2765, 2006. 
[92] Ravindran, S., Gao, Q., Kotecha, M., Magin, R.L., Karol, S., Bedran-Russo, A., and 
George, A. Biomimetic extracellular matrix-incorporated scaffold induces 
osteogenic gene expression in human marrow stromal cells. Tissue engineering Part 
A 18, 295, 2012. 
[93] Wilhelm, C., Bal, L., Smirnov, P., Galy-Fauroux, I., Clement, O., Gazeau, F., and 
Emmerich, J. Magnetic control of vascular network formation with magnetically 
labeled endothelial progenitor cells. Biomaterials 28, 3797, 2007. 
[94] Li, W., Hong, L., Hu, L., and Magin, R.L. Magnetization transfer imaging provides a 
quantitative measure of chondrogenic differentiation and tissue development. Tissue 
engineering. Part C, Methods 16, 1407, 2010. 
[95] Xu, H.H., Othman, S.F., and Magin, R.L. Monitoring Tissue Engineering Using 
Magnetic Resonance Imaging. Journal of Bioscience and Bioengineering 106, 515, 
2008. 
[96] Di Ieva, A., Grizzi, F., Rognone, E., Tse, Z.T.H., Parittotokkaporn, T., Baena, 
F.R.Y., Tschabitscher, M., Matula, C., Trattnig, S., and Baena, R.R.Y. Magnetic 
resonance elastography: a general overview of its current and future applications in 
brain imaging. Neurosurgical Review 33, 137, 2010. 
[97] Mariappan, Y.K., Glaser, K.J., and Ehman, R.L. Magnetic resonance elastography: a 
review. Clinical anatomy (New York, N Y) 23, 497, 2010. 
[98] Asbach, P., Klatt, D., Schlosser, B., Biermer, M., Muche, M., Rieger, A., 
Loddenkemper, C., Somasundaram, R., Berg, T., Hamm, B., Braun, J., and Sack, I. 
Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR 
elastography. Radiology 257, 80, 2010. 
[99] Lunt, S.J., Chaudary, N., and Hill, R.P. The tumor microenvironment and metastatic 
disease. Clinical & Experimental Metastasis 26, 19, 2009. 
[100] Yu, H., Mouw, J.K., and Weaver, V.M. Forcing form and function: biomechanical 




[101] Kumar, S., and Weaver, V.M. Mechanics, malignancy, and metastasis: the force 
journey of a tumor cell. Cancer Metastasis Reviews 28, 113, 2009. 
[102] Huang, S., and Ingber, D.E. Cell tension, matrix mechanics, and cancer 
development. Cancer Cell 8, 175, 2005. 
[103] Jugé, L., Doan, B.T., Seguin, J., Larrat, B., Herscovici, J., Scherman, D., and 
Sinkus, R. Characterization of tumor vascularization in mice using MRE. 
International Society for Magnetic Resonance in Medicine 18, 1053, 2010. 
[104] Juge, L., Doan, B.T., Seguin, J., Albuquerque, M., Larrat, B., Mignet, N., Chabot, 
G.G., Scherman, D., Paradis, V., Vilgrain, V., Van Beers, B.E., and Sinkus, R. 
Colon tumor growth and antivascular treatment in mice: complementary 
assessment with MR elastography and diffusion-weighted MR imaging. Radiology 
264, 436, 2012. 
[105] Choyke, P.L., Dwyer, A.J., and Knopp, M.V. Functional tumor imaging with 
dynamic contrast-enhanced magnetic resonance imaging. Journal of Magnetic 
Resonance Imaging 17, 509, 2003. 
[106] O'Connor, J.P., Jackson, A., Parker, G.J., and Jayson, G.C. DCE-MRI biomarkers 
in the clinical evaluation of antiangiogenic and vascular disrupting agents. British 
journal of cancer 96, 189, 2007. 
[107] Bulte, J.W., and Kraitchman, D.L. Iron oxide MR contrast agents for molecular and 
cellular imaging. NMR in biomedicine 17, 484, 2004. 
[108] Matsuo, M., Kanematsu, M., Itoh, K., Ito, K., Maetani, Y., Kondo, H., Kako, N., 
Matsunaga, N., Hoshi, H., and Shiraishi, J. Detection of Malignant Hepatic 
Tumors. American Journal of Roentgenology 177, 637, 2001. 
[109] Shapiro, E.M., Skrtic, S., Sharer, K., Hill, J.M., Dunbar, C.E., and Koretsky, A.P. 
MRI detection of single particles for cellular imaging. Proceedings of the National 
Academy of Sciences of the United States of America 101, 10901, 2004. 
[110] Yu, M.K., Park, J., and Jon, S. Targeting strategies for multifunctional 




[111] Babic, M., Horak, D., Trchova, M., Jendelova, P., Glogarova, K., Lesny, P., 
Herynek, V., Hajek, M., and Sykova, E. Poly(L-lysine)-modified iron oxide 
nanoparticles for stem cell labeling. Bioconjug Chem 19, 740, 2008. 
[112] Sadeghiani N, Barbosa LS, Silva LP, Azevedo RB, Morais PC, Lacava ZGM. 
Genotoxicity and inflammatory investigation in mice treated with magnetite 
nanoparticles surface coated with polyaspartic acid. J. Magnetism Magnetic 
Materials 2005; 289: 466–8. 
[113] Shirakawa, K., Shibuya, M., Heike, Y., Takashima, S., Watanabe, I., Konishi, F., 
Kasumi, F., Goldman, C.K., Thomas, K.A., Bett, A., Terada, M., and Wakasugi, 
H. Tumor-infiltrating endothelial cells and endothelial precursor cells in 
inflammatory breast cancer. International Journal of Cancer 99, 344, 2002. 
[114] Dome, B., Timar, J., Dobos, J., Meszaros, L., Raso, E., Paku, S., Kenessey, I., 
Ostoros, G., Magyar, M., Ladanyi, A., Bogos, K., and Tovari, J. Identification and 
clinical significance of circulating endothelial progenitor cells in human non-small 
cell lung cancer. Cancer Research 66, 7341, 2006. 
[115] Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., 
Heissig, B., Marks, W., Witte, L., Wu, Y., Hicklin, D., Zhu, Z.P., Hackett, N.R., 
Crystal, R.G., Moore, M.A.S., Hajjar, K.A., Manova, K., Benezra, R., and Rafii, S. 
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic 
precursor cells blocks tumor angiogenesis and growth. Nature medicine 7, 1194, 
2001. 
[116] Duda, D.G., Cohen, K.S., Kozin, S.V., Perentes, J.Y., Fukumura, D., Scadden, 
D.T., and Jain, R.K. Evidence for incorporation of bone marrow-derived 
endothelial cells into perfused blood vessels in tumors. Blood 107, 2774, 2006. 
[117] Gao, D., Nolan, D.J., Mellick, A.S., Bambino, K., McDonnell, K., and Mittal, V. 
Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung 




[118] Gimi, B., Mori, N., Ackerstaff, E., Frost, E.E., Bulte, J.W., and Bhujwalla, Z.M. 
Noninvasive MRI of endothelial cell response to human breast cancer cells. 
Neoplasia 8, 207, 2006. 
[119] Barrett, T., Kobayashi, H., Brechbiel, M., and Choyke, P.L. Macromolecular MRI 
contrast agents for imaging tumor angiogenesis. European journal of radiology 60, 
353, 2006. 
[120] Kiessling, F. Noninvasive Cell Tracking; Molecular Imaging II. In: Semmler, W. 
and Schwaiger, M., eds.: Springer Berlin Heidelberg, 2008, pp. 305-321. 
[121] Zhang, C., Jugold, M., Woenne, E.C., Lammers, T., Morgenstern, B., Mueller, 
M.M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., and Kiessling, F. 
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall 
superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance 
scanner. Cancer Research 67, 1555, 2007. 
[122] Schmieder, A.H., Caruthers, S.D., Zhang, H., Williams, T.A., Robertson, J.D., 
Wickline, S.A., and Lanza, G.M. Three-dimensional MR mapping of angiogenesis 
with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-
MB-435 xenograft mouse model. The FASEB journal: official publication of the 
Federation of American Societies for Experimental Biology 22, 4179, 2008. 
[123] Waters, E.A., Chen, J., Allen, J.S., Zhang, H., Lanza, G.M., and Wickline, S.A. 
Detection and quantification of angiogenesis in experimental valve disease with 
integrin-targeted nanoparticles and 19-fluorine MRI/MRS. J Cardiovasc Magn 
Reson 10, 43, 2008. 
[124] Pathak, A.P., Kim, E., Zhang, J., and Jones, M.V. Three-dimensional imaging of 
the mouse neurovasculature with magnetic resonance microscopy. PloS one 6, 
e22643, 2011. 
[125] Zhang, Z., Mascheri, N., Dharmakumar, R., Fan, Z., Paunesku, T., Woloschak, G., 
and Li, D. Superparamagnetic iron oxide nanoparticle-labeled cells as an effective 
vehicle for tracking the GFP gene marker using magnetic resonance imaging. 




[126] Jeng, H.A., and Swanson, J. Toxicity of metal oxide nanoparticles in mammalian 
cells. Journal of environmental science and health Part A, Toxic/hazardous 
substances & environmental engineering 41, 2699, 2006. 
[127] Hussain, S.M., Hess, K.L., Gearhart, J.M., Geiss, K.T., and Schlager, J.J. In vitro 
toxicity of nanoparticles in BRL 3A rat liver cells. Toxicology in vitro : an 
international journal published in association with BIBRA 19, 975, 2005. 
[128] Stroh, A., Zimmer, C., Gutzeit, C., Jakstadt, M., Marschinke, F., Jung, T., 
Pilgrimm, H., and Grune, T. Iron oxide particles for molecular magnetic resonance 
imaging cause transient oxidative stress in rat macrophages. Free radical biology 
& medicine 36, 976, 2004. 
[129] Zhang, Z., van den Bos, E.J., Wielopolski, P.A., de Jong-Popijus, M., Bernsen, 
M.R., Duncker, D.J., and Krestin, G.P. In vitro imaging of single living human 
umbilical vein endothelial cells with a clinical 3.0-T MRI scanner. MAGMA 18, 
175, 2005. 
[130] Drobny, J.G. Radiation Technology for Polymers. : CRC Press/Taylor & Francis, 
2010. 
[131] Webster, J.G. Minimally Invasive Medical Technology. : Institute of Physics Pub., 
2001. 
[132] Louis, L., Wong, T., Baud, P., and Tembe, S. Imaging strain localization by X-ray 
computed tomography: discrete compaction bands in Diemelstadt sandstone. 
Journal of Structural Geology 28, 762, 2006. 
[133] Wan, S.Y., Kiraly, A.P., Ritman, E.L., and Higgins, W.E. Extraction of the hepatic 
vasculature in rats using 3-D micro-CT images. Ieee Transactions on Medical 
Imaging 19, 964, 2000. 
[134] Garcia-Sanz, A., Rodriguez-Barbero, A., Bentley, M.D., Ritman, E.L., and 
Romero, J.C. Three-dimensional microcomputed tomography of renal vasculature 
in rats. Hypertension 31, 440, 1998. 
[135] Rai, B., Oest, M.E., Dupont, K.M., Ho, K.H., Teoh, S.H., and Guldberg, R.E. 




scaffolds for segmental bone defect repair. Journal of Biomedical Materials 
Research Part A 81A, 888, 2007. 
[136] Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M.E.K., and Mikos, A.G. 
Dual delivery of an angiogenic and an osteogenic growth factor for bone 
regeneration in a critical size defect model. Bone 43, 931, 2008. 
[137] Schmidt, C., Bezuidenhout, D., Beck, M., Van der Merwe, E., Zilla, P., and Davies, 
N. Rapid three-dimensional quantification of VEGF-induced scaffold 
neovascularisation by microcomputed tomography. Biomaterials 30, 5959, 2009. 
[138] Kerbel, R.S. Tumor Angiogenesis. N Engl J Med 358, 2039, 2008. 
[139] Kargiotis, O., Geka, A., Rao, J.S., and Kyritsis, A.P. Effects of irradiation on tumor 
cell survival, invasion and angiogenesis. Journal of Neuro-Oncology 100, 323, 
2010. 
[140] Takahashi, Y., Teshima, T., Kawaguchi, N., Hamada, Y., Mori, S., Madachi, A., 
Ikeda, S., Mizuno, H., Ogata, T., Nojima, K., Furusawa, Y., and Matsuura, N. 
Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer 
Research 63, 4253, 2003. 
[141] Young, S., Kretlow, J.D., Nguyen, C., Bashoura, A.G., Baggett, L.S., Jansen, J.A., 
Wong, M., and Mikos, A.G. Microcomputed tomography characterization of 
neovascularization in bone tissue engineering applications. Tissue Engineering 
Part B-Reviews 14, 295, 2008. 
[142] Kim, I.G. Radiation-induced tumorigenesis. Journal of biochemistry and molecular 
biology 36, 144, 2003. 
[143] Mullenders, L., Atkinson, M., Paretzke, H., Sabatier, L., and Bouffler, S. Assessing 
cancer risks of low-dose radiation. Nat Rev Cancer 9, 596, 2009. 
[144] Hlushchuk, R., Riesterer, O., Baum, O., Wood, J., Gruber, G., Pruschy, M., and 
Djonov, V. Tumor recovery by angiogenic switch from sprouting to 
intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing 




[145] Sasaki, T., Yamamoto, M., Yamaguchi, T., and Sugiyama, S. Development of 
Multicellular Spheroids of Hela-Cells Cocultured with Fibroblasts and Their 
Response to X-Irradiation. Cancer Research 44, 345, 1984. 
[146] Saha, G.B. Basics of PET Imaging: Physics, Chemistry, and Regulations. : 
Springer, 2010. 
[147] Knoll, G.F. Single-photon emission computed tomography. Proceedings of the 
IEEE 71, 320, 1983. 
[148] Niu, G., and Chen, X. PET Imaging of Angiogenesis. PET clinics 4, 17, 2009. 
[149] Cherry, S.R., Shao, Y., Siegel, S., Silverman, R.W., Meadors, K., Young, J., Jones, 
W.F., Newport, D., Moyers, C., Mumcuoglu, E.U., Chatziioannou, A., Farquhar, 
T., Andreaco, M., Paulus, M., Binkley, D., Nutt, R., and Phelps, M.E. MicroPET: 
A high resolution PET scanner for imaging small animals. 1996 IEEE Nuclear 
Science Symposium - Conference Record, Vols 1-3 , 1120, 1997. 
[150] Zeniya, T., Watabe, H., Aoi, T., Kim, K.M., Teramoto, N., Takeno, T., Ohta, Y., 
Hayashi, T., Mashino, H., Ota, T., Yamamoto, S., and Iida, H. Use of a compact 
pixellated gamma camera for small animal pinhole SPECT imaging. Annals of 
Nuclear Medicine 20, 409, 2006. 
[151] Zaidi, H., and Del Guerra, A. An outlook on future design of hybrid PET/MRI 
systems. Medical Physics 38, 5667, 2011. 
[152] Abramoff, M.D., Magalhaes, P.J.,Ram S.J. Image Processing with Image J. 
Biophotonics International 11, 36, 2004. 
[153] Sarkanen, J.R., Mannerstrom, M., Vuorenpaa, H., Uotila, J., Ylikomi, T., and 
Heinonen, T. Intra-Laboratory Pre-Validation of a Human Cell Based in vitro 
Angiogenesis Assay for Testing Angiogenesis Modulators. Frontiers in 
pharmacology 1, 147, 2010. 
[154] Beilmann, M., Birk, G., and Lenter, M.C. Human primary co-culture angiogenesis 
assay reveals additive stimulation and different angiogenic properties of VEGF 




[155] Sarabi, A., Kramp, B.K., Drechsler, M., Hackeng, T.M., Soehnlein, O., Weber, C., 
Koenen, R.R., and von Hundelshausen, P. CXCL4L1 inhibits angiogenesis and 
induces undirected endothelial cell migration without affecting endothelial cell 
proliferation and monocyte recruitment. Journal of Thrombosis and Haemostasis 9, 
209, 2011. 
[156] Wang, C.K., Cao, J.G., Qu, J.Q., Li, Y.F., Peng, B., Gu, Y.X., and He, Z.M. 
Recombinant Vascular Basement Membrane Derived Multifunctional Peptide 
Blocks Endothelial Cell Angiogenesis and Neovascularization. Journal of Cellular 
Biochemistry 111, 453, 2010. 
[157] Wang, B.H., Pearson, T., Manning, G., and Donnelly, R. In Vitro Study of 
Thrombin on Tubule Formation and Regulators of Angiogenesis. Clinical and 
Applied Thrombosis-Hemostasis 16, 674, 2010. 
[158] Niemisto, A., Dunmire, V., Yli-Harja, O., Zhang, W., and Shmulevich, I. Robust 
quantification of in vitro angiogenesis through image analysis. Ieee Transactions 
on Medical Imaging 24, 549, 2005. 
[159] Doukas, C.N., Maglogiannis, I., Chatziioannou, A., and Papapetropoulos, A. 
Automated angiogenesis quantification through advanced image processing 
techniques. Conf Proc IEEE Eng Med Biol Soc 1, 2345, 2006. 
[160] Gould, D.J., Vadakkan, T.J., Poche, R.A., and Dickinson, M.E. Multifractal and 
lacunarity analysis of microvascular morphology and remodeling. 
Microcirculation 18, 136, 2011. 
[161] Abdul-Karim, M.A., Al-Kofahi, K., Brown, E.B., Jain, R.K., and Roysam, B. 
Automated tracing and change analysis of angiogenic vasculature from in vivo 
multiphoton confocal image time series. Microvasc Res 66, 113, 2003. 
[162] Rytlewski, J.A., Geuss, L.R., Anyaeji, C.I., Lewis, E.W., and Suggs, L.J. Three-
dimensional image quantification as a new morphometry method for tissue 
engineering. Tissue engineering Part C, Methods 18, 507, 2012. 
[163] Borgert, J., Schmidt, J.D., Schmale, I., Rahmer, J., Bontus, C., Gleich, B., David, 




J., Vogt, F.M., and Barkhausen, J. Fundamentals and applications of magnetic 
particle imaging. Journal of cardiovascular computed tomography 6, 149, 2012. 
[164] Markov, D.E., Boeve, H., Gleich, B., Borgert, J., Antonelli, A., Sfara, C., and 
Magnani, M. Human erythrocytes as nanoparticle carriers for magnetic particle 






CHAPTER 8  
 
Summary and Future Works 
 
8.1  SUMMARY  
The in vitro modeling of blood vessels from the artery down to capillary-level is a 
complex challenge, in terms of the anatomical and bio-fluid considerations. This 
dissertation addresses the problem  through experimental and computational studies of a 
branching network that mimics artery/arteriole and vein/venuole structure and connects to 
a compartment with embedded porous scaffolds. Based on Murray’s Law of branching 
networks and published anatomical studies, the computer-generated networks bifurcate 
along a single plane. The flexibility of the computer-generated vascular trees will allow 
for the design to be extended, such that the tree bifurcates in three dimensions. The 
idealized “arterial-like” vascular tree (in terms of inner diameter and cylindrical 
geometry) bifurcates over four generations to reach the minimum inner diameter 
resolution of most rapid prototyping methods. There are a myriad of rapid prototyping 
methods available to tissue engineers. For the fabrication of the presented dynamic 
imaging phantom, selective laser sintering (SLS) (along with fused deposition modeling) 
provided the best spatial resolution to reliably generate hollow, cylindrical, bifurcating 
networks. To achieve the luminal diameter and/tortuosity that could achieve bulk flow 
behavior characteristic of microcirculation, scaffolds (pore diameters 0.11 - 2.2 mm) 
were incorporated into the design of the distributed flow construct. For both the dynamic 
imaging phantom and dynamic bioreactor, the SLS technique was used to generate 
scaffolds that met the target flow ranges (in terms of differential flow and shear stress, 
respectively) of the system designed. The same construct was used for both applications; 
however, the fluid and boundary conditions were optimized for the respective systems. 
In the development of the dynamic imaging phantom, the inlet flow rate of the system 




(DCE)-Computed Tomography (CT) patient protocol and setup, which included contrast 
agent solution and contrast injector were used within their normal operating ranges. An 
inline mixer was incorporated into the streamline of the system prior to the phantom inlet, 
in order to achieve the mixing of contrast agent and blood-like fluid through the body, 
which normally occurs in the patient’s bloodstream. Adequate mixing was visualized in 
simulations of the system. Simulations also confirmed theoretical estimates of uniform 
flow splitting across the bifurcations of the vascular tree and porous scaffold 
compartments. Experimental and computational differential flow (DF) measurements 
confirmed that high and low differential flows were generated within the phantom, using 
scaffolds with controlled architecture and perfusion characteristics. Using a porous jump 
computational fluid dynamics (CFD) model, based on the desired differential flow, the 
intrinsic permeability required of the scaffold was determined. This information can be 
used to design an appropriate SLS scaffold to incorporate into future generations of the 
dynamic imaging phantom, in order to fine-tune or expand the range of fluid flow rate 
changes realized by the dynamic imaging phantom. The phantom successfully 
demonstrated distinct differential flows, wherein imaged anatomical structures were 
below the resolution of a clinical scanner, as with actual patient data. The simplicity of 
the manufacturing method and the reusability of the system (due to acetic acid surface 
treatment) render the phantom a useful tool to be further studied for use in the quality 
assurance of DCE-CT. Initial DCE-CT post-processing analysis based on a single input, 
single output, capillary model demonstrated similar results to the experimental and 
computational differential flow measurements. Further studies can be performed to 
validate and/or understand the sensitivity of post-analysis tools and methods, using these 
comparison standards (computational and experimental).  
The second application of the designed construct involved the development of thick 
engineered tissue. The vascular tree design distributed uniform flow to scaffolds, 
mimicking the bathing of tissue volumes by arterioles/small arteries. A perfusion 
bioreactor was adopted as a favorable in vitro pre-vascularization strategy to enable 
future implantation studies, in which the construct would be anastomosed to a nearby 
artery and vein. The biocompatibility and operating conditions of the bioreactor were 




angiogenesis. Two large scaffold architectures were considered to determine which 
geometry stimulated endothelial cell growth over 1 - 10 dynes/cm
2 
under laminar flow 
conditions, with the best tradeoff between cell stimulation and detachment. Based on 
simulations, the spherical scaffold was selected to perform biocompatibility studies, as 
the geometry provided more uniform flow across the scaffold and achieved the target 
shear stress range over a larger portion of the surface area. The biocompatibility 
properties of untreated PCL were compared to three surface modifications: RGD peptide 
conjugation, vascular endothelial growth factor conjugation and sodium hydroxide 
hydrolysis. The cell proliferation and cell spatial distribution of human umbilical vein 
endothelial cells cultured under static conditions for three days on surface-modified PCL 
matrices was assessed. Cells were seeded drop-wise onto the scaffold to avoid washout of 
seeding gels. Across treatment groups, the cell proliferation and vWF release were 
comparable, with RGD peptide-modified constructs exhibiting slightly higher cell 
proliferation across the edges of the scaffold. The successful implementation of the 
optimized in vitro perfusion bioreactor lends itself to future bone cell co-culture studies, 
as well as three-dimensional tumor model investigations where the localization of 
endothelial cells can create gradients needed for necrosis or be uniform for homogenous 
tissue growth.  
 
8.1.1  Original Contributions 
The original contributions of this research are as follows: 
(1) Developed a computerized “arterial” vascular tree for fabrication using SLS. The 
vascular tree has an inlet and outlet inner diameter of 2.2 mm and 0.620 mm, 
respectively. 
(2) Developed a construct that adjoined two vascular trees to modular scaffold 
compartments for distribution and then the collection of fluid. The construct 
allowed for the connection of a fluid source to perfuse the system, mimicking 
small artery-like inlet perfusion characteristics, in terms of either shear stress or 





(3) Developed a prototype dynamic imaging phantom manufactured using SLS. The 
phantom achieves the range of differential flow measurable by DCE-CT imaging 
post-processing analysis.  
(4) Demonstrated the utility of CFD in the validation of a dynamic imaging phantom. 
Validated experimental differential flow measurements against computational 
simulations through the bioreactor, for low and high permeability scaffolds. The 
entire phantom system was simulated to ensure proper fluid mixing and the 
uniformity of flow through the system.  
(5) Introduced a predictive model to determine the flow changes characteristics of a 
model scaffold (based on input architecture), in terms of the intrinsic permeability 
required to realize a range of differential flow useful for imaging within a 
dynamic phantom. 
(6) Demonstrated the usefulness of using computational simulations to determine the 
fluid-induced shear stress distribution within tissue engineered scaffolds 
(structured lattice) in a cell bioreactor. Determined the inlet velocity for which 
large (11 mm height x 11 mm diameter) spherical pore scaffold imposed a shear 
stress between 1 - 10 dynes/cm
2
 over a larger surface area than orthogonal pore 
scaffold.  
(7) Confirmed that of the two bone scaffold architectures previously studied in the 
Hollister group, the spherical pore (2.22 mm pore diameter) geometry was more 
likely than the orthogonal geometry to produce shear stress within the range 
required for in vitro endothelial cell dynamic studies. 
(8) Determined that RGD-functionalized PCL scaffolds supported greater endothelial 
cell proliferation and cell function, over the hydrolyzed and protein conjugated 
(particularly, vascular endothelial growth factor) PCL scaffolds. The RGD-
functionalized PCL scaffolds also demonstrated greater attachment at the edges of 
the scaffold, which is ideal for use in an angiogenesis bioreactor, where the 




(9) Determined that vascular endothelial growth factor conjugation onto heparin 
functionalized PCL scaffolds fabricated using SLS did not improve the temporal 
release of VEGF.  Conjugation and adsorption showed similar VEGF retention 
and burst releases on day 1. 
(10) Developed an in vitro dynamic endothelial cell bioreactor that supports the 
proliferation of endothelial cells anchored by RGD onto large bone scaffolds.  
 
8.2 FUTURE RESEARCH 
There are several directions for future projects that can extend from this dissertation. The 
following outlines a few of them: 
 
8.2.1  Future Design Considerations for a Distributed Flow Polymer Construct 
- It would beneficial for future re-designs to consider alternate fabrication methods that 
produce less permeable structures. During the course of a 5 - 30 minute DCE imaging 
study, the network leaked. Based on observations, the cause of leakage at the entry of 
the porous compartment was due to the continued fluid force imposed on the structure 
prior to entering the compartment. Thicker vessel walls were not feasible, since an 
increased wall thickness would result in a narrowing of luminal spaces and/or the loss 
of features (i.e. holder threading). A stronger polymer such as ABSplus (used in fused 
deposition modeling) may withstand greater pressure. Polymers available for SLS and 
other RP systems with comparable resolutions should also be explored. 
- In Chapter 3, the DCE imaging studies were performed on vascular trees that 
bifurcated along a single plane. The vascular tree perfused four porous compartments 
(volume approximately 4 ml). Future iterations of the phantom design should develop 
a vascular tree that bifurcates along three-dimensions to perfuse a larger volume of 
porous compartments. Chapter 2 references previously promulgated algorithms for 
achieving larger, randomly generated structures. A three-dimensional vascular tree 




volume comparable to a given tissue volume of interest e.g. a lobule of the liver ≈ 900 
ml.  
 
8.2.2  Next Generation of Dynamic Phantom 
- The current phantom system does not circulate fluid, instead requires the continuous 
addition of simulated blood fluid. The implementation of a filter or cleansing method 
that removes or separates (i.e. by chelation) the iodinated contrast agent from the 
waste reservoir would allow for a circulating closed system that would only require 
periodic (over weeks or months) changes of fluid. The addition of 10% bleach to the 
fluid would reduce potential for molding. The 0.5 mm spaces, preceding and 
following the scaffold within the compartment, provide a space for air bubbles to 
aggregate in the system. Sealing of all the connection points within the system would 
reduce the opportunities for air to be introduced to the system. A gear or dispensing 
pump may also minimize air-bubbles in the closed system. These design changes 
would make the phantom re-useable and improve the reproducibility of results over 
time. 
- Based on the relationship between the intrinsic permeability and differential flow 
discussed in Chapter 4, alternate scaffold fabrication techniques can be explored to 
expand the range of differential flows, lower than 20%. The pore diameter of SLS 
scaffolds can be tailored to generate differential flows between 20 - 80%. The 
sensitivity of image-extracted perfusion metrics can be evaluated to understand the 
influence of partial volume averaging and fluid behavior (constant versus pulsatile), 
in the context of the single-input, single-compartment model for a given 
system/protocol/post-processing algorithm. Similar studies would be needed to 
experimentally and computationally validate flow across a two-input compartment 
model. A longitudinal study should also be conducted to evaluate the repeatability of 
metrics over the course of weeks, in order to determine the lifetime of the phantom 




- DCE-Magnetic Resonance Imaging (MRI) has practical benefits over DCE-CT and 
other functional imaging modalities. The technique offers evaluation of angiogenesis, 
in terms of blood flow, blood volume, vascular density and vascular permeability [1], 
without the introduction of ionizing radiation. DCE-MRI can also visualize structures 
compromised by bone artifacts under CT. The developed phantom system can be 
adapted to DCE-MRI with minor modifications to the system to ensure magnetic 
compatibility. The tissue equivalent liquid surrounding the vascular phantom can be 
modified by the addition of paramagnetic ions (water or gel-based) to achieve T1 and 
T2 relaxation times characteristic of human tissue, 270 - 860 ms and 50 – 80 ms 
respectively [2]. The peristaltic pump would also require magnetic field shielding. 
Gadolinium (similar viscosity and density properties to iodinate contrast agent) would 
be used as the contrast agent within the non-water-soluble PCL polymer that would 
otherwise be invisible under MRI. A recent study by Blanquer et al. investigated the 
development of a MRI-visible poly(epsilon-caprolactone) (PCL) graft coated with 
paramagnetic agents that improved T1 contrast enhancement [3]. Advances in the 
field of materials/macromolecules would be needed to establish coatings that lengthen 
T2 relaxation times characteristic of polymers and strengthen the MRI signal.  
- The designed vascular network can also be scaled to meet the requirements of 
particular organ systems, such as the liver, which requires a dual-input single 
compartment model with separate input arterial and venous perfusion. With the 
addition of a second inlet into the phantom box, two boluses can be injected at two 
different rates, on delays, into the dynamic phantom to generate the three time-
enhancement curves typically evaluated in liver perfusion analysis. 
- Lastly, future experiments should investigate a new inlet flow rate for contrast agent 
and simulated blood fluid. The two fluids should have identical or closely matching 
input velocities, so as to avoid the fluctuations in speed that can influence the 





8.2.3  Modeling of an Endothelial Cell Bioreactor 
- Chapter 5 discusses the initial flow rate conditions required to achieve an ideal range 
of shear stress rates within the developed endothelial cell bioreactor. However, the 
model does not account for the growth of endothelial cells and ultimately blood 
vessels on the surface of the PCL. The integration of a cell growth model, which 
takes into account this growth over time, would provide a guide for flow rate 
adjustments over a 7-14 day study. These changes would further create favorable 
conditions for cell growth and sprouting. 
 
8.2.4  Enhancement of Endothelial Cell Activity on PCL 
- Future work should include a larger scale investigation of the PCL surface 
modification study discussed in Chapter 6. The preliminary findings were adequate 
for an initial dynamic bioreactor study. To further support this work, the investigation 
should be repeated for 4 - 5 independent studies for Passage 5-10 endothelial cells to 
quantify the increased growth expected for HUVECs and human microvascular 
dermal endothelial (HMVEC-ds) cultured on VEGF immobilized by heparin on 
sodium hydroxide treated PCL scaffolds, dependent on the amount of loaded and 
retained heparin and VEGF. 
- The effects of VEGF are dose dependent. Large doses have been shown to produce a 
greater fraction of immature vessels, compared to lower effective doses, which 
generate mature vessels. The generation of mature or immature vessels would be 
relevant to the investigation of tumor-like and/or normal vasculature. An increased 
dose of VEGF may increase the amount of VEGF release per day, after the initial 
burst effect. The release kinetics for PCL scaffolds loaded with varying amounts of 
VEGF should be explored to determine if higher amounts of loaded VEGF can 
increase the daily release to 100 ng/day, as recommended by the literature 
(summarized in Table 1 of Chapter 6) after the initial burst release. Currently, the 
literature does not provide a standard method to assess VEGF bioactivity under in 




VEGF may be added to the PCL using the conjugation method discussed in Chapter 
6, then evaluated based on the rate of endothelial cell proliferation measured through 
MTT assays.  
- Advancements in conjugation methods for the immobilization of VEGF onto PCL 
scaffolds may improve release kinetics. Alternate methods may eliminate the need for 
heparin, which competes with angiogenesis through the inhibition of endothelial cell 
proliferation and organization [4]. He et al.
 [5]
 demonstrated that the cross-linker 
reagents, Traut’s reagent and sulfo-SMCC (4-(N-maleimidomethyl) cyclohexane-1-
carboxylic acid 3-sulfo-N-hydroxysuccinimide ester sodium salt), can be used to 
immobilize VEGF onto collagen. These two reagents can be explored for PCL. 
 
8.2.5  Endothelial Cell Bioreactor 
- Chapter 6 discusses only the viability of HUVEC cells in the bioreactor. Continued 
studies should also examine the viability of HMVEC-ds in the bioreactor, under 
appropriate shear stress conditions. Under in vivo conditions, microvascular and 
macrovascular cells are exposed to different levels of shear stress. An HMVEC-d 
study would demonstrate the robustness of the design.  
- In addition, the endothelial cell bioreactor study was performed under constant flow, 
which would be ideal for microvascular cells, but may not be for macrovascular cells, 
which under in vivo conditions experience oscillatory or pulsatile flow. Future studies 
should examine the influence of the flow behavior on the proliferation of HUVECs 
and HMVEC-ds within the endothelial cell bioreactor.  
- Future angiogenesis bioreactor investigations can use the constructed system to study 
tumor angiogenesis and explore in vitro tumorigenesis. Wells et al. [6] demonstrated 
the feasibility of growing solid tumor masses in vitro in a microfluidic device. The 
developed perfusion bioreactor can be adapted to provide a platform for future basic 
cancer research related to bone or breast cancer. The bioreactor environment needs to 




cells and leukocytes) that promote cancer cell proliferation and ultimately the 
formation of a solid tumor mass.   
- The developed bioreactor lends itself to in vivo studies, where the inlet and outlet 
would be anastomosed to an artery and vein, respectively. The design can be scaled 
down to fit a mouse model. As a pre-vascularization strategy, bone marrow stromal 
cells or chondrocytes can be seeded onto the scaffolds, cultured in vitro then 
implanted to study the degree of bone in-growth and the associated mechanical 
properties of the generated bone or cartilage, respectively. 
 
8.2.6  Imaging Angiogenesis 
- It has been hypothesized that Von Willebrand factor (vWF) regulates angiogenesis 
through the promotion of EC migration [7-8].
 
The work by 
Zanetta 
et al. suggested that 
vWF messenger ribonucleic acid levels correlated with the endothelium or 
angiogenesis
 activation [9]. An investigation of the relationship (cumulative and/or 
temporal) between vWF release and tubulation may support findings garnered using 
emergent in vitro angiogenesis imaging methods for opaque constructs.   
- In this thesis, proliferation across the large scaffolds was assessed at the center and 
two outer sections of the porous scaffold. An MTT assay of the three sections 
quantified the proliferation across each section. This intrusive method can be 
substituted with a bioluminescence imaging (BLI) assay. Measurement of a BLI 
signal from the luciferase-transfected endothelial cells can provide a non-invasive 
method of evaluating cell attachment and proliferation under both static and dynamic 
culture conditions. Initial work should assess the cell toxicity and/or changes in 
proliferation due to the introduction of luciferase. 
- Chapter 7 discusses recent investigations into the use of DCE-MRI and targeted MRI 
in the evaluation of angiogenesis through the localization of endothelial cells or 
related-signals. The use of either of these methods to evaluate tubulation under static 




vessels. The vascular permeability can be evaluated based on the uptake of these 
agents, as shown in the investigation reported by Grainger et al. [10]. Vasculature 
generated during tumor angiogenesis is characterized by the leakiness of the vessel 
network [11]. Thus, in the development of vascular networks characteristic of tumor 
growths, enhanced MRI techniques may be valuable. Initial work requires an initial 
cell toxicity and cell growth study to determine the effects of the contrast agent or 
nanoparticles on the endothelial cells. 
 
8.3  MAJOR CONTRIBUTIONS 
The major achievements of this dissertation to the field are as follows 
(1) Prototyping of a dynamic flow imaging phantom: In this thesis, the first dynamic 
imaging phantom to incorporate a vascular tree and scaffolds was prototyped for 
end-to-end DCE-CT testing. Using SLS, A fourth-order vascular phantom with 
vessels between 2.2 mm and 790 µm (below typical CT scanner resolution). A 
minimum inner diameter size of 620 microns was achievable for hollow vessels, 
with a minimum resolution of 770 ± 110 microns being reliably achieved. The 
DCE-CT data collected demonstrated a bolus entrance and clearance form within 
a desired behavior range, and image-extract DFs of -96 ± 5% and -15 ± 8%, for 
low and high permeability compartments, respectively. Measured experimental 
DF values were -81% ± 6% and -22% ± 3%, for the low and high permeability 
compartments, respectively.  
 
(2) Effect of inline mixer on contrast agent (CA) and simulation blood fluid (SBF) 
mixing: Simulations illustrated that under laminar flow inlet boundary conditions, 
the CA and SBF fluid layers were stratified prior to entry into the helical mixer. 
The addition of an inline six-unit helical mixer (1.45 inches long) offered 
adequate mixing of layers. The stream path after the mixer demonstrated 
increased mixing of the fluids, with a reduced layering effect. However, existing 




promulgated work to discuss the importance of an inline mixer. These results 
suggest that all future DCE phantoms should incorporate a mixer to reduce the 
variability across the system, from which time-contrast enhancement curves are 
generated. 
(3) Computational validation of a dynamic imaging phantom: The prototyped 
dynamic imaging phantom was modeled within a CFD software program. Prior 
patient-specific or idealized CFD models have focused on large vessels involved 
in cardiac circulation or have not been physically realized. This work is the first to 
valid a dynamic imaging phantom using CFD. Simulation results showed that the 
velocities exhibited at the inlet (1.5 x 10-3 m/s) and outlet (3 x 10-4 m/s) of the 
vascular tree were characteristic of microcirculation [12]. The DF was measured 
across the porous geometry model and compared to measurements extracted from 
DCE-CT data performed on the dynamic imaging phantom. The computational 
estimations of the DF across the low and high permeability compartments from 
the porous geometry model were -77% and -21%, respectively. Both values were 
within ±4% of experimental results, which had a standard deviation of 6% and 
3%, respectively. Although, air bubbles within the system remain a prevalent 
issue, the computational results along with experimental measurements, for the 
high and low permeability scaffolds, provide benchmark range for comparisons to 
image-derived metrics. 
(4) Porous jump model to predict realizable differential flow range: This 
investigation is the first to provide a porous jump model that uses experimentally 
determined intrinsic permeability values to determine the differential flow 
achievable across a compartment. The measured DFs were -73% and -25%, for 
the low and high permeability scaffolds, respectively. Simulations results for the 
porous geometry and porous jump-geometry closely matched (± 4%). The DFs 
were significantly less than the experimentally measured DF for the high 
permeability compartment. For the low permeability compartment, the DF was 
significantly higher than the DCE-CT imaging measurements. The experimental 




porous jump DF measurement. Overall, the predictive model provides a DF range 
with some error. Based on the suggested intrinsic permeability value, an 
appropriate scaffold should be selected to create a porous geometry model for 
further simulations, as previously discussed. 
(5) Evaluation of shear stress across large spherical and orthogonal scaffold: 
Orthogonal and spherical scaffold architectures are commonly adopted in bone 
tissue engineering to promote bone in-growth; while, recent bone growth 
investigations have demonstrated the utility of seeding endothelial and osteogenic 
cell lineages [13-15]. These simulations are the first for a scaffold embedded 
within an endothelial cell bioreactor system. These results were used to determine 
the appropriate inlet velocity for an in vitro perfusion bioreactor construct. For 
inlet velocities between 0.54 - 0.61 m/s, the spherical geometry provided the best 
balance between EC detachment and stimulation. More than 50% of SA 
experienced 1 - 10 dynes/cm
2
 of shear stress for an inlet velocity equal to or 
greater than 0.54 m/s. The simulation showed that scaffolds with a well-organized 
spherical pore (2.22 mm diameter) lattice, provided more uniform shear stress 
across the scaffold, within the target shear stress range, under a laminar flow 
regime, compared to an orthogonal design (1.46 mm). The computational model 
can readily be extended to other pore geometries (i.e. hexagonal and cubical) to 
identify an optimal bone scaffold design for future EC co-culture studies. 
(6) Determined that endothelial cells cultured on RGD-modified scaffolds over 7 
days proliferated at a significantly higher rate and demonstrated more favorable 
cell function (in term of vWF productive) than sodium hydroxide treated and 
VEGF (10μg) conjugated and untreated PCL constructs. Identified RGD-modified 
PCL scaffolds as an optimal modification for future bioreactor investigations. 
Demonstrated that RGD-modified scaffolds supported cell viability across the 
scaffold, with higher densities at the edges of the scaffold. In computational 
simulations, the top edge of spherical scaffold was shown to experience the 




(7) Optimized the first PCL endothelial cell bioreactor in terms of imposed shear 
stress and cell-scaffold biocompatibility. A protocol for implementing the in vitro 
perfusion bioreactor system was outlined. 
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APPENDIX A - CHAPTER 1 
 
A.1 SUMMARY OF RAPID PROTOTYED BRANCHING MODELS WITH 
MEDICAL APPLICATION 
 
Table A.1 Review of rapid prototyped air and fluid flow models. 
Study Description Model Citation 
Side view of the Sophia anatomical 
infant nose-throat (SAINT) model 
made using stereolithography, with the 




Replica of vasculature of the human 
thoracic aorta (20 - 25 mm i.d.) from 3-
D MRI data using PolyJet technology. 
 
[2] 
Tracheobronchial hollow airway model 
fabricated using selective laser sintering 
(1 - 2 mm i.d.). 
 
[3]  
Microfluidic phantom with four 
generations of channels (1 mm - 55 μm 
i.d.) produced via soft lithography, 
whereby a capillary network is 




Microfluidic device produced using 
microfabrication (0.03 - 1 mm i.d.). 







Designed in FEMLAB, then fabricated 
using lithography from 
polymethylmethacrylate (PMMA) 
polymer. Root branch 120 µm i.d, with 
dimension halving at each bifurcation.  
[6]  
MRI microchannel phantom 
microfabricated using ion etching, then 
casted with PDMS. Each capillary 
network 2 mm deep and 0.8 mm wide, 







Cross-sectional view (3 mm i.d.) of 
hepatic vascular system scaffold 
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APPENDIX B - CHAPTER 2 
 
B.1 INVERTED COLLOIDAL CRYSTAL SCAFFOLD FABRICATION 
Name of Procedure: ICC Scaffold Fabrication 
Prepared by: Auresa Thomas; based on Kotov Lab’s published work. 
 
Materials 
Glass beads (Polysciences, 30-50 µm #18901; 3-10 µm #07666; 105-150 µm #15927) 





Polycaprolactone (PCL) (Polysciences #19561, MW: 43,000-50,000) 
Chloroform (Fischer Scientific, C298-1, Certified ACS) 
5.75 inch glass pipettes w/ rubber tops 
Glass vials (Fischer Scientific, 03-339-30F, shell type 1 glass, vial, 19x65mm 3 dram) 
 
Procedure 
Note:   
• The sonicator overheats, so monitor (by touch), adding ice or cold water to the 
bath every 45 minutes. Each time remove water to keep the water level consistent. 
• Ethylene glycol has a flashpoint of 111˚C. 
 
Before starting 
1. Make space for the oven in the fume hood. Preheat oven to 90˚C. 
2. Mark the desired scaffold height on the glass vials with a black marker or tape. 
Allow for 2-3mm of additional height that will be removed later in the fabrication 
process. 
3. Setup glass vials with pipette tops in sonicator. Secure with zip ties. 
4. Prepare solution of beads. Add beads to ethylene glycol (1 g/ 5 mL). 
 
Step 1: Lattice 
5. Fill vials with 5 ml of ethylene glycol. 
6. Add water to sonicator, to cover the glassware halfway (above level of black 
line). 
7. Fill pipette with bead solution. Add 6-7 drops every 20 minutes to the glass vial. 
8. Sonicate for 30 minutes after the desired height is achieved. 
 




9. Drain the sonicator. 
10. Carefully cut the zip ties without disturbing the contents of the vial. 
11. Carefully remove the vial from the sonicator. 
12. Remove excess ethylene glycol from the top of the scaffold surface. 
13. Place the vials in the oven in the fume hood. Remove the vials once the ethylene 
glycol has dried out. 
 
Step 3: Annealing  
14. Anneal the beads in the oven at X˚C for Y hours. 
15. Allow glass surface to cool down. Then, carefully break the glass vial around the 
scaffold (a wrench can be used). 
16. Scrape off 1 mm of the top and bottom surface of the scaffold (and sides if 
needed). 
17. Pour water at top of surface to assess the latency of porous structure. 
18. Allow water to completely evaporate (overnight). 
 
Step 4: PCL infusing 
19. Prepare Z% PCL (g of PCL / mL of chloroform = X/100). 
20. Infuse PCL into scaffold. Add Z% PCL to centrifuge tube with scaffold.  
21. Centrifuge contents at 5800 rpm for 60 minutes (may need to break into 3 
intervals). 
22. All the contents of the tube to dry in the fume hood at room temperature. 
23. Place under vacuum for 24 hours. 
24. Remove top, bottom and side layers of the scaffold. 
 
Step 5: Glass dissolving 
25. Place scaffold in centrifuge tube and add 5% HF for 1 day to dissolve glass beads. 
26. Change the 5% HF and saturate scaffolds for a second day. 
27. Rinse scaffold with distilled water for 2 hours on shaker. 
28. Saturate scaffold in 1 N HCl for 1 day. Change the solution every 6-8 hours for 24 
hours. 
29. Repeat steps 27 and 18 a second time. 




Cuddihy, Meghan J.: Utilizing Inverted Colloidal Crystal Scaffolds to Engineer in 





APPENDIX C - CHAPTER 3 
 
C.1 REDUCTION OF CONTRAST AGENT UPTAKE BY SURFACE-MODIFIED 
PCL 
As such, a secondary objective of this chapter is to evaluate the hydrophobicity and 
uptake of contrast agent by surface-modified constructs. Initial DCE imaging 
experiments showed significant uptake of contrast agent in early designs of the phantom, 
which was made of polycaprolactone (PCL), a polyester with hydroxyl end groups (OH-) 
(Fig. C.1). Although, the aqueous iodine contrast agent, iopamidol is documented as 
stable and nonreactive agent, its interaction with PCL may lead to the replacement of 
hydroxyl groups on the surface of PCL. Another method of adherence of iopamidol onto 
PCL may be due to adsorption, as the rough surface of the polymer contains macro- and 
micro-pores, which may trap the contrast agent during perfusion. To resolve the issue of 
contrast agent retention after each experiment, the surface of the PCL constructs were 
chemically treated. Degradation of PCL occurs by hydrolysis of its ester linkages (R-
CO2- ′, where   and  ′ are alkyl groups) at the surface-level. The hydroxyl group on 
PCL was capped by acylation with acetic acid, converting them into acetoxy groups 
(CH3-C(=O)-O-R). The relatively low reactivity of the acetoxy groups and iodine was 
hypothesized to reduce PCL uptake of the contrast agent. As a result of the hydrolysis, 
the PCL was hypothesized to become more hydrophobic.  
 





PCL scaffolds and flat discs were treated with 17.4 M acetic acid (≥99.7 w/w %, 
Certified ACS, Fisher Scientific) (Fig. C.2). The wettability of discs treated for 15, 5 and 
0 seconds was measured using a goniometer (Rame-Hart Instrument, Co., Netcong, NJ) 
and drop-shape analysis program (DROPImage, Rame-Hart Instrument, Co., Netcong, 
NJ).  Three repeat tests were performed for three treated and untreated circular discs. For 
each disc, the water contact angle between the droplet and the surface of the disc was 
measured as water was added and removed from the surface. The goniometer measured 
the contact angle (receding an ascending) formed due to the surface tension between the 
discs and water droplets add to its surface. The average receding and ascending contact 
angle was calculated for each group. A two-tail Student’s t-test assuming unequal 
variance was used to compare the measured contact angles. P-values less than 0.05 were 
considered to show significant difference between the two groups. 
 
 
Figure C.2 Hydrolysis of PCL surface. 
 
Changes in the perfusion characteristics of the treatment group that showed the greatest 
increase in hydrophobicity were assessed. The differential flow was experimentally 
measured using equations 3 and 4, then compared to the respective values for untreated 
PCL scaffolds. A two-tail Student’s t-test assuming unequal variance was used to 
compare the measured differential flow. Significance was set at P -values< 0.05. Fig. C.3 
illustrates acetic acid treatment increases the hydrophobicity of the PCL. A greater 
contact angle was measured for longer exposure times. Fig. C.4 shows that the 
differential flow was not significantly different for untreated high permeability scaffolds 






Figure C.3 Average maximal (ascending) and minimal (receding) contact angle measurements for 
PCL disc treated with acetic acid for 5 seconds and 15 seconds. Increased wettability was observed 




Figure C.4 Average differential flow measurements for untreated scaffolds and scaffolds treated for 
15 seconds with acetic acid. Treated scaffolds showed an increase in resistance to flow across the 
scaffold. Small = 2.02 mm spherical pore diameter (low permeability). (Sample size was 5 for large 
pore scaffolds and 6 for small pore scaffolds.) 
 
Lastly, the difference in intensity between the start (baseline: 1 - 5 seconds before bolus) 
and end (5 - 10 seconds during SBF flush after bolus injection) of a DCE analysis was 
computed for a treated and untreated vascular phantom to determine whether there was a 
difference in contrast agent uptake between the groups. Both experiments were 




























the imaging protocol and system parameters used to collect the DCE data. Contrast agent 
uptake (HU) was defined as the final intensity after a 15 second flush with SBF, minus 
the baseline intensity during the first 5 seconds prior to injection. Figure C.5 shows that 
the acetic acid treatment to the PCL construct reduced the uptake of contrast agent. Thus, 
with acetic acid treatment for 15 seconds, the same vascular phantom can be used for 
repeated DCE imaging studies. 
 
 
Figure C.5 The average contrast agent uptake by a PCL construct treated with acetic acid was 
negligible compared to that of an untreated construct, for a single pass of bolus through the vascular 
construct. The reported average enhancement values represent the difference between the final 
plateau (after peak of bolus) and the initial baseline, for four regions of interests that encompassed 
each compartment. 
 
There was only a significant difference in differential flow for the larger pore diameter, 
which showed an increased differential flow for acetic acid treated scaffolds. As such, 
future experiments should evaluate the sensitivity of DCE-extracted flow rates to these 


























APPENDIX D - CHAPTER 4 
 
D.1 MESH INDEPENDENT TESTS 
The following data confirms that the models evaluated in Chapter 4 were within 
acceptable mesh resolution limits that minimized the error associated with mesh settings. 
 
Table D.1 Mesh data over four levels of mesh refinement for the modeled T-junction/mixer model. 
Mesh Refinement Number of Elements Number of Nodes 
Baseline 59,424 208,332 
1 96,486 375,651 
2 124,693 473,350 
3 132,211 509,611 
 
 
Figure D.1 Spatial mesh independence for T-junction with an inline static mixer. Illustrates the 
variation in ‘Mass Flow Average’ at the mid-plane of the tube distal to the scaffold, with increased 






Table D.2 Mesh data over four levels of mesh refinement for the permeability chamber simulation 
for a high permeability scaffold. 
Mesh Refinement Number of Elements Number of Nodes 
Baseline 293,870 110,606 
1 383,550 144,232 
2 463,056 169,577 




Figure D.2 Mesh Independence. Illustrates the variation in ‘Mass Flow Average’ at the mid-plane of 




Table D.3 Mesh data over four levels of mesh refinement for the modeled vascular tree. 
Mesh Refinement Number of Elements Number of Nodes 
Baseline 217,299 45,427 
1 311,195 60,091 
2 404,505 74,731 
3 491,181 88,397 
 
 
Figure D.3 Vascular tree mesh independence. Illustrates the variation in ‘Mass Flow Average’ at the 
topmost outlet of the vascular tree, with increased mesh resolution. Sensitivity falls within ±5% over 




Table D.4 Mesh data over five levels of mesh refinement for the low permeability compartment. 
Mesh Refinement Number of Elements Number of Nodes 
Baseline 158, 540 36,892 
1 241,426 54,096 
2 322,369 70,405 
3 455,239 96,994 
4 506,663 107,040 
 
 
Figure D.4 Low permeability compartment mesh independence. Illustrates the variation in ‘Mass 
Flow Average’ along plane downstream of scaffold and prior to the compartment outlets. Sensitivity 
falls within ±5% across all levels of refinement. 
 
Table D.5 Mesh data over four levels of mesh refinement for the high permeability compartment. 
Mesh Refinement Number of Elements Number of Nodes 
Baseline 204,389 45,220 
1 305,798 70,947 
2 461,123 102,716 







Figure D.5 High permeability compartment mesh independence. Illustrates the variation in ‘Mass 
Flow Average’ along plane downstream of scaffold and prior to the compartment outlets. Sensitivity 
falls within ±5% for the third level of refinement. 
 
Table D.6 Mesh data over five levels of mesh refinement for a single scaffold compartment with four 
0.79 mm inlets and a porous jump (intrinsic permeability of 1 x 10-9 m2) positioned at the mid-plane. 
Mesh Refinement Number of Elements Number of Nodes 
Baseline 142,204 63,934 
1 249,202 107,310 
2 356,411 146,802 
3 448,598 180,593 







Figure D.6 Mesh Independence. Variation in ‘Mass Flow Average’ with increasing mesh resolution. 
Sensitivity falls within ±5%. 
 
 
D.2  EFFECT OF REYNOLDS NUMBER ON PERMEABILITY 
In the discussion of the reliability of results acquired using the in-house mass 
flow/permeability system, it was shown that the system underestimated the permeability 
of the Sponceram® when compared to the results published by Sanz-Herrera et al. [1]. 
Further studies were conducted to determine the influence of the Reynolds number on the 
measured perfusion metric of permeability. Fig. D.7 shows that the measured intrinsic 
permeability using water (highest Reynolds number of approximately 100) generated 
lower permeability measurements. Using a glycerin/water mixture (60-80% v/v), the 
Reynolds number was reduced to less than or equal to 10, to be within assumptions limits 
of Darcy’s Law. The data presented in Fig. D.7 indicates that true permeability may be 5 
to 100 times larger than that estimated by water. There were similar trends in the 
permeability for both the high permeability and low permeability scaffolds. These 
findings support the data presented in Table 4.3, which indicated that compared to the 
results published by Sanz-Herrera et al. [1], our system when used with water, 
underestimates the permeability by an order of one or two. Based on these observations, a 




1 to 10 may be used to provide a relative value. In chapter 4, a correct factor of 2.7 is 
applied to the experimentally measured hydraulic permeabilities to closely match the 
differential flow values acquired using the porous geometry CFD model for the low and 









Figure D.7 Illustrates exponential relationship between the Reynolds number and intrinsic 
permeability within the in-house flow meter system for (a) high permeability and (b) low 
permeability scaffolds. (Note: The scaffolds used were designed at a lower voxel higher resolution.) 
(All standard deviations of the intrinsic permeability values are an order smaller.) 
 
D.3  TRANSIENT FLOW USER-DEFINED FUNCTIONS 
Macros implemented to set material and boundary conditions for transient flow 
simulation of T-junction/mixer model. 
/********************************************************************* 




DEFINE_PROPERTY(cell_density, c, t) 
{ 
   real my_rho_baf = 1080; 
   real my_rho_ca = 1369; 
 
 if (CURRENT_TIME<=5) 
  return my_rho_baf; 
 else if (CURRENT_TIME == 6 || CURRENT_TIME == 7) 
  return my_rho_ca; 
 else if (CURRENT_TIME >=8) 





   UDF that simulates change in viscosity of fluid type over time  (kg/m*s)  
   UDF that simulates viscosity of non-Newtonian blood analog fluid based on Carreau 




DEFINE_PROPERTY(cell_viscosity, c, t) 
{ 
   real my_mu_baf, mu_z, mu_inf, n,lambda,gamma, a, temp; 
   real my_mu_ca = 0.0047; 
 
 if (CURRENT_TIME<=5) 
        { 
    mu_inf = 0.00364; 
    mu_z = 0.076; 
                  n = 0.23; 




    a = 2; 
    gamma = C_STRAIN_RATE_MAG(c,t); 
                  temp = n-1/a; 
    my_mu_baf= mu_inf + (mu_z - mu_inf) * pow((1+pow(lambda,a) * 
pow(gamma,a)), temp); 
    return my_mu_baf; 
 } 
 
 else if (CURRENT_TIME == 6 || CURRENT_TIME == 7) 
      return my_mu_ca; 
 
 else if (CURRENT_TIME>=8) 
 { 
    mu_inf = 0.00364; 
    mu_z = 0.076; 
                  n = 0.23; 
           lambda = 22.06; 
    a = 2; 
    gamma = C_STRAIN_RATE_MAG(c,t); 
                  temp = n-1/a; 
    my_mu_baf= mu_inf + (mu_z - mu_inf) * pow((1+pow(lambda,a) * 
pow(gamma,a)), temp); 






/* umyinlet.c                                                         */ 
/* UDF for specifying a transient mass flow rate profile boundary condition */ 
/**********************************************************************/ 
/* at t<=2 sec the target mass flow rate set to 0.002748 kg/s for contrast agent   */ 
/* when t>2 sec the target mass flow rate will change to 0.0014 kg/s for blood analog 
fluid */ 




DEFINE_PROFILE(trans_mf, thread, position)  
{ 
  real my_mf; 
  face_t f; 
  real mf_baf = 0.00108 ; 
  real mf_ca = 0 .002738;  
 




    { 
  if (CURRENT_TIME<=5) 
          F_PROFILE(f, thread, position) = mf_baf; 
  else if (CURRENT_TIME == 6 || CURRENT_TIME == 7) 
          F_PROFILE(f, thread, position) = mf_ca; 
  else if (CURRENT_TIME>=8) 
          F_PROFILE(f, thread, position) = mf_baf; 
    } 




[1] Sanz-Herrera, J A, Kasper, C, van Griensven, M, Garcia-Aznar, J M, Ochoa, I and 
Doblare, M 2008 Mechanical and flow characterization of Sponceram carriers: 
Evaluation by homogenization theory and experimental validation J Biomed Mater 





APPENDIX E - CHAPTER 5 
 
E.1 SURVEY OF DYNAMIC ENDOTHELIAL CELL CULTURES 
 
Table E.1Comparative summary of published in vitro dynamic angiogenesis bioreactor studies (3-10 
days). 
Reference Cell Line(s) 
Scaffold 




















western blot, cell 
morphology 
(microscopy),                                                       
VEGF/TGFβ1/ 
PDGF-BB ELISA 
[2] HUVEC fibrin gel constant: 7 ml/h undisclosed 
Quantification of 






























Table E.2  Summary of EC behavior and protein/gene expression from selected FSS studies 
performed on macrovascular cells (SS compared to 0 dynes/cm2 static environment, unless alternate 
SS value provided). 







mm culture dish   
10  
(orbital)                     
ECs elongated and aligned,  
↓ apoptosis,  
↑ VEGF receptor 2 expression  
[6] HUVEC 
cone and plate 
rheological 
system 
0.5 and 12 
All conditions: ↔ cell density 
 
Isolated cells at 0.5 dynes/cm
2
:   
↓ directionality of migration,  
↓ migration speed; 
 
Isolated cells at 12 dynes/cm
2
:   
↑ directionality of migration,  
↓ migration speed (compared to 




Monolayer at 12 dynes/cm
2
:   
↑ EC elongation,  
↑ homogenous orientation in the 
direction of flow 
[7] HUVEC 
channels in  
microfluidic 
device  infused 
with 50 ng/ml of 
VEGF 
3  
attenuated sprout formation 
through NO signaling,  















↑ sprouting density,  
↑ sprouting extension,  
↑ narrowing of sprouts,  
↓ Atk activation 











elongated shape, alignment in the 
direction of flow,  







5    
(orbital) 
time-dependent ↑ cell elongation 
and alignment, 
endothelial F-actin microfilament 
organization, 
↑ E-selectin expression, 






















↑ proliferation, ↑ apoptosis,  
↓ Akt phosphorylation,  
↑ ICAM expression,  
↓ E-selectin down-regulation 








↑network formation,  
↑ total network length,  
↑ EC migration velocity, 






1, 15, 30 
(laminar)  
↓ evidence of apoptosis, 
↑ expression of the anti-apoptotic 
FasExo6Del and Bcl-xL, 
↑ pro-apoptotic Bak, 






















All conditions:  
↑ PDGF-B, ↑ bFGF m NA,  



















 alignment in the direction of flow, 
↑ ellipsoidal shape,  
↔ cell density; 
 
Turbulent:  
random orientation of cells in the 
monolayer,  
↑ roundness, ↑ EC turnover,  
↑ DNA synthesis, ↓ cell density, 












0.07 - 3 
(stepwise 
ramping) 
adherent monolayer formed,  
typical subcellular and gross 
morphology, 







E.1  MESH INDEPENDENCE TESTS 
The following data confirms that the models evaluated in Chapter 5 were within 
acceptable mesh resolution limits that minimized the error associated with mesh settings. 
Mesh refinement was performed until the number of meshing elements reduced the 
sensitivity in the maximum and average shear stress to less than 5%. Refinement was 
performed over approximately 100,000 to 600,000 elements. 
 
Table E.3 Mesh data over four levels of mesh refinement for the spherical compartment. 
Mesh Refinement Number of Elements Number of Nodes 
Baseline 186,884 41,168 
1 270,112 60,173 
2 329,068 71,884 
3 418,579 89,850 
4 511,814 108,766 
5 1,535,792 339,922 
6 2,504,894 519,208 
7 3,185,524 639,985 







Figure E.1 Spatial mesh independence for the spherical compartment. Illustrates the variation in 
‘Average Shear Stress,’ across the porous compartment shown in Fig. 5.2a, with increased mesh 
resolution. Sensitivity falls within ±5% for refinements 7 and 8. 
 
Table E.4 Mesh data over six levels of mesh refinement for the orthogonal compartment. 
Mesh Refinement Number of Elements Number of Nodes 
Baseline 299,885 74,501 
1 680,255 147,956 
2 1,357,644 273,586 
3 2,308,528 476,849 
4 3,284,090 668,384 






Figure E.2 Spatial mesh independence for the orthogonal compartment. Illustrates the variation in 
‘Average Shear Stress,’ across the porous compartment shown in Fig. 2b, with increased mesh 
resolution. Sensitivity falls within ±5% for refinements 4-5. 
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APPENDIX F - CHAPTER 6 
 
F.1  REVIEW OF OPTIMAL VEGF CONCENTRATIONS SHOWN TO 
PROMOTE ENDOTHELIAL CELL GROWTH IN VIVO AND IN VITRO. 
 
Table F.1 Summary of VEGF concentrations shown to support angiogenesis. 
Optimal VEGF 
Concentration 





neighboring cells in vivo [1]  
Released: 
50-150 ng/day 
solubilized in vivo [2] 
Loaded: 2 µg/scaffold 




















in vitro and in vivo [5] 






















F.2  HEPARIN CONJUGATION EFFICIENCY ASSAY 
The quantification of immobilized heparin was performed using a Toluidine blue assay 
described by Smith et al. 
[
8]. A 0.0005% toluidine blue solution was prepared from 
toluidine blue (Sigma-Aldrich, St Louis, MO), 0.01 N HCl (Acros Organics) and 0.2% 
(w/v) NaCl (Certified ACS, Fisher Scientific). Heparin standards were prepared from 
stock solution of sterilized aqueous heparin solution: 100 µg, 50 µg, 25 µg, 12.5 µg, 6.25 
µg, and 3.1 µg. Untreated and sodium hydroxide treated discs and scaffolds were 
prepared. Aminated and heparin-immobilized 2-D discs and 3-D scaffolds were 
submerged in 3 ml of toluidine blue solution in a glass vial. 400 µl of 0.2% NaCl solution 
was added to all samples. The scaffolds and standards were vortexed for 30 seconds, then 
placed on a shaker for 3-24 hours at room temperature. The PCL disks and scaffolds were 
stained purple in the presence of heparin. 3ml of n-hexane (Sigma-Aldrich, St Louis, 
MO), was added to each vial to extract the formed toluidine blue-heparin complexes. The 
toluidine blue-heparin complexes formed on the surface of the scaffolds were the 
scaffolds, but the hexane was still added to the samples to ensure uniform treatment. The 
vials were vortexed for 30 seconds, then placed on a shaker for 3 hours at room 
temperature. Thereafter, the aqueous layer containing unextracted toluidine blue was 
extracted from the vial and the absorbance of 500 µl samples of the solution were 
measured at 630 nm by microplate reader (Multiskan Spectrum, Thermo Electron 
Corporation). Based on a derived calibration curve, the amount of immobilized heparin 
on the PCL scaffold was estimated.  The average amount of retained heparin from each 
respective 0 µg sample group was subtracted from the average of each sample within that 
group to remove the baseline absorbance. Fig. E.1 plots the retention of heparin onto 















F.3  CHARACTERIZATION OF DEGRADATION EFFECTS ON MECHANICAL 
AND PERFUSION PROPERTIES OF SODIUM HYDROXIDE-TREATED PCL 
SCAFFOLDS 
Eight specimens were used to estimate the compressive modulus. The moduli were 
calculated through unconfined compression testing using an MTS Alliance RT30 
electromechanical test frame (MTS Systems Corp., MN). TestWorks4 software (MTS 
Systems Corp., MN) was used to collect and analyze data during compression testing. 
Compressive modulus was calculated using area measurements derived from caliper 
height and diameter measurements of pre-tested samples. Compressive modulus was 
defined as the slope of the linear portion of the stress–strain curve. The permeability of 
the scaffolds was also estimated using our flow meter system described in Section 3.3.3. 
A two-tail Student’s t-test assuming unequal variance was used to determine whether 
there significance was significant difference in the measured compressive moduli and 
hydraulic permeability. 
The mean elastic moduli of the untreated and NaOH-treated PCL scaffolds were 23 ± 1 
MPa and 20 ± 2 MPa, respectively. The stiffness of the two scaffolds was not 
significantly different (P-value < 0.05). The hydraulic permeability of the untreated and 
NaOH-treated PCL scaffolds was 4.3 x 10
-7 




/N·s and 2.4 x 10
-6 











Figure F.2  (a) Average elastic modulus and (b) average hydraulic permeability for the untreated and 
NaOH-treated PCL scaffolds. 
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APPENDIX G- CHAPTER 7 
 
G.1  OPERATING THE VASCULAR-LIKE ENDOTHELIAL CELL 
BIOREACTOR 
 
Name of Procedure: Setting up and operating angiogenesis bioreactor.  
Prepared by: Auresa Thomas and Leonie Genesteir 
Hazards: none  
Protective equipment: Use latex gloves, sterilizing with 70% ethanol, ethylene gas or 
autoclave; lab coat 
Waste disposal: Items that interact with cells should be placed in the biohazard trash bin. 
All other items can go into normal trash. 
 
Materials 
MasterFlex® Silicone Tubing (Platinum) L/S® 25 (25 ft)  
Three-way stopcock Leurlock, PVDF  
Rubber stopper  
Clamp, punch valve,large  
Clamp, punch valve,small  
Male LuerLock coupling (for 3/16’’ tube), polypropylene  
Female LuerLock coupling (for 3/16’’ tube), polypropylene  
Male LuerLock caps  
Female LuerLock caps  
*
~
Pulse dampener, for all Masterflex® L/S® and I/P® tubing  
*Pump  
*Flowmeter  
(Modified) Petri dish  
Flow splitter (manifold), polypropylene  
Media storage bottle, 1 L 
*Sterile 0.22 µm syringe filter 
*Sterile 5 ml Syringe 
Sterile Liquid Filters (larger than syringe filters) 
*pH test strips 
magnetic stirrer (1.5 in and 0.5 in - Length) 








Cautery system (only tips autoclaved) 
Sterile gloves 
 











Connections Connection Size 
Pump Tubing (everywhere except 
reservoir II to pump to pulse dampener) 
L/S® 25 (3/16’’ ;  4.8 mm) 
 
Pulse dampener inlet/out 3/16‘’ tube end to  1/8" NPT 
Pulse dampener out 1/8" NPT to 3/16‘’ tube  
Flow splitter inlet 3/16’’ tube end to 1/4" NPT 
Flow splitter outlet 3/16’’ tube end  to 1/8" NPT 
Flow meter 1/8" NPT 
Petri dish inlet/interior Luer Lock 3/16’’ tube end 





 Petri dish inlet/outlet/interior tube 3/16’’ 
Vascular network inlet/outlet 2.2 mm into standard Luer Lock 
Stopcock (all) standard Luer Lock 
Reservoir I inlet 5 mm  
Reservoir II inlet Glass rod fitting 3/16‘’ tube 
Reservoir I outlet Glass rod fitting 3/16‘’ tube 
Reservoir II outlet Glass rod fitting 3/16‘’ tube 
 
A. Getting Started: Testing the System 
1. No sterilization is needed. 
2. Assemble the components in the incubator based on Figure 1. The follow meter 
should be connected to the system. 
3. The Modified Petri Dishes should have a tube connecting the luer lock ends (as a 
place holder for the vascular networks).   
4. Load 500-900 ml of water into reservoir 1. 
5. Turn on pump at arbitrary setting (ml/min). 
6. Monitor the flow meter readings. Determine the pump speed needed to have a 4 
g/s reading at the flow meter. 
7. Once the pump speed is determined, place the flow meter at each manifold tube 
outlet to ensure speed is the same at each outlet (that will be connected to a Petri 
dish). 
8. Record how long it takes for the water to reach the flow meter. 
9. Alternatively, the permeability chamber set-up can be used to measure flowrate. 
 
B. Getting Started: Sterilization 
 
Ethylene Oxide Sterilization (1 week before study) 
1. Ethylene oxide the pulse dampener. Allow to air out in the hood for 2-3 days 
before using with cells. 
 
Sterilize Supplies (2 days before study) 
2. Autoclave or ethylene oxide all supplies. 
3. Decontaminate the incubator. 
4. Sterile the stir plates with 70% ethanol. Place stir plates in the incubator. The stir 
plate cords should be run through the hole in the back of the incubator and 
plugged into a power source. 
5. Cut up plenty of parafilm strips and soak them in a 70% ethanol bath in a large 
Petri dish. Allow to dry for 24 hours in hood. 
 
Vascular Network and Scaffold Sterilization (2 days before study) 
6. Soak scaffolds and vascular network/holders in 70% ethanol for 24 hours. 




8. Allow to dry for 24 hours in hood. 
 
C. Getting Started: Bioreactor Study Day 0 
1. Seed cells onto the scaffold at an appropriate density. (See ‘Seeding Protocol’) 
2. Incubate the scaffolds in EC media (2ml) in a ‘Low Attachment’ well plate for 
24-48 hours (or longer, as desired).  
 
D. Getting Started: Bioreactor Study Day 1 
 
Caution:  
1. Wash your hands with soap before begin the assembly.  
2. Next, change gloves every 30 minutes.  
3. Every time the hands are out of the hood, clean your gloves with ethanol before 
placing your hands in the hood. 
4. If you touch an unsterile item with your gloves outside of the hood, CHANGE 
your gloves 
5. Manipulate sterile elements in the center of the hood; always avoid manipulating 
close to the aeration grid. 
6. Do not handle above other sterile elements.   
 
In the hood 
1. Disinfect the hood before using it with 70% ethanol. 
2. Bring incubator shelf into the hood.  Do all assembly of parts on the shelf (for 
easy transfer of shelf to incubator). Tape components to the shelf as needed based 
on the Figure 1. 
3. Define a place for waste in the hood. 
4. Insert the clamps around silicone tubing (see the figure 1). 
5. Place the filters and the luer lock couplings at the end of the tubes and connect it 
to the media storage bottles and to the pulse dampener. 
6. Place small magnetic stirrer in pulse dampener. 
7. Place the connectors and the three-way luer lock stopcocks and install the tubes. 
8. Place 2 male luer lock couplings at the ends of silicone tubings to connect them 
with the female luer lock couplings of the Petri Dish. 
9. Attach 3 filters with tubing to the rubber stoppers. 
10. Check that all the system components are closed and well-fixed. 
11. The Modified Petri Dishes should have a tube connecting the luer lock ends (as a 
place holder for the vascular networks).   
12. Put 900 ml of 70% ethanol into the media storage bottles.  
13. Connect the silicone tubing to the pump and cycle the ethanol through the system 
for 30 minutes. (Some of the tube will have to hang outside the hood. Place pump 
on table/chair.) 
14. Turn off the pump. Empty the ethanol from the storage bottles by pipetting or 
aspirating . 
15. Wipe cord that was outside the incubator with 70% ethanol. 




17. Pre-soak scaffolds in media in closed well plate. 
18. Put 900 ml of sterilized water into the media storage bottles.  
19. Connect the silicone tubing to the pump and cycle the water through the system 
for 30 minutes. (Some of the tube will have to hang outside the hood. Place pump 
on table/chair.) 
20. Turn off the pump. Empty the water from the storage bottles by pipetting or 
aspirating. 
21. Wipe cord that was outside the incubator with 70% ethanol. 
22. Put 900 ml of PBS into the media storage bottles.  
23. Connect the silicone tubing to the pump and cycle the PBS through the system for 
30 minutes. (Some of the tube will have to hang outside the hood. Place pump on 
table/chair.) 
24. Turn off the pump. Empty the PBS from the storage bottles by pipetting or 
aspirating. 
25. Wipe cord that was outside the incubator with 70% ethanol. 
26. Put 900 ml of media into the media storage bottles. Place magnetic stir bar in each 
media bottle. 
27. Close the bottles with the rubber stoppers. 
28. Connect the silicone tubing to the pump and run the media through the system 
until it reaches Point I. (Some of the tube will have to hang outside the hood. 
Place pump on table/chair.) 
29. Turn the pump off. Clamp the tubing at Point 1. 
30. Pre-fill networks as much as possible with media using a syringe and closing off 
an end of the network with a luer lock cap. 
31. Carefully (so as to not disturb cells), place the scaffolds (retrieve from the 
incubator) in the network. 
32. Use the cautery to seal the circumference of the holder at the two connection 
points. 
33. Position the vascular network in the Modified Petri Dish using the male luer lock 
couplings at the extremities of the dish. 
34. Aspirate any media that falls onto the dish. 
35. Transfer the system to the incubator (May require 2-3 people). 
36. Place the pulse dampener, and reservoir 1 and 2 on top of stir plates.  
37. Connect the silicone tubing to the pump through the hole in the back of the 
incubator. Chose the value of the flow and turn on the pump. 
38. Close the incubator hole with the rubber stopper or autoclaved gauze. 
39. Open the clamp to the petri dish (Point 1 on the Figure 1). 
40. Turn on pump a low speed and slowly ramp up to the pre-determined speed (ramp 
over 5 minutes, with 5 intervals). 
 
 
Figure F.4 (A) Sealed vascular network. (B) Operating bioreactor positioned within incubator. 
 
Daily Operation During Study 
1. Run bioreactor for 10 days. 
2. Each day, spray 70% ethanol on tubing and connections in the incubator (and 




3. Monitor bioreactor twice a day (early morning and late afternoon) 
 
Monitoring Media pH 
1) Attach a 5ml syringe to the capped tubing at the top of the rubber stopper on the 
media bottle. 
2) Close the tubing with cap once the task is completed. 
3) Measure the pH with a pH strip. Record the value. The value of the pH in the 
medium bottle should be 7.5 ± 0.5. 
 
Changing the Media and Dampener 
There will be no need to change the media for a culture study less than 10 days, if 
500+ ml of media used at the start.  
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